data_1diu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1diu _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.83 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.01 102.21 11.22 Favored 'General case' 0 N--CA 1.517 2.914 1 C-N-CA 131.892 4.077 . . . . 0.0 104.994 -172.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.266 1.5 p90 -149.13 170.61 18.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.31 132.76 32.11 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.205 173.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.35 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.49 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.643 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.8 t70 -68.88 -28.11 66.4 Favored 'General case' 0 N--CA 1.484 1.251 1 O-C-N 113.913 -5.492 . . . . 0.0 115.502 -178.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -84.13 -20.93 31.67 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 166.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 . . . . . 0 N--CA 1.497 1.878 0 CA-C-N 120.643 1.565 . . . . 0.0 113.347 155.677 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.8 p . . . . . 0 CA--C 1.557 1.238 0 CA-C-O 115.969 -1.967 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 m -67.75 117.61 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.407 0 CA-C-N 125.257 3.662 . . . . 0.0 104.876 165.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.9 -6.13 66.8 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.231 4.56 . . . . 0.0 121.626 177.612 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.74 73.69 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.3 -7.57 56.22 Favored 'General case' 0 N--CA 1.493 1.687 1 O-C-N 114.37 -5.206 . . . . 0.0 117.66 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -67.22 130.45 93.63 Favored Pre-proline 0 CA--C 1.576 1.951 0 CA-C-N 121.495 1.952 . . . . 0.0 109.94 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.06 -53.29 7.01 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.632 2.888 . . . . 0.0 117.088 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.62 133.47 35.08 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.097 0.559 . . . . 0.0 110.367 167.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -133.65 98.14 15.17 Favored Pre-proline 0 N--CA 1.488 1.431 0 CA-C-O 116.069 -1.92 . . . . 0.0 109.993 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.63 152.25 86.19 Favored 'Cis proline' 0 CA--C 1.557 1.666 0 CA-C-N 123.27 2.203 . . . . 0.0 114.67 2.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.87 136.19 94.41 Favored Pre-proline 0 N--CA 1.493 1.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.019 157.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.98 166.25 5.75 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.657 4.905 . . . . 0.0 119.323 -162.155 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.643 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.29 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.8 tp -109.41 102.88 11.74 Favored 'General case' 0 N--CA 1.514 2.733 1 C-N-CA 131.753 4.021 . . . . 0.0 105.077 -172.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.262 1.6 p90 -149.72 170.54 18.47 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.8 132.75 33.1 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.076 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.47 154.33 45.48 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.12 23.46 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.692 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 32.4 t70 -71.39 -31.7 67.59 Favored 'General case' 0 N--CA 1.485 1.32 1 O-C-N 113.977 -5.452 . . . . 0.0 115.407 -175.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.64 -29.36 56.42 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 . . . . . 0 CA--C 1.569 1.691 0 CA-C-N 120.356 1.435 . . . . 0.0 114.173 162.656 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 114.242 -2.79 . . . . 0.0 115.721 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.75 103.6 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.147 0 CA-C-N 125.37 3.714 . . . . 0.0 106.149 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.21 -6.13 39.35 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.848 3.931 . . . . 0.0 121.626 -169.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.16 73.01 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -77.77 -7.09 56.09 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.404 -5.185 . . . . 0.0 117.715 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.49 130.67 93.24 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 121.652 2.024 . . . . 0.0 109.876 166.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.94 -52.92 7.73 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.621 2.88 . . . . 0.0 117.138 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.96 133.7 35.06 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.135 0.574 . . . . 0.0 110.345 166.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -133.45 98.25 15.35 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-O 116.064 -1.922 . . . . 0.0 110.01 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.41 152.33 87.11 Favored 'Cis proline' 0 CA--C 1.557 1.645 0 CA-C-N 123.276 2.206 . . . . 0.0 114.652 2.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.263 0.2 OUTLIER -67.62 137.0 92.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-O 121.258 0.551 . . . . 0.0 110.017 157.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.11 166.25 5.62 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.879 5.053 . . . . 0.0 119.323 -161.602 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.692 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.1 101.38 10.43 Favored 'General case' 0 N--CA 1.518 2.934 1 C-N-CA 131.995 4.118 . . . . 0.0 105.039 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.272 1.4 p90 -148.83 170.39 18.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.96 32.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.922 1.289 . . . . 0.0 109.25 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.0 154.33 44.93 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.24 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.654 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 36.4 t70 -70.02 -29.3 66.32 Favored 'General case' 0 N--CA 1.486 1.341 1 O-C-N 113.65 -5.656 . . . . 0.0 115.665 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.09 -24.6 32.6 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 . . . . . 0 N--CA 1.494 1.75 0 CA-C-N 120.709 1.595 . . . . 0.0 113.851 157.192 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 p . . . . . 0 CA--C 1.56 1.348 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.09 133.3 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.162 0 CA-C-O 114.644 -2.598 . . . . 0.0 104.494 143.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.26 -6.13 82.53 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.169 4.077 . . . . 0.0 121.626 168.19 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.8 -6.98 57.37 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.824 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -67.49 128.28 93.57 Favored Pre-proline 0 CA--C 1.577 1.989 0 CA-C-N 121.82 2.1 . . . . 0.0 109.677 167.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.51 -52.18 9.47 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.675 2.916 . . . . 0.0 117.255 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.7 131.63 36.28 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.073 0.549 . . . . 0.0 110.07 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -130.03 99.26 20.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 115.996 -1.954 . . . . 0.0 109.939 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -79.63 156.68 89.37 Favored 'Cis proline' 0 CA--C 1.559 1.762 0 CA-C-N 123.308 2.217 . . . . 0.0 114.981 2.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.284 0.1 OUTLIER -68.62 130.55 91.86 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 157.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.01 166.25 16.86 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.761 5.641 . . . . 0.0 119.323 -165.484 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.654 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.39 53.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.37 104.0 13.03 Favored 'General case' 0 N--CA 1.513 2.712 1 C-N-CA 131.726 4.01 . . . . 0.0 105.028 -172.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.257 1.7 p90 -150.74 170.77 18.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.75 132.64 33.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.065 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.26 154.33 45.7 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.45 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.671 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 34.9 t70 -69.11 -28.33 66.38 Favored 'General case' 0 N--CA 1.484 1.245 1 O-C-N 113.996 -5.44 . . . . 0.0 115.527 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.8 -17.85 46.13 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 165.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 N--CA 1.493 1.716 0 CA-C-N 120.249 1.386 . . . . 0.0 113.284 157.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 113.727 -3.035 . . . . 0.0 115.244 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.73 104.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 125.534 3.788 . . . . 0.0 106.777 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 -6.13 48.49 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.207 3.639 . . . . 0.0 121.626 -168.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -76.98 -8.18 56.93 Favored 'General case' 0 N--CA 1.492 1.671 1 O-C-N 114.36 -5.212 . . . . 0.0 117.733 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -67.39 131.04 93.29 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 121.503 1.956 . . . . 0.0 109.984 167.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.96 -52.95 7.67 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.58 2.854 . . . . 0.0 117.138 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.12 134.18 34.74 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.169 0.588 . . . . 0.0 110.365 167.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.6 mtm105 -134.63 97.91 13.89 Favored Pre-proline 0 N--CA 1.488 1.443 0 CA-C-O 116.044 -1.931 . . . . 0.0 109.963 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.49 150.73 84.77 Favored 'Cis proline' 0 CA--C 1.556 1.597 0 CA-C-N 123.253 2.198 . . . . 0.0 114.502 2.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.261 0.2 OUTLIER -67.83 137.94 92.79 Favored Pre-proline 0 N--CA 1.492 1.667 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 158.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.28 166.25 4.48 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.715 4.943 . . . . 0.0 119.323 -160.033 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.671 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.92 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tp -108.42 101.97 11.1 Favored 'General case' 0 N--CA 1.515 2.811 1 C-N-CA 131.788 4.035 . . . . 0.0 104.957 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.284 1.4 p90 -148.63 169.92 19.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 132.43 31.09 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.995 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.11 154.33 44.81 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.99 23.79 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 38.8 t70 -71.88 -22.44 61.51 Favored 'General case' 0 N--CA 1.487 1.408 1 O-C-N 113.455 -5.778 . . . . 0.0 115.999 177.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.72 -26.06 20.86 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 125.6 1.56 . . . . 0.0 114.821 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 . . . . . 0 CA--C 1.568 1.635 0 CA-C-N 119.574 1.079 . . . . 0.0 113.901 154.296 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.3 p . . . . . 0 CA--C 1.555 1.155 0 CA-C-O 114.627 -2.606 . . . . 0.0 116.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.275 0.9 OUTLIER -63.12 113.91 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 125.778 3.899 . . . . 0.0 106.012 169.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.78 -6.13 58.57 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.764 3.893 . . . . 0.0 121.626 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.87 71.58 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.0 p -79.68 -5.27 54.82 Favored 'General case' 0 N--CA 1.493 1.719 1 O-C-N 114.303 -5.248 . . . . 0.0 117.882 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.8 129.91 93.13 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-N 122.025 2.193 . . . . 0.0 109.876 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.77 -52.41 9.04 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 123.58 2.854 . . . . 0.0 117.322 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -91.69 134.82 34.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.092 0.557 . . . . 0.0 110.277 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -132.83 98.34 16.2 Favored Pre-proline 0 N--CA 1.488 1.453 0 CA-C-O 116.095 -1.907 . . . . 0.0 110.217 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.01 153.12 89.62 Favored 'Cis proline' 0 CA--C 1.557 1.632 0 CA-C-N 123.182 2.172 . . . . 0.0 114.686 1.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 137.86 96.62 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.236 0.541 . . . . 0.0 109.935 156.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.65 166.25 4.11 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.371 4.714 . . . . 0.0 119.323 -164.031 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.479 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.03 54.06 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 tp -108.49 102.32 11.42 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 131.677 3.991 . . . . 0.0 104.84 -172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.281 1.5 p90 -148.61 169.81 19.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.54 32.46 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.983 173.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.91 154.33 45.03 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.91 23.23 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.708 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 32.9 t70 -68.31 -27.77 66.58 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.835 -5.54 . . . . 0.0 115.844 -176.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.39 -23.72 34.81 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 166.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 . . . . . 0 N--CA 1.497 1.883 0 CA-C-N 120.855 1.661 . . . . 0.0 114.005 156.847 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 114.164 -2.826 . . . . 0.0 115.874 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 m -64.99 103.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 1 CA-C-O 111.52 -4.086 . . . . 0.0 106.901 -170.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.41 -6.13 45.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.17 4.532 . . . . 0.0 121.626 -167.776 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.18 71.87 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -79.3 -5.66 54.94 Favored 'General case' 0 N--CA 1.494 1.755 1 O-C-N 114.332 -5.23 . . . . 0.0 117.866 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.71 129.94 93.21 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 121.964 2.165 . . . . 0.0 109.791 167.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.42 -52.63 8.47 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 C-N-CA 123.637 2.891 . . . . 0.0 117.18 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.68 132.4 36.39 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.022 0.529 . . . . 0.0 110.099 165.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -130.36 99.47 19.27 Favored Pre-proline 0 N--CA 1.488 1.459 0 CA-C-O 115.987 -1.958 . . . . 0.0 110.045 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.12 155.95 91.15 Favored 'Cis proline' 0 CA--C 1.559 1.749 0 CA-C-N 123.323 2.223 . . . . 0.0 114.877 2.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.292 0.1 OUTLIER -69.3 131.58 90.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 121.377 0.608 . . . . 0.0 109.474 157.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.5 166.25 15.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.008 5.806 . . . . 0.0 119.323 -164.518 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.708 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.95 100.52 9.71 Favored 'General case' 0 N--CA 1.517 2.903 1 C-N-CA 132.079 4.152 . . . . 0.0 104.999 -171.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.283 1.3 p90 -147.96 170.03 18.6 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 133.04 32.04 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.189 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.28 154.33 44.63 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.33 23.7 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.651 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 36.3 t70 -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.487 1.404 1 O-C-N 113.473 -5.767 . . . . 0.0 115.747 -177.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.24 -21.84 33.25 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 N--CA 1.491 1.623 0 CA-C-N 119.892 1.224 . . . . 0.0 113.333 158.092 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 CA--C 1.561 1.378 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.87 136.63 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 137.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.35 -6.13 80.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.694 3.861 . . . . 0.0 121.626 165.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.9 71.6 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.71 -6.05 56.43 Favored 'General case' 0 N--CA 1.493 1.685 1 O-C-N 114.32 -5.238 . . . . 0.0 117.98 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -67.62 129.18 93.54 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 122.018 2.19 . . . . 0.0 109.663 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.13 -52.14 9.59 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.656 2.904 . . . . 0.0 117.344 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.12 133.43 35.35 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.047 0.539 . . . . 0.0 110.155 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -131.5 98.7 17.94 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-O 115.982 -1.961 . . . . 0.0 110.072 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 154.61 89.57 Favored 'Cis proline' 0 CA--C 1.559 1.748 0 CA-C-N 123.274 2.205 . . . . 0.0 114.768 2.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.281 0.1 OUTLIER -68.06 133.95 91.75 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-O 121.346 0.593 . . . . 0.0 109.663 157.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.48 166.25 10.59 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.684 5.589 . . . . 0.0 119.323 -163.715 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.651 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.8 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 tp -108.71 102.13 11.21 Favored 'General case' 0 N--CA 1.516 2.828 1 C-N-CA 131.813 4.045 . . . . 0.0 104.955 -172.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.272 1.5 p90 -148.77 170.32 18.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.09 132.85 32.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.185 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.82 154.33 45.12 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.21 23.44 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.685 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.2 t70 -68.65 -29.51 68.0 Favored 'General case' 0 N--CA 1.486 1.328 1 O-C-N 113.705 -5.622 . . . . 0.0 115.589 -177.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.69 -24.69 36.07 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 . . . . . 0 N--CA 1.496 1.848 0 CA-C-N 120.887 1.676 . . . . 0.0 113.872 157.471 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.3 p . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 114.878 -2.487 . . . . 0.0 114.921 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.51 117.24 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 CA-C-N 125.743 3.883 . . . . 0.0 105.592 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.13 68.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.958 4.436 . . . . 0.0 121.626 179.382 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.28 71.99 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.78 -7.5 57.87 Favored 'General case' 0 N--CA 1.493 1.699 1 O-C-N 114.305 -5.247 . . . . 0.0 117.924 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -67.27 130.12 93.64 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-N 121.872 2.124 . . . . 0.0 109.893 167.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.57 -52.73 8.22 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.671 2.914 . . . . 0.0 117.168 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.46 132.53 36.18 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.105 0.562 . . . . 0.0 110.201 166.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -131.57 99.31 17.25 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 115.982 -1.961 . . . . 0.0 109.947 -172.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.28 154.6 89.91 Favored 'Cis proline' 0 CA--C 1.559 1.745 0 CA-C-N 123.356 2.234 . . . . 0.0 114.799 2.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.283 0.2 OUTLIER -69.33 129.95 91.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 158.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -81.56 166.25 17.8 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.225 5.95 . . . . 0.0 119.323 -163.359 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.2 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.685 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.82 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tp -108.73 100.15 9.42 Favored 'General case' 0 N--CA 1.517 2.925 1 C-N-CA 131.974 4.11 . . . . 0.0 104.938 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.293 1.2 p90 -147.4 169.65 19.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.89 132.62 30.72 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.161 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.4 154.33 44.52 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.42 23.35 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.4 t70 -72.79 -25.37 61.14 Favored 'General case' 0 N--CA 1.486 1.353 1 O-C-N 113.46 -5.775 . . . . 0.0 115.815 178.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt -85.89 -26.84 25.39 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 . . . . . 0 N--CA 1.491 1.617 0 CA-C-N 119.626 1.103 . . . . 0.0 113.869 158.735 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 CA--C 1.561 1.378 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.36 139.43 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 CA-C-O 115.39 -2.243 . . . . 0.0 105.204 135.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 -6.13 82.09 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.626 3.83 . . . . 0.0 121.626 165.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.29 73.17 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.24 -5.63 52.5 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.362 -5.211 . . . . 0.0 117.697 173.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -67.46 129.93 93.47 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-N 121.568 1.986 . . . . 0.0 109.932 166.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.6 -52.9 7.83 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.653 2.902 . . . . 0.0 117.141 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.21 134.11 34.82 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.12 0.568 . . . . 0.0 110.24 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -132.91 98.21 16.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 116.046 -1.93 . . . . 0.0 110.106 -172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.38 152.87 87.87 Favored 'Cis proline' 0 CA--C 1.558 1.679 0 CA-C-N 123.27 2.203 . . . . 0.0 114.723 2.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.433 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -65.06 137.54 97.11 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.124 0.488 . . . . 0.0 109.993 156.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.79 166.25 3.98 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.117 4.545 . . . . 0.0 119.323 -164.011 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.35 54.0 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 tp -109.33 104.2 13.28 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 131.668 3.987 . . . . 0.0 105.051 -172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.251 1.7 p90 -150.79 170.85 18.26 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.5 132.79 33.78 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.88 1.272 . . . . 0.0 109.124 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.16 154.33 45.8 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.83 23.55 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.618 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.4 t70 -69.59 -26.2 64.35 Favored 'General case' 0 N--CA 1.481 1.11 1 O-C-N 114.193 -5.317 . . . . 0.0 115.451 -179.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.2 -17.54 36.82 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 166.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 . . . . . 0 N--CA 1.495 1.78 0 CA-C-N 120.32 1.418 . . . . 0.0 113.037 155.492 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 113.469 -3.158 . . . . 0.0 115.411 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.253 2.7 m -61.24 107.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 125.886 3.948 . . . . 0.0 107.024 -173.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.88 -6.13 54.15 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.28 74.54 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.5 p -76.4 -7.48 55.13 Favored 'General case' 0 N--CA 1.492 1.657 1 O-C-N 114.427 -5.171 . . . . 0.0 117.576 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.42 131.67 93.17 Favored Pre-proline 0 CA--C 1.576 1.976 0 CA-C-N 121.33 1.877 . . . . 0.0 109.998 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -53.31 6.82 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.601 2.867 . . . . 0.0 117.034 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.15 134.11 34.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.169 0.587 . . . . 0.0 110.397 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 mtm105 -134.83 97.8 13.69 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.068 -1.92 . . . . 0.0 109.982 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.46 150.64 84.72 Favored 'Cis proline' 0 CA--C 1.557 1.643 0 CA-C-N 123.282 2.208 . . . . 0.0 114.499 2.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -67.67 138.72 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 158.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -91.07 166.25 3.73 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.557 4.838 . . . . 0.0 119.323 -159.988 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.618 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tp -108.26 101.41 10.62 Favored 'General case' 0 N--CA 1.515 2.788 1 C-N-CA 131.767 4.027 . . . . 0.0 104.878 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.291 1.3 p90 -147.83 169.7 19.23 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.48 132.58 31.5 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.035 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.3 23.71 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 38.6 t70 -72.61 -24.49 61.08 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.567 -5.708 . . . . 0.0 115.796 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.2 -27.11 26.34 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 . . . . . 0 CA--C 1.567 1.634 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 158.776 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 114.374 -2.727 . . . . 0.0 116.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.282 1.9 m -61.98 111.37 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-N 125.757 3.889 . . . . 0.0 106.528 173.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.69 -6.13 54.68 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.059 3.572 . . . . 0.0 121.626 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.69 72.47 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.34 -7.55 57.41 Favored 'General case' 0 N--CA 1.494 1.75 1 O-C-N 114.307 -5.246 . . . . 0.0 117.824 173.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.2 130.42 93.66 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 121.714 2.052 . . . . 0.0 110.1 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.34 -53.07 7.54 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.595 2.863 . . . . 0.0 117.222 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.72 134.52 34.65 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.109 0.564 . . . . 0.0 110.345 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -134.12 98.61 14.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 116.043 -1.932 . . . . 0.0 110.03 -171.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.27 151.15 86.27 Favored 'Cis proline' 0 CA--C 1.558 1.703 0 CA-C-N 123.227 2.188 . . . . 0.0 114.682 2.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.432 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.13 132.24 94.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 158.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.4 166.25 9.27 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.091 5.194 . . . . 0.0 119.323 -162.493 . . . . . . . . 5 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.5 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.514 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.64 100.05 9.34 Favored 'General case' 0 N--CA 1.517 2.888 1 C-N-CA 131.936 4.094 . . . . 0.0 104.889 -171.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.295 1.2 p90 -147.01 169.63 18.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.77 132.71 31.1 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.337 -1.302 . . . . 0.0 109.144 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.44 154.33 44.47 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.43 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 38.7 t70 -73.21 -25.37 60.72 Favored 'General case' 0 N--CA 1.486 1.373 1 O-C-N 113.588 -5.695 . . . . 0.0 115.826 178.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.84 -31.76 23.64 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 171.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 158.134 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p . . . . . 0 CA--C 1.561 1.385 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.29 133.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 CA-C-O 115.23 -2.319 . . . . 0.0 104.866 143.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.16 -6.13 83.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.356 3.707 . . . . 0.0 121.626 168.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.93 -6.04 53.09 Favored 'General case' 0 N--CA 1.493 1.714 1 O-C-N 114.36 -5.212 . . . . 0.0 117.718 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.43 130.0 93.48 Favored Pre-proline 0 CA--C 1.574 1.9 0 CA-C-N 121.454 1.934 . . . . 0.0 110.021 167.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.58 -53.13 7.39 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.606 2.871 . . . . 0.0 117.148 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.21 134.05 34.87 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.078 0.551 . . . . 0.0 110.305 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -133.24 98.35 15.56 Favored Pre-proline 0 N--CA 1.488 1.427 0 CA-C-O 116.068 -1.92 . . . . 0.0 110.091 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.5 152.42 86.9 Favored 'Cis proline' 0 CA--C 1.558 1.704 0 CA-C-N 123.223 2.187 . . . . 0.0 114.785 2.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.466 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -64.51 135.21 96.26 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.86 156.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.43 166.25 5.31 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.314 4.676 . . . . 0.0 119.323 -164.281 . . . . . . . . 5 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.492 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.96 54.07 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 tp -108.54 100.4 9.67 Favored 'General case' 0 N--CA 1.513 2.705 0 C-N-CA 131.698 3.999 . . . . 0.0 104.934 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.3 1.3 p90 -146.66 169.3 19.29 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.26 31.03 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.023 173.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.3 154.33 44.62 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 38.5 t70 -72.32 -25.12 61.44 Favored 'General case' 0 N--CA 1.487 1.392 1 O-C-N 113.626 -5.671 . . . . 0.0 115.745 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -83.09 -33.72 26.3 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.099 1.36 . . . . 0.0 113.87 169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 158.791 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 m -66.82 102.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 CA-C-O 112.691 -3.528 . . . . 0.0 105.878 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.13 35.95 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.03 4.013 . . . . 0.0 121.626 -171.243 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.26 73.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.3 p -79.1 -4.21 49.2 Favored 'General case' 0 N--CA 1.494 1.742 1 O-C-N 114.415 -5.178 . . . . 0.0 117.696 172.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -67.25 129.1 93.86 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-N 121.562 1.983 . . . . 0.0 109.852 166.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -52.77 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.639 2.893 . . . . 0.0 117.176 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.73 133.87 35.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.13 0.572 . . . . 0.0 110.138 165.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -130.84 98.58 19.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 116.028 -1.939 . . . . 0.0 110.172 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -79.22 155.46 90.62 Favored 'Cis proline' 0 CA--C 1.558 1.688 0 CA-C-N 123.34 2.229 . . . . 0.0 114.753 1.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -68.66 136.18 90.38 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.529 0.68 . . . . 0.0 109.759 157.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.75 166.25 8.77 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.487 5.458 . . . . 0.0 119.323 -163.908 . . . . . . . . 5 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.554 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.27 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tp -109.0 102.92 11.87 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 131.678 3.991 . . . . 0.0 104.949 -172.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.269 1.6 p90 -149.4 170.19 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.72 132.62 33.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.058 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.34 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.88 23.24 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.7 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 22.2 t70 -68.6 -29.11 67.55 Favored 'General case' 0 N--CA 1.486 1.345 1 O-C-N 113.929 -5.482 . . . . 0.0 115.599 -176.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.93 -23.16 41.93 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 . . . . . 0 N--CA 1.494 1.77 0 CA-C-N 120.75 1.614 . . . . 0.0 113.993 158.832 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 113.529 -3.129 . . . . 0.0 115.495 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.71 105.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 125.777 3.899 . . . . 0.0 107.246 -171.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.96 -6.13 51.14 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.889 3.949 . . . . 0.0 121.626 -169.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.42 72.15 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.58 -7.0 57.11 Favored 'General case' 0 N--CA 1.493 1.694 1 O-C-N 114.327 -5.233 . . . . 0.0 117.843 173.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.49 130.41 93.31 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-N 121.896 2.134 . . . . 0.0 109.848 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.36 -52.65 8.43 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.684 2.923 . . . . 0.0 117.177 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.45 133.78 35.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.097 0.559 . . . . 0.0 110.269 166.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -132.68 98.46 16.31 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-O 115.998 -1.954 . . . . 0.0 110.077 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.22 153.28 88.91 Favored 'Cis proline' 0 CA--C 1.557 1.663 0 CA-C-N 123.351 2.232 . . . . 0.0 114.62 2.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.281 0.2 OUTLIER -68.68 135.85 90.32 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-O 121.49 0.662 . . . . 0.0 109.839 158.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -87.13 166.25 8.24 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.416 5.411 . . . . 0.0 119.323 -162.012 . . . . . . . . 5 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.7 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 tp -108.51 101.79 10.93 Favored 'General case' 0 N--CA 1.516 2.847 1 C-N-CA 131.797 4.039 . . . . 0.0 104.856 -172.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.277 1.5 p90 -148.15 170.09 18.59 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.82 32.89 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.168 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.88 154.33 45.05 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.26 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.651 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 36.8 t70 -70.49 -29.89 66.55 Favored 'General case' 0 N--CA 1.484 1.261 1 O-C-N 113.843 -5.536 . . . . 0.0 115.454 -177.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.82 -23.0 36.73 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 165.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 . . . . . 0 N--CA 1.495 1.781 0 CA-C-N 120.025 1.284 . . . . 0.0 113.157 157.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 114.36 -2.733 . . . . 0.0 115.462 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.261 1.6 m -63.81 112.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-N 125.742 3.883 . . . . 0.0 105.703 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.13 59.34 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.279 3.672 . . . . 0.0 121.626 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.86 72.66 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.23 -7.26 56.92 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.345 -5.222 . . . . 0.0 117.797 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.27 130.19 93.63 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-N 121.708 2.049 . . . . 0.0 109.907 167.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.7 -52.84 7.95 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.607 2.871 . . . . 0.0 117.151 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 133.26 35.55 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.127 0.571 . . . . 0.0 110.253 166.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -132.58 98.75 16.21 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 116.05 -1.929 . . . . 0.0 110.031 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.28 153.61 89.0 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 CA-C-N 123.297 2.213 . . . . 0.0 114.75 2.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.263 0.1 OUTLIER -67.59 133.51 92.7 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-O 121.107 0.479 . . . . 0.0 109.778 158.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.87 166.25 10.04 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.196 5.264 . . . . 0.0 119.323 -163.246 . . . . . . . . 5 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.651 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.18 54.03 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 tp -108.82 102.85 11.84 Favored 'General case' 0 N--CA 1.512 2.663 1 C-N-CA 131.708 4.003 . . . . 0.0 104.876 -172.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.268 1.6 p90 -149.06 170.29 18.73 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.74 132.53 32.92 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.097 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.45 154.33 45.5 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.48 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.648 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 36.0 t70 -70.48 -29.77 66.39 Favored 'General case' 0 N--CA 1.483 1.224 1 O-C-N 114.226 -5.296 . . . . 0.0 115.281 -177.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -81.29 -18.12 46.95 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 165.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 . . . . . 0 CA--C 1.569 1.69 0 CA-C-N 119.789 1.177 . . . . 0.0 112.754 157.336 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 113.986 -2.912 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.26 103.4 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 125.45 3.75 . . . . 0.0 106.501 -169.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.22 -6.13 42.41 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.224 3.647 . . . . 0.0 121.626 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.07 74.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -77.04 -6.45 52.77 Favored 'General case' 0 N--CA 1.493 1.709 1 O-C-N 114.413 -5.18 . . . . 0.0 117.591 173.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.52 130.82 93.15 Favored Pre-proline 0 CA--C 1.576 1.948 0 CA-C-N 121.376 1.898 . . . . 0.0 109.899 166.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.32 -53.32 6.86 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 C-N-CA 123.627 2.885 . . . . 0.0 116.992 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.06 133.67 35.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.145 0.578 . . . . 0.0 110.312 167.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mtm105 -133.51 98.23 15.28 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-O 116.041 -1.933 . . . . 0.0 109.952 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.51 152.14 86.51 Favored 'Cis proline' 0 CA--C 1.556 1.62 0 CA-C-N 123.267 2.203 . . . . 0.0 114.594 2.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.276 0.1 OUTLIER -68.09 137.05 91.81 Favored Pre-proline 0 N--CA 1.493 1.71 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 158.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.92 166.25 5.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.974 5.116 . . . . 0.0 119.323 -161.045 . . . . . . . . 5 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.648 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.5 101.41 10.58 Favored 'General case' 0 N--CA 1.516 2.869 1 C-N-CA 131.818 4.047 . . . . 0.0 104.885 -172.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.284 1.4 p90 -147.92 169.92 18.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.33 132.58 31.79 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.08 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.04 154.33 44.89 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.667 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.7 t70 -69.58 -28.97 66.42 Favored 'General case' 0 N--CA 1.488 1.426 1 O-C-N 113.626 -5.671 . . . . 0.0 115.681 -177.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.22 -20.52 34.44 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 167.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 . . . . . 0 N--CA 1.494 1.73 0 CA-C-N 120.392 1.451 . . . . 0.0 113.348 157.406 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 CA--C 1.555 1.16 0 CA-C-O 115.124 -2.37 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 2.2 m -64.28 115.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-N 125.75 3.886 . . . . 0.0 105.903 168.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.08 -6.13 63.77 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.446 4.203 . . . . 0.0 121.626 179.588 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.92 -6.34 55.95 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.853 173.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.51 129.85 93.45 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 121.773 2.079 . . . . 0.0 109.799 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.48 -52.56 8.61 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 123.602 2.868 . . . . 0.0 117.221 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.25 133.5 35.34 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.037 0.535 . . . . 0.0 110.228 166.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.7 mtm105 -132.23 98.6 16.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.095 -172.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.36 154.06 89.08 Favored 'Cis proline' 0 CA--C 1.558 1.697 0 CA-C-N 123.282 2.208 . . . . 0.0 114.799 2.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.263 0.1 OUTLIER -66.72 134.45 94.22 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.173 0.511 . . . . 0.0 109.645 157.213 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.98 166.25 8.45 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.99 5.127 . . . . 0.0 119.323 -164.23 . . . . . . . . 5 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.667 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.07 54.05 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 tp -108.59 101.1 10.28 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 131.628 3.971 . . . . 0.0 104.828 -172.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.29 1.4 p90 -147.13 169.18 19.85 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.59 132.99 33.88 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.07 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.63 23.52 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.623 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.9 t70 -73.73 -29.88 62.5 Favored 'General case' 0 N--CA 1.483 1.22 1 O-C-N 113.933 -5.48 . . . . 0.0 115.525 -176.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 mp -82.48 -27.15 31.99 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 . . . . . 0 N--CA 1.494 1.765 0 CA-C-N 120.54 1.518 . . . . 0.0 114.088 158.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 113.936 -2.935 . . . . 0.0 115.739 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 2.4 m -62.61 108.33 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 125.848 3.931 . . . . 0.0 106.519 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.43 -6.13 49.31 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.36 71.2 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.4 -8.09 58.85 Favored 'General case' 0 N--CA 1.494 1.764 1 O-C-N 114.224 -5.298 . . . . 0.0 118.004 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -66.67 131.21 94.05 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-N 122.132 2.242 . . . . 0.0 110.233 168.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.9 -52.97 7.8 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.585 2.857 . . . . 0.0 117.259 176.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -92.49 135.11 34.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.119 0.567 . . . . 0.0 110.354 166.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -134.22 98.87 13.76 Favored Pre-proline 0 N--CA 1.488 1.466 0 CA-C-O 116.111 -1.9 . . . . 0.0 110.102 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.69 151.03 88.14 Favored 'Cis proline' 0 CA--C 1.557 1.662 0 CA-C-N 123.25 2.196 . . . . 0.0 114.566 2.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.259 0.1 OUTLIER -67.63 132.97 92.65 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.897 159.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.94 166.25 9.93 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.376 5.384 . . . . 0.0 119.323 -161.521 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.623 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.83 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.01 102.21 11.22 Favored 'General case' 0 N--CA 1.517 2.914 1 C-N-CA 131.892 4.077 . . . . 0.0 104.994 -172.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.771 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.266 1.5 p90 -149.13 170.61 18.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 178.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.31 132.76 32.11 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.205 173.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.35 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.49 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.643 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.8 t70 -68.88 -28.11 66.4 Favored 'General case' 0 N--CA 1.484 1.251 1 O-C-N 113.913 -5.492 . . . . 0.0 115.502 -178.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -84.13 -20.93 31.67 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 166.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 -60.3 -45.01 94.85 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 120.643 1.565 . . . . 0.0 113.347 155.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -73.8 -19.84 60.64 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 116.689 -1.624 . . . . 0.0 115.181 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -60.65 -56.57 19.73 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 122.463 2.392 . . . . 0.0 111.05 161.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.866 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 69.0 ttt180 -53.06 -36.08 60.23 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.03 -27.37 10.68 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -60.09 -15.72 25.68 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 120.977 1.717 . . . . 0.0 115.123 154.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.8 p -125.54 27.33 6.54 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 115.969 -1.967 . . . . 0.0 114.196 161.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 m -67.75 117.61 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.407 0 CA-C-N 125.257 3.662 . . . . 0.0 104.876 165.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.9 -6.13 66.8 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.231 4.56 . . . . 0.0 121.626 177.612 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.74 73.69 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.3 -7.57 56.22 Favored 'General case' 0 N--CA 1.493 1.687 1 O-C-N 114.37 -5.206 . . . . 0.0 117.66 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -67.22 130.45 93.63 Favored Pre-proline 0 CA--C 1.576 1.951 0 CA-C-N 121.495 1.952 . . . . 0.0 109.94 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.732 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.3 Cg_exo -53.06 -53.29 7.01 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.632 2.888 . . . . 0.0 117.088 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.62 133.47 35.08 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.097 0.559 . . . . 0.0 110.367 167.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -133.65 98.14 15.17 Favored Pre-proline 0 N--CA 1.488 1.431 0 CA-C-O 116.069 -1.92 . . . . 0.0 109.993 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.63 152.25 86.19 Favored 'Cis proline' 0 CA--C 1.557 1.666 0 CA-C-N 123.27 2.203 . . . . 0.0 114.67 2.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.87 136.19 94.41 Favored Pre-proline 0 N--CA 1.493 1.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.019 157.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.98 166.25 5.75 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.657 4.905 . . . . 0.0 119.323 -162.155 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.866 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 12.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.643 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.771 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.29 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.8 tp -109.41 102.88 11.74 Favored 'General case' 0 N--CA 1.514 2.733 1 C-N-CA 131.753 4.021 . . . . 0.0 105.077 -172.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.758 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.262 1.6 p90 -149.72 170.54 18.47 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 178.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.8 132.75 33.1 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.076 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.47 154.33 45.48 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.12 23.46 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.692 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 32.4 t70 -71.39 -31.7 67.59 Favored 'General case' 0 N--CA 1.485 1.32 1 O-C-N 113.977 -5.452 . . . . 0.0 115.407 -175.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.64 -29.36 56.42 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -66.98 -34.02 76.85 Favored 'General case' 0 CA--C 1.569 1.691 0 CA-C-N 120.356 1.435 . . . . 0.0 114.173 162.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -74.02 -26.15 60.27 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 116.64 -1.648 . . . . 0.0 114.724 163.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -54.28 -54.51 39.25 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 122.571 2.441 . . . . 0.0 111.646 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.999 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 57.2 ttt85 -48.1 -59.8 3.11 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.7 -24.48 25.18 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 -171.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -60.37 -14.69 20.06 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 155.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.0 p -118.45 3.5 11.84 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 114.242 -2.79 . . . . 0.0 115.721 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.75 103.6 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.147 0 CA-C-N 125.37 3.714 . . . . 0.0 106.149 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.21 -6.13 39.35 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.848 3.931 . . . . 0.0 121.626 -169.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.16 73.01 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -77.77 -7.09 56.09 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.404 -5.185 . . . . 0.0 117.715 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.49 130.67 93.24 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 121.652 2.024 . . . . 0.0 109.876 166.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.711 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.9 Cg_exo -52.94 -52.92 7.73 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.621 2.88 . . . . 0.0 117.138 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.96 133.7 35.06 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.135 0.574 . . . . 0.0 110.345 166.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -133.45 98.25 15.35 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-O 116.064 -1.922 . . . . 0.0 110.01 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.41 152.33 87.11 Favored 'Cis proline' 0 CA--C 1.557 1.645 0 CA-C-N 123.276 2.206 . . . . 0.0 114.652 2.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.263 0.2 OUTLIER -67.62 137.0 92.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-O 121.258 0.551 . . . . 0.0 110.017 157.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.11 166.25 5.62 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.879 5.053 . . . . 0.0 119.323 -161.602 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.999 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 9.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.692 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.758 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.1 101.38 10.43 Favored 'General case' 0 N--CA 1.518 2.934 1 C-N-CA 131.995 4.118 . . . . 0.0 105.039 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.741 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.272 1.4 p90 -148.83 170.39 18.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 179.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.96 32.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.922 1.289 . . . . 0.0 109.25 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.0 154.33 44.93 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.24 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.654 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 36.4 t70 -70.02 -29.3 66.32 Favored 'General case' 0 N--CA 1.486 1.341 1 O-C-N 113.65 -5.656 . . . . 0.0 115.665 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.09 -24.6 32.6 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.486 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 69.6 m-70 -59.86 -41.17 90.88 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 120.709 1.595 . . . . 0.0 113.851 157.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -74.27 -20.94 59.97 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 168.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.43 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 3.4 t80 -63.44 -52.44 61.47 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 122.533 2.424 . . . . 0.0 111.88 161.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 1.032 ' HA ' HH12 ' A' ' 57' ' ' ARG . 47.3 ttt85 -38.98 -42.66 0.89 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 171.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.67 -27.58 7.04 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -60.02 -20.69 59.19 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 121.168 1.804 . . . . 0.0 114.711 153.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 p -126.06 64.17 1.23 Allowed 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 119.29 0.95 . . . . 0.0 109.792 153.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.09 133.3 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.162 0 CA-C-O 114.644 -2.598 . . . . 0.0 104.494 143.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.26 -6.13 82.53 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.169 4.077 . . . . 0.0 121.626 168.19 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.8 -6.98 57.37 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.824 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -67.49 128.28 93.57 Favored Pre-proline 0 CA--C 1.577 1.989 0 CA-C-N 121.82 2.1 . . . . 0.0 109.677 167.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.63 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.2 Cg_exo -52.51 -52.18 9.47 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.675 2.916 . . . . 0.0 117.255 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.7 131.63 36.28 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.073 0.549 . . . . 0.0 110.07 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -130.03 99.26 20.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 115.996 -1.954 . . . . 0.0 109.939 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -79.63 156.68 89.37 Favored 'Cis proline' 0 CA--C 1.559 1.762 0 CA-C-N 123.308 2.217 . . . . 0.0 114.981 2.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.284 0.1 OUTLIER -68.62 130.55 91.86 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 157.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.01 166.25 16.86 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.761 5.641 . . . . 0.0 119.323 -165.484 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 1.032 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.654 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.741 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.39 53.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.37 104.0 13.03 Favored 'General case' 0 N--CA 1.513 2.712 1 C-N-CA 131.726 4.01 . . . . 0.0 105.028 -172.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.726 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.257 1.7 p90 -150.74 170.77 18.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.75 132.64 33.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.065 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.26 154.33 45.7 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.45 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.671 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 34.9 t70 -69.11 -28.33 66.38 Favored 'General case' 0 N--CA 1.484 1.245 1 O-C-N 113.996 -5.44 . . . . 0.0 115.527 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.8 -17.85 46.13 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 165.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.519 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 12.2 m-70 -67.55 -41.23 84.58 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.249 1.386 . . . . 0.0 113.284 157.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -72.3 -25.52 61.61 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 116.98 -1.486 . . . . 0.0 114.905 167.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -57.0 -52.23 66.07 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 122.117 2.235 . . . . 0.0 112.006 161.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.881 ' HA ' HH12 ' A' ' 57' ' ' ARG . 53.7 ttt85 -42.42 -64.05 0.66 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 170.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.35 -23.18 19.32 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 118.274 2.694 . . . . 0.0 118.274 -165.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -62.04 -6.22 2.77 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 154.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.2 p -122.63 -4.76 8.7 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 113.727 -3.035 . . . . 0.0 115.244 164.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.73 104.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 125.534 3.788 . . . . 0.0 106.777 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 -6.13 48.49 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.207 3.639 . . . . 0.0 121.626 -168.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -76.98 -8.18 56.93 Favored 'General case' 0 N--CA 1.492 1.671 1 O-C-N 114.36 -5.212 . . . . 0.0 117.733 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -67.39 131.04 93.29 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 121.503 1.956 . . . . 0.0 109.984 167.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.682 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.8 Cg_exo -52.96 -52.95 7.67 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.58 2.854 . . . . 0.0 117.138 175.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.12 134.18 34.74 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.169 0.588 . . . . 0.0 110.365 167.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.6 mtm105 -134.63 97.91 13.89 Favored Pre-proline 0 N--CA 1.488 1.443 0 CA-C-O 116.044 -1.931 . . . . 0.0 109.963 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.49 150.73 84.77 Favored 'Cis proline' 0 CA--C 1.556 1.597 0 CA-C-N 123.253 2.198 . . . . 0.0 114.502 2.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.261 0.2 OUTLIER -67.83 137.94 92.79 Favored Pre-proline 0 N--CA 1.492 1.667 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 158.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.28 166.25 4.48 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.715 4.943 . . . . 0.0 119.323 -160.033 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.881 HH12 ' HA ' ' A' ' 31' ' ' ARG . 5.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.671 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.726 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.92 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tp -108.42 101.97 11.1 Favored 'General case' 0 N--CA 1.515 2.811 1 C-N-CA 131.788 4.035 . . . . 0.0 104.957 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.715 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.284 1.4 p90 -148.63 169.92 19.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 178.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 132.43 31.09 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.995 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.11 154.33 44.81 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.99 23.79 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 38.8 t70 -71.88 -22.44 61.51 Favored 'General case' 0 N--CA 1.487 1.408 1 O-C-N 113.455 -5.778 . . . . 0.0 115.999 177.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.72 -26.06 20.86 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 125.6 1.56 . . . . 0.0 114.821 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -61.39 -45.34 94.78 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 119.574 1.079 . . . . 0.0 113.901 154.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -77.35 -24.1 50.75 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.487 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.2 t80 -56.88 -56.96 14.88 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 122.393 2.36 . . . . 0.0 111.351 161.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 1.008 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 66.7 ttt180 -46.9 -42.37 17.47 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.87 -18.9 13.91 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -56.25 -45.85 79.87 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 121.009 1.732 . . . . 0.0 112.171 152.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.3 p -94.18 16.82 13.85 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 114.627 -2.606 . . . . 0.0 116.17 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.275 0.9 OUTLIER -63.12 113.91 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 125.778 3.899 . . . . 0.0 106.012 169.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.78 -6.13 58.57 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.764 3.893 . . . . 0.0 121.626 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.87 71.58 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.0 p -79.68 -5.27 54.82 Favored 'General case' 0 N--CA 1.493 1.719 1 O-C-N 114.303 -5.248 . . . . 0.0 117.882 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.8 129.91 93.13 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-N 122.025 2.193 . . . . 0.0 109.876 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.597 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.3 Cg_exo -51.77 -52.41 9.04 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 123.58 2.854 . . . . 0.0 117.322 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -91.69 134.82 34.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.092 0.557 . . . . 0.0 110.277 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -132.83 98.34 16.2 Favored Pre-proline 0 N--CA 1.488 1.453 0 CA-C-O 116.095 -1.907 . . . . 0.0 110.217 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.01 153.12 89.62 Favored 'Cis proline' 0 CA--C 1.557 1.632 0 CA-C-N 123.182 2.172 . . . . 0.0 114.686 1.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 137.86 96.62 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.236 0.541 . . . . 0.0 109.935 156.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.65 166.25 4.11 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.371 4.714 . . . . 0.0 119.323 -164.031 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 1.008 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 6.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.479 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.715 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.03 54.06 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 tp -108.49 102.32 11.42 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 131.677 3.991 . . . . 0.0 104.84 -172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.75 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.281 1.5 p90 -148.61 169.81 19.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.54 32.46 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.983 173.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.91 154.33 45.03 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.91 23.23 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.708 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 32.9 t70 -68.31 -27.77 66.58 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.835 -5.54 . . . . 0.0 115.844 -176.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.39 -23.72 34.81 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 166.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -59.87 -42.77 94.46 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 120.855 1.661 . . . . 0.0 114.005 156.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -74.34 -26.08 59.93 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 116.678 -1.629 . . . . 0.0 114.829 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.425 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 12.9 t80 -55.41 -53.27 58.32 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 122.543 2.428 . . . . 0.0 111.614 162.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.944 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 53.7 ttt85 -44.66 -66.67 0.36 Allowed 'General case' 0 C--N 1.355 0.833 0 O-C-N 124.191 0.932 . . . . 0.0 113.024 172.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.76 -24.28 28.87 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 118.173 2.657 . . . . 0.0 118.173 -167.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -61.99 -9.64 7.69 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 155.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.0 p -122.13 1.49 9.75 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 114.164 -2.826 . . . . 0.0 115.874 165.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 m -64.99 103.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 1 CA-C-O 111.52 -4.086 . . . . 0.0 106.901 -170.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.41 -6.13 45.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.17 4.532 . . . . 0.0 121.626 -167.776 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.18 71.87 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -79.3 -5.66 54.94 Favored 'General case' 0 N--CA 1.494 1.755 1 O-C-N 114.332 -5.23 . . . . 0.0 117.866 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.71 129.94 93.21 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 121.964 2.165 . . . . 0.0 109.791 167.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.647 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.2 Cg_exo -52.42 -52.63 8.47 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 C-N-CA 123.637 2.891 . . . . 0.0 117.18 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.68 132.4 36.39 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.022 0.529 . . . . 0.0 110.099 165.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -130.36 99.47 19.27 Favored Pre-proline 0 N--CA 1.488 1.459 0 CA-C-O 115.987 -1.958 . . . . 0.0 110.045 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.12 155.95 91.15 Favored 'Cis proline' 0 CA--C 1.559 1.749 0 CA-C-N 123.323 2.223 . . . . 0.0 114.877 2.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.292 0.1 OUTLIER -69.3 131.58 90.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 121.377 0.608 . . . . 0.0 109.474 157.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.5 166.25 15.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.008 5.806 . . . . 0.0 119.323 -164.518 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.944 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 1.9 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.708 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.75 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.95 100.52 9.71 Favored 'General case' 0 N--CA 1.517 2.903 1 C-N-CA 132.079 4.152 . . . . 0.0 104.999 -171.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.752 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.283 1.3 p90 -147.96 170.03 18.6 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 133.04 32.04 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.189 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.28 154.33 44.63 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.33 23.7 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.651 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 36.3 t70 -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.487 1.404 1 O-C-N 113.473 -5.767 . . . . 0.0 115.747 -177.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.24 -21.84 33.25 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.67 -40.75 95.94 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.892 1.224 . . . . 0.0 113.333 158.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -74.35 -20.87 59.93 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 3.7 t80 -63.34 -53.23 55.91 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 122.556 2.434 . . . . 0.0 111.713 161.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.868 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 56.0 ttt180 -54.19 -22.59 11.77 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.4 -27.58 5.17 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -60.55 -21.69 62.82 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 121.249 1.84 . . . . 0.0 114.569 151.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.6 p -124.3 72.68 1.2 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 151.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.87 136.63 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 137.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.35 -6.13 80.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.694 3.861 . . . . 0.0 121.626 165.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.9 71.6 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.71 -6.05 56.43 Favored 'General case' 0 N--CA 1.493 1.685 1 O-C-N 114.32 -5.238 . . . . 0.0 117.98 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -67.62 129.18 93.54 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 122.018 2.19 . . . . 0.0 109.663 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.632 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.1 Cg_exo -52.13 -52.14 9.59 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.656 2.904 . . . . 0.0 117.344 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.12 133.43 35.35 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.047 0.539 . . . . 0.0 110.155 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -131.5 98.7 17.94 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-O 115.982 -1.961 . . . . 0.0 110.072 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 154.61 89.57 Favored 'Cis proline' 0 CA--C 1.559 1.748 0 CA-C-N 123.274 2.205 . . . . 0.0 114.768 2.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.411 HD11 ' OXW' ' A' ' 163' ' ' BDM 0.281 0.1 OUTLIER -68.06 133.95 91.75 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-O 121.346 0.593 . . . . 0.0 109.663 157.326 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.48 166.25 10.59 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.684 5.589 . . . . 0.0 119.323 -163.715 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.868 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 9.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.651 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.818 H192 ' HD2' ' A' ' 31' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.8 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 tp -108.71 102.13 11.21 Favored 'General case' 0 N--CA 1.516 2.828 1 C-N-CA 131.813 4.045 . . . . 0.0 104.955 -172.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.772 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.272 1.5 p90 -148.77 170.32 18.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.09 132.85 32.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.185 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.82 154.33 45.12 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.21 23.44 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.685 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.2 t70 -68.65 -29.51 68.0 Favored 'General case' 0 N--CA 1.486 1.328 1 O-C-N 113.705 -5.622 . . . . 0.0 115.589 -177.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.69 -24.69 36.07 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -59.32 -42.57 91.73 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 120.887 1.676 . . . . 0.0 113.872 157.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -74.06 -22.15 59.65 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 116.687 -1.625 . . . . 0.0 115.234 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 5.7 t80 -60.09 -55.13 37.69 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 122.46 2.391 . . . . 0.0 111.437 161.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 1.067 ' HA ' HH12 ' A' ' 57' ' ' ARG . 57.8 ttt85 -43.64 -45.07 6.7 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.94 -27.63 10.57 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -170.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -59.76 -14.86 16.36 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 120.772 1.624 . . . . 0.0 115.238 154.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.3 p -124.01 19.84 9.17 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 114.878 -2.487 . . . . 0.0 114.921 161.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.51 117.24 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 CA-C-N 125.743 3.883 . . . . 0.0 105.592 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.13 68.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.958 4.436 . . . . 0.0 121.626 179.382 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.28 71.99 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.78 -7.5 57.87 Favored 'General case' 0 N--CA 1.493 1.699 1 O-C-N 114.305 -5.247 . . . . 0.0 117.924 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -67.27 130.12 93.64 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-N 121.872 2.124 . . . . 0.0 109.893 167.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.631 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.5 Cg_exo -52.57 -52.73 8.22 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.671 2.914 . . . . 0.0 117.168 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.46 132.53 36.18 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.105 0.562 . . . . 0.0 110.201 166.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -131.57 99.31 17.25 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 115.982 -1.961 . . . . 0.0 109.947 -172.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.28 154.6 89.91 Favored 'Cis proline' 0 CA--C 1.559 1.745 0 CA-C-N 123.356 2.234 . . . . 0.0 114.799 2.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.283 0.2 OUTLIER -69.33 129.95 91.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 158.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -81.56 166.25 17.8 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.225 5.95 . . . . 0.0 119.323 -163.359 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 1.067 HH12 ' HA ' ' A' ' 31' ' ' ARG . 13.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.2 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.685 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.772 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.82 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tp -108.73 100.15 9.42 Favored 'General case' 0 N--CA 1.517 2.925 1 C-N-CA 131.974 4.11 . . . . 0.0 104.938 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.751 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.293 1.2 p90 -147.4 169.65 19.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.89 132.62 30.72 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.161 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.4 154.33 44.52 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.42 23.35 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.4 t70 -72.79 -25.37 61.14 Favored 'General case' 0 N--CA 1.486 1.353 1 O-C-N 113.46 -5.775 . . . . 0.0 115.815 178.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt -85.89 -26.84 25.39 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.577 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 88.4 m-70 -66.61 -40.98 89.07 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.626 1.103 . . . . 0.0 113.869 158.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -73.89 -20.49 60.39 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 172.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.7 t80 -61.01 -52.69 63.91 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 121.697 2.044 . . . . 0.0 111.973 158.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.918 ' HA ' HH12 ' A' ' 57' ' ' ARG . 73.5 ttt180 -42.05 -36.02 1.04 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 118.397 2.739 . . . . 0.0 118.397 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.28 -24.11 5.13 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -59.42 -36.06 75.15 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 121.217 1.826 . . . . 0.0 113.384 154.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.1 p -110.6 71.48 0.75 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 155.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.36 139.43 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 CA-C-O 115.39 -2.243 . . . . 0.0 105.204 135.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 -6.13 82.09 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.626 3.83 . . . . 0.0 121.626 165.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.29 73.17 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.24 -5.63 52.5 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.362 -5.211 . . . . 0.0 117.697 173.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -67.46 129.93 93.47 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-N 121.568 1.986 . . . . 0.0 109.932 166.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.659 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.2 Cg_exo -52.6 -52.9 7.83 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.653 2.902 . . . . 0.0 117.141 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.21 134.11 34.82 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.12 0.568 . . . . 0.0 110.24 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -132.91 98.21 16.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 116.046 -1.93 . . . . 0.0 110.106 -172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.38 152.87 87.87 Favored 'Cis proline' 0 CA--C 1.558 1.679 0 CA-C-N 123.27 2.203 . . . . 0.0 114.723 2.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.433 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -65.06 137.54 97.11 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.124 0.488 . . . . 0.0 109.993 156.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.79 166.25 3.98 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.117 4.545 . . . . 0.0 119.323 -164.011 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.918 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.751 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.35 54.0 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 tp -109.33 104.2 13.28 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 131.668 3.987 . . . . 0.0 105.051 -172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.743 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.251 1.7 p90 -150.79 170.85 18.26 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.5 132.79 33.78 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.88 1.272 . . . . 0.0 109.124 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.16 154.33 45.8 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.83 23.55 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.618 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.4 t70 -69.59 -26.2 64.35 Favored 'General case' 0 N--CA 1.481 1.11 1 O-C-N 114.193 -5.317 . . . . 0.0 115.451 -179.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.2 -17.54 36.82 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 166.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.425 ' HD1' ' C22' ' A' ' 163' ' ' BDM . 29.8 m-70 -64.05 -45.14 90.14 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.32 1.418 . . . . 0.0 113.037 155.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -73.79 -22.89 59.67 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 116.835 -1.555 . . . . 0.0 115.146 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -57.55 -56.4 22.35 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 122.266 2.303 . . . . 0.0 111.172 161.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.924 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 59.3 ttt180 -49.35 -47.91 47.03 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.65 -24.11 14.15 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 117.993 2.59 . . . . 0.0 117.993 -169.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -60.09 -10.24 4.12 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 120.903 1.683 . . . . 0.0 115.511 152.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.4 p -117.94 -4.35 11.09 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 113.469 -3.158 . . . . 0.0 115.411 164.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.253 2.7 m -61.24 107.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 125.886 3.948 . . . . 0.0 107.024 -173.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.88 -6.13 54.15 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.28 74.54 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.5 p -76.4 -7.48 55.13 Favored 'General case' 0 N--CA 1.492 1.657 1 O-C-N 114.427 -5.171 . . . . 0.0 117.576 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.42 131.67 93.17 Favored Pre-proline 0 CA--C 1.576 1.976 0 CA-C-N 121.33 1.877 . . . . 0.0 109.998 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.751 ' HD3' BR11 ' A' ' 163' ' ' BDM . 50.3 Cg_exo -53.43 -53.31 6.82 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.601 2.867 . . . . 0.0 117.034 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.15 134.11 34.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.169 0.587 . . . . 0.0 110.397 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 mtm105 -134.83 97.8 13.69 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.068 -1.92 . . . . 0.0 109.982 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.46 150.64 84.72 Favored 'Cis proline' 0 CA--C 1.557 1.643 0 CA-C-N 123.282 2.208 . . . . 0.0 114.499 2.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -67.67 138.72 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 158.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -91.07 166.25 3.73 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.557 4.838 . . . . 0.0 119.323 -159.988 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.924 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 5.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.618 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.751 BR11 ' HD3' ' A' ' 50' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tp -108.26 101.41 10.62 Favored 'General case' 0 N--CA 1.515 2.788 1 C-N-CA 131.767 4.027 . . . . 0.0 104.878 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.746 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.291 1.3 p90 -147.83 169.7 19.23 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 178.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.48 132.58 31.5 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.035 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.3 23.71 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 38.6 t70 -72.61 -24.49 61.08 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.567 -5.708 . . . . 0.0 115.796 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.2 -27.11 26.34 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -66.24 -42.09 89.07 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 158.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -75.77 -25.16 56.22 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 116.723 -1.608 . . . . 0.0 114.911 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.489 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.7 t80 -55.6 -54.8 39.63 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 122.517 2.417 . . . . 0.0 111.275 159.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.831 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 53.3 ttt85 -44.87 -49.3 11.0 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.251 . . -103.64 -17.46 15.13 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 118.184 2.661 . . . . 0.0 118.184 -171.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -55.76 -46.56 77.84 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 120.935 1.698 . . . . 0.0 112.117 153.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.4 p -92.57 10.04 32.05 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 114.374 -2.727 . . . . 0.0 116.903 171.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.282 1.9 m -61.98 111.37 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-N 125.757 3.889 . . . . 0.0 106.528 173.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.69 -6.13 54.68 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.059 3.572 . . . . 0.0 121.626 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.69 72.47 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.34 -7.55 57.41 Favored 'General case' 0 N--CA 1.494 1.75 1 O-C-N 114.307 -5.246 . . . . 0.0 117.824 173.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.2 130.42 93.66 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 121.714 2.052 . . . . 0.0 110.1 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.633 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.1 Cg_exo -52.34 -53.07 7.54 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.595 2.863 . . . . 0.0 117.222 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.72 134.52 34.65 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.109 0.564 . . . . 0.0 110.345 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -134.12 98.61 14.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 116.043 -1.932 . . . . 0.0 110.03 -171.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.27 151.15 86.27 Favored 'Cis proline' 0 CA--C 1.558 1.703 0 CA-C-N 123.227 2.188 . . . . 0.0 114.682 2.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.432 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.13 132.24 94.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 158.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.4 166.25 9.27 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.091 5.194 . . . . 0.0 119.323 -162.493 . . . . . . . . 5 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.831 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 9.5 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.5 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.514 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.746 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.64 100.05 9.34 Favored 'General case' 0 N--CA 1.517 2.888 1 C-N-CA 131.936 4.094 . . . . 0.0 104.889 -171.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.77 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.295 1.2 p90 -147.01 169.63 18.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.027 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.77 132.71 31.1 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.337 -1.302 . . . . 0.0 109.144 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.44 154.33 44.47 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.43 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 38.7 t70 -73.21 -25.37 60.72 Favored 'General case' 0 N--CA 1.486 1.373 1 O-C-N 113.588 -5.695 . . . . 0.0 115.826 178.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.84 -31.76 23.64 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 171.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.567 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 73.7 m-70 -60.66 -42.59 97.33 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 158.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -74.13 -19.52 60.55 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.9 t80 -62.14 -52.37 64.11 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 122.008 2.185 . . . . 0.0 111.945 159.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 1.055 ' HA ' HH12 ' A' ' 57' ' ' ARG . 47.0 ttt85 -39.54 -42.25 1.12 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.57 -24.8 8.61 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -58.48 -29.92 66.59 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.198 1.817 . . . . 0.0 114.165 153.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p -118.57 62.58 0.78 Allowed 'General case' 0 CA--C 1.561 1.385 0 CA-C-N 118.97 0.804 . . . . 0.0 109.943 157.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.29 133.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 CA-C-O 115.23 -2.319 . . . . 0.0 104.866 143.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.16 -6.13 83.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.356 3.707 . . . . 0.0 121.626 168.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.93 -6.04 53.09 Favored 'General case' 0 N--CA 1.493 1.714 1 O-C-N 114.36 -5.212 . . . . 0.0 117.718 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.43 130.0 93.48 Favored Pre-proline 0 CA--C 1.574 1.9 0 CA-C-N 121.454 1.934 . . . . 0.0 110.021 167.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.672 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.0 Cg_exo -52.58 -53.13 7.39 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.606 2.871 . . . . 0.0 117.148 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.21 134.05 34.87 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.078 0.551 . . . . 0.0 110.305 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -133.24 98.35 15.56 Favored Pre-proline 0 N--CA 1.488 1.427 0 CA-C-O 116.068 -1.92 . . . . 0.0 110.091 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.5 152.42 86.9 Favored 'Cis proline' 0 CA--C 1.558 1.704 0 CA-C-N 123.223 2.187 . . . . 0.0 114.785 2.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.466 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -64.51 135.21 96.26 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.86 156.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.43 166.25 5.31 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.314 4.676 . . . . 0.0 119.323 -164.281 . . . . . . . . 5 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 1.055 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.492 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.77 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.96 54.07 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 tp -108.54 100.4 9.67 Favored 'General case' 0 N--CA 1.513 2.705 0 C-N-CA 131.698 3.999 . . . . 0.0 104.934 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.778 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.3 1.3 p90 -146.66 169.3 19.29 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 178.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.26 31.03 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.023 173.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.3 154.33 44.62 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 38.5 t70 -72.32 -25.12 61.44 Favored 'General case' 0 N--CA 1.487 1.392 1 O-C-N 113.626 -5.671 . . . . 0.0 115.745 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -83.09 -33.72 26.3 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.099 1.36 . . . . 0.0 113.87 169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -57.21 -44.67 83.9 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 158.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -76.51 -23.73 53.71 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 116.803 -1.57 . . . . 0.0 114.829 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.529 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 14.3 t80 -53.72 -52.99 58.34 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 122.332 2.333 . . . . 0.0 111.914 161.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 1.027 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 64.8 ttt180 -50.85 -67.04 0.29 Allowed 'General case' 0 C--N 1.355 0.808 0 O-C-N 123.912 0.757 . . . . 0.0 112.733 174.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.86 -11.76 59.54 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -170.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -61.32 -50.61 72.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.624 1.556 . . . . 0.0 111.689 154.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 p -88.9 10.85 19.79 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 m -66.82 102.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 CA-C-O 112.691 -3.528 . . . . 0.0 105.878 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.13 35.95 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.03 4.013 . . . . 0.0 121.626 -171.243 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.26 73.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.3 p -79.1 -4.21 49.2 Favored 'General case' 0 N--CA 1.494 1.742 1 O-C-N 114.415 -5.178 . . . . 0.0 117.696 172.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -67.25 129.1 93.86 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-N 121.562 1.983 . . . . 0.0 109.852 166.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.668 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.6 Cg_exo -52.25 -52.77 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.639 2.893 . . . . 0.0 117.176 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.73 133.87 35.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.13 0.572 . . . . 0.0 110.138 165.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -130.84 98.58 19.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 116.028 -1.939 . . . . 0.0 110.172 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -79.22 155.46 90.62 Favored 'Cis proline' 0 CA--C 1.558 1.688 0 CA-C-N 123.34 2.229 . . . . 0.0 114.753 1.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -68.66 136.18 90.38 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.529 0.68 . . . . 0.0 109.759 157.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.75 166.25 8.77 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.487 5.458 . . . . 0.0 119.323 -163.908 . . . . . . . . 5 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 1.027 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.554 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.778 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.27 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tp -109.0 102.92 11.87 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 131.678 3.991 . . . . 0.0 104.949 -172.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.753 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.269 1.6 p90 -149.4 170.19 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.72 132.62 33.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.058 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.34 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.88 23.24 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.7 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 22.2 t70 -68.6 -29.11 67.55 Favored 'General case' 0 N--CA 1.486 1.345 1 O-C-N 113.929 -5.482 . . . . 0.0 115.599 -176.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.93 -23.16 41.93 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 84.3 m-70 -62.92 -40.9 99.02 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 120.75 1.614 . . . . 0.0 113.993 158.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -73.86 -27.18 60.96 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 116.866 -1.54 . . . . 0.0 114.795 167.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -55.64 -51.01 68.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 122.293 2.315 . . . . 0.0 111.95 160.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.772 ' HA ' HH12 ' A' ' 57' ' ' ARG . 52.8 ttt85 -42.31 -59.43 1.83 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.53 -23.75 15.4 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.93 2.567 . . . . 0.0 117.93 -165.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -60.96 -6.61 1.93 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 152.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.5 p -122.32 -4.14 8.9 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 113.529 -3.129 . . . . 0.0 115.495 163.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.71 105.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 125.777 3.899 . . . . 0.0 107.246 -171.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.96 -6.13 51.14 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.889 3.949 . . . . 0.0 121.626 -169.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.42 72.15 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.58 -7.0 57.11 Favored 'General case' 0 N--CA 1.493 1.694 1 O-C-N 114.327 -5.233 . . . . 0.0 117.843 173.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.49 130.41 93.31 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-N 121.896 2.134 . . . . 0.0 109.848 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.637 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.7 Cg_exo -52.36 -52.65 8.43 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.684 2.923 . . . . 0.0 117.177 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.45 133.78 35.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.097 0.559 . . . . 0.0 110.269 166.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -132.68 98.46 16.31 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-O 115.998 -1.954 . . . . 0.0 110.077 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.22 153.28 88.91 Favored 'Cis proline' 0 CA--C 1.557 1.663 0 CA-C-N 123.351 2.232 . . . . 0.0 114.62 2.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.281 0.2 OUTLIER -68.68 135.85 90.32 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-O 121.49 0.662 . . . . 0.0 109.839 158.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -87.13 166.25 8.24 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.416 5.411 . . . . 0.0 119.323 -162.012 . . . . . . . . 5 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.772 HH12 ' HA ' ' A' ' 31' ' ' ARG . 6.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.7 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.753 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 tp -108.51 101.79 10.93 Favored 'General case' 0 N--CA 1.516 2.847 1 C-N-CA 131.797 4.039 . . . . 0.0 104.856 -172.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.797 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.277 1.5 p90 -148.15 170.09 18.59 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 178.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.82 32.89 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.168 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.88 154.33 45.05 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.26 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.651 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 36.8 t70 -70.49 -29.89 66.55 Favored 'General case' 0 N--CA 1.484 1.261 1 O-C-N 113.843 -5.536 . . . . 0.0 115.454 -177.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.82 -23.0 36.73 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 165.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -58.69 -45.19 90.01 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 120.025 1.284 . . . . 0.0 113.157 157.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -76.04 -17.56 59.61 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-O 116.51 -1.709 . . . . 0.0 115.338 169.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 8.1 t80 -62.0 -57.68 10.75 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 122.751 2.523 . . . . 0.0 110.825 162.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.929 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 73.2 ttt180 -48.91 -42.46 37.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.62 -26.32 12.84 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 -170.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -59.42 -17.35 29.92 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 121.025 1.739 . . . . 0.0 115.166 153.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.4 p -118.11 12.28 13.54 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 114.36 -2.733 . . . . 0.0 115.462 163.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.261 1.6 m -63.81 112.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-N 125.742 3.883 . . . . 0.0 105.703 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.13 59.34 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.279 3.672 . . . . 0.0 121.626 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.86 72.66 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.23 -7.26 56.92 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.345 -5.222 . . . . 0.0 117.797 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.27 130.19 93.63 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-N 121.708 2.049 . . . . 0.0 109.907 167.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.661 ' HD3' BR11 ' A' ' 163' ' ' BDM . 52.3 Cg_exo -52.7 -52.84 7.95 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.607 2.871 . . . . 0.0 117.151 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 133.26 35.55 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.127 0.571 . . . . 0.0 110.253 166.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -132.58 98.75 16.21 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 116.05 -1.929 . . . . 0.0 110.031 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.28 153.61 89.0 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 CA-C-N 123.297 2.213 . . . . 0.0 114.75 2.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.263 0.1 OUTLIER -67.59 133.51 92.7 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-O 121.107 0.479 . . . . 0.0 109.778 158.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.87 166.25 10.04 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.196 5.264 . . . . 0.0 119.323 -163.246 . . . . . . . . 5 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.929 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 11.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.651 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.797 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.18 54.03 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 tp -108.82 102.85 11.84 Favored 'General case' 0 N--CA 1.512 2.663 1 C-N-CA 131.708 4.003 . . . . 0.0 104.876 -172.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.784 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.268 1.6 p90 -149.06 170.29 18.73 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.74 132.53 32.92 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.097 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.45 154.33 45.5 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.48 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.648 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 36.0 t70 -70.48 -29.77 66.39 Favored 'General case' 0 N--CA 1.483 1.224 1 O-C-N 114.226 -5.296 . . . . 0.0 115.281 -177.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -81.29 -18.12 46.95 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 165.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -63.1 -46.42 87.45 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 119.789 1.177 . . . . 0.0 112.754 157.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -73.84 -23.34 59.61 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 116.762 -1.59 . . . . 0.0 115.119 170.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -55.39 -55.11 35.34 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 122.375 2.352 . . . . 0.0 111.575 162.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.927 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 55.7 ttt85 -47.19 -62.1 1.58 Allowed 'General case' 0 C--N 1.353 0.758 0 O-C-N 124.38 1.05 . . . . 0.0 113.539 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.97 -23.54 25.04 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -169.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -62.12 -8.32 5.33 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 154.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p -121.09 -2.22 9.7 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 113.986 -2.912 . . . . 0.0 115.32 165.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.26 103.4 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 125.45 3.75 . . . . 0.0 106.501 -169.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.22 -6.13 42.41 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.224 3.647 . . . . 0.0 121.626 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.07 74.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -77.04 -6.45 52.77 Favored 'General case' 0 N--CA 1.493 1.709 1 O-C-N 114.413 -5.18 . . . . 0.0 117.591 173.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.52 130.82 93.15 Favored Pre-proline 0 CA--C 1.576 1.948 0 CA-C-N 121.376 1.898 . . . . 0.0 109.899 166.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.751 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.0 Cg_exo -53.32 -53.32 6.86 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 C-N-CA 123.627 2.885 . . . . 0.0 116.992 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.06 133.67 35.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.145 0.578 . . . . 0.0 110.312 167.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mtm105 -133.51 98.23 15.28 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-O 116.041 -1.933 . . . . 0.0 109.952 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.51 152.14 86.51 Favored 'Cis proline' 0 CA--C 1.556 1.62 0 CA-C-N 123.267 2.203 . . . . 0.0 114.594 2.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.276 0.1 OUTLIER -68.09 137.05 91.81 Favored Pre-proline 0 N--CA 1.493 1.71 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 158.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.92 166.25 5.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.974 5.116 . . . . 0.0 119.323 -161.045 . . . . . . . . 5 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.927 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 2.6 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.648 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.784 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.5 101.41 10.58 Favored 'General case' 0 N--CA 1.516 2.869 1 C-N-CA 131.818 4.047 . . . . 0.0 104.885 -172.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.773 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.284 1.4 p90 -147.92 169.92 18.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.33 132.58 31.79 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.08 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.04 154.33 44.89 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.667 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.7 t70 -69.58 -28.97 66.42 Favored 'General case' 0 N--CA 1.488 1.426 1 O-C-N 113.626 -5.671 . . . . 0.0 115.681 -177.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.22 -20.52 34.44 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 167.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.453 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 21.9 m-70 -64.32 -41.38 96.84 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.392 1.451 . . . . 0.0 113.348 157.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -74.08 -22.18 59.61 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 116.626 -1.654 . . . . 0.0 115.152 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 5.1 t80 -61.07 -55.08 36.77 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 122.639 2.472 . . . . 0.0 111.408 161.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.957 ' HA ' HH12 ' A' ' 57' ' ' ARG . 51.9 ttt85 -37.79 -49.45 1.18 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 172.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.44 -26.42 10.47 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -168.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -59.78 -14.91 16.76 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 120.948 1.704 . . . . 0.0 115.126 154.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.9 p -123.18 20.33 9.82 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 115.124 -2.37 . . . . 0.0 114.764 161.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 2.2 m -64.28 115.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-N 125.75 3.886 . . . . 0.0 105.903 168.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.08 -6.13 63.77 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.446 4.203 . . . . 0.0 121.626 179.588 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.92 -6.34 55.95 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.853 173.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.51 129.85 93.45 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 121.773 2.079 . . . . 0.0 109.799 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.652 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.6 Cg_exo -52.48 -52.56 8.61 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 123.602 2.868 . . . . 0.0 117.221 176.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.25 133.5 35.34 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.037 0.535 . . . . 0.0 110.228 166.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.7 mtm105 -132.23 98.6 16.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.095 -172.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.36 154.06 89.08 Favored 'Cis proline' 0 CA--C 1.558 1.697 0 CA-C-N 123.282 2.208 . . . . 0.0 114.799 2.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.263 0.1 OUTLIER -66.72 134.45 94.22 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.173 0.511 . . . . 0.0 109.645 157.213 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.98 166.25 8.45 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.99 5.127 . . . . 0.0 119.323 -164.23 . . . . . . . . 5 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.957 HH12 ' HA ' ' A' ' 31' ' ' ARG . 9.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.667 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.773 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.07 54.05 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 tp -108.59 101.1 10.28 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 131.628 3.971 . . . . 0.0 104.828 -172.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.782 ' HA ' HN42 ' A' ' 163' ' ' BDM 0.29 1.4 p90 -147.13 169.18 19.85 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.59 132.99 33.88 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.07 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.451 HD22 ' H72' ' A' ' 163' ' ' BDM . 40.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.63 23.52 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.623 ' HA ' ' HH ' ' A' ' 155' ' ' TYR . 35.9 t70 -73.73 -29.88 62.5 Favored 'General case' 0 N--CA 1.483 1.22 1 O-C-N 113.933 -5.48 . . . . 0.0 115.525 -176.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 mp -82.48 -27.15 31.99 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 92.7 m-70 -60.95 -41.83 97.06 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.54 1.518 . . . . 0.0 114.088 158.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -74.61 -23.92 58.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 116.93 -1.51 . . . . 0.0 114.995 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 12.1 t80 -57.59 -53.56 56.83 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 122.183 2.265 . . . . 0.0 111.929 161.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.919 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 57.0 ttt85 -40.73 -54.09 2.69 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 172.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.25 -24.56 14.22 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -168.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -57.87 -18.56 23.44 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 153.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -114.49 4.25 15.18 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 113.936 -2.935 . . . . 0.0 115.739 164.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 2.4 m -62.61 108.33 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 125.848 3.931 . . . . 0.0 106.519 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.43 -6.13 49.31 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.36 71.2 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.4 -8.09 58.85 Favored 'General case' 0 N--CA 1.494 1.764 1 O-C-N 114.224 -5.298 . . . . 0.0 118.004 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -66.67 131.21 94.05 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-N 122.132 2.242 . . . . 0.0 110.233 168.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.621 ' HD2' BR11 ' A' ' 163' ' ' BDM . 53.3 Cg_exo -51.9 -52.97 7.8 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.585 2.857 . . . . 0.0 117.259 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -92.49 135.11 34.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.119 0.567 . . . . 0.0 110.354 166.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -134.22 98.87 13.76 Favored Pre-proline 0 N--CA 1.488 1.466 0 CA-C-O 116.111 -1.9 . . . . 0.0 110.102 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.69 151.03 88.14 Favored 'Cis proline' 0 CA--C 1.557 1.662 0 CA-C-N 123.25 2.196 . . . . 0.0 114.566 2.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.259 0.1 OUTLIER -67.63 132.97 92.65 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.897 159.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.94 166.25 9.93 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.376 5.384 . . . . 0.0 119.323 -161.521 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.919 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 4.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 78' ' ' ASP 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 77' ' ' HIS 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.105 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 15' ' ' LYS 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.491 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 152' ' ' THR . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 146' ' ' ASP . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.623 ' HH ' ' HA ' ' A' ' 26' ' ' ASP . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' BDM . . . . . 0.782 HN42 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.83 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.934 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.9 tp -109.01 102.21 11.22 Favored 'General case' 0 N--CA 1.517 2.914 1 C-N-CA 131.892 4.077 . . . . 0.0 104.994 -172.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.266 1.5 p90 -149.13 170.61 18.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.31 132.76 32.11 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.205 173.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.35 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.49 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.88 -28.11 66.4 Favored 'General case' 0 N--CA 1.484 1.251 1 O-C-N 113.913 -5.492 . . . . 0.0 115.502 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -84.13 -20.93 31.67 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 166.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 . . . . . 0 N--CA 1.497 1.878 0 CA-C-N 120.643 1.565 . . . . 0.0 113.347 155.677 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.511 ' CG2' HD22 ' A' ' 4' ' ' LEU . 43.8 p . . . . . 0 CA--C 1.557 1.238 0 CA-C-O 115.969 -1.967 . . . . 0.0 114.196 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 m -67.75 117.61 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.407 0 CA-C-N 125.257 3.662 . . . . 0.0 104.876 165.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.9 -6.13 66.8 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.231 4.56 . . . . 0.0 121.626 177.612 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.74 73.69 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.3 -7.57 56.22 Favored 'General case' 0 N--CA 1.493 1.687 1 O-C-N 114.37 -5.206 . . . . 0.0 117.66 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -67.22 130.45 93.63 Favored Pre-proline 0 CA--C 1.576 1.951 0 CA-C-N 121.495 1.952 . . . . 0.0 109.94 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.06 -53.29 7.01 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.632 2.888 . . . . 0.0 117.088 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.62 133.47 35.08 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.097 0.559 . . . . 0.0 110.367 167.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -133.65 98.14 15.17 Favored Pre-proline 0 N--CA 1.488 1.431 0 CA-C-O 116.069 -1.92 . . . . 0.0 109.993 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.63 152.25 86.19 Favored 'Cis proline' 0 CA--C 1.557 1.666 0 CA-C-N 123.27 2.203 . . . . 0.0 114.67 2.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.591 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.87 136.19 94.41 Favored Pre-proline 0 N--CA 1.493 1.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.019 157.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.98 166.25 5.75 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.657 4.905 . . . . 0.0 119.323 -162.155 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.934 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.29 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.8 tp -109.41 102.88 11.74 Favored 'General case' 0 N--CA 1.514 2.733 1 C-N-CA 131.753 4.021 . . . . 0.0 105.077 -172.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.262 1.6 p90 -149.72 170.54 18.47 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.8 132.75 33.1 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.076 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.47 154.33 45.48 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.12 23.46 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.39 -31.7 67.59 Favored 'General case' 0 N--CA 1.485 1.32 1 O-C-N 113.977 -5.452 . . . . 0.0 115.407 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.64 -29.36 56.42 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 . . . . . 0 CA--C 1.569 1.691 0 CA-C-N 120.356 1.435 . . . . 0.0 114.173 162.656 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.573 ' CG2' HD22 ' A' ' 4' ' ' LEU . 37.0 p . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 114.242 -2.79 . . . . 0.0 115.721 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.75 103.6 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.147 0 CA-C-N 125.37 3.714 . . . . 0.0 106.149 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.21 -6.13 39.35 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.848 3.931 . . . . 0.0 121.626 -169.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.16 73.01 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -77.77 -7.09 56.09 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.404 -5.185 . . . . 0.0 117.715 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.49 130.67 93.24 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 121.652 2.024 . . . . 0.0 109.876 166.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.94 -52.92 7.73 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.621 2.88 . . . . 0.0 117.138 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.96 133.7 35.06 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.135 0.574 . . . . 0.0 110.345 166.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -133.45 98.25 15.35 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-O 116.064 -1.922 . . . . 0.0 110.01 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.41 152.33 87.11 Favored 'Cis proline' 0 CA--C 1.557 1.645 0 CA-C-N 123.276 2.206 . . . . 0.0 114.652 2.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.2 OUTLIER -67.62 137.0 92.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-O 121.258 0.551 . . . . 0.0 110.017 157.984 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.11 166.25 5.62 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.879 5.053 . . . . 0.0 119.323 -161.602 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.6 tp -109.1 101.38 10.43 Favored 'General case' 0 N--CA 1.518 2.934 1 C-N-CA 131.995 4.118 . . . . 0.0 105.039 -171.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.272 1.4 p90 -148.83 170.39 18.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.96 32.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.922 1.289 . . . . 0.0 109.25 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.0 154.33 44.93 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.24 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.02 -29.3 66.32 Favored 'General case' 0 N--CA 1.486 1.341 1 O-C-N 113.65 -5.656 . . . . 0.0 115.665 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.09 -24.6 32.6 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 . . . . . 0 N--CA 1.494 1.75 0 CA-C-N 120.709 1.595 . . . . 0.0 113.851 157.192 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 p . . . . . 0 CA--C 1.56 1.348 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.09 133.3 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.162 0 CA-C-O 114.644 -2.598 . . . . 0.0 104.494 143.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.26 -6.13 82.53 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.169 4.077 . . . . 0.0 121.626 168.19 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.8 -6.98 57.37 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.824 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -67.49 128.28 93.57 Favored Pre-proline 0 CA--C 1.577 1.989 0 CA-C-N 121.82 2.1 . . . . 0.0 109.677 167.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.51 -52.18 9.47 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.675 2.916 . . . . 0.0 117.255 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.7 131.63 36.28 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.073 0.549 . . . . 0.0 110.07 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -130.03 99.26 20.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 115.996 -1.954 . . . . 0.0 109.939 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -79.63 156.68 89.37 Favored 'Cis proline' 0 CA--C 1.559 1.762 0 CA-C-N 123.308 2.217 . . . . 0.0 114.981 2.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 54' ' ' LEU 0.284 0.1 OUTLIER -68.62 130.55 91.86 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 157.42 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.01 166.25 16.86 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.761 5.641 . . . . 0.0 119.323 -165.484 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.39 53.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.4 tp -109.37 104.0 13.03 Favored 'General case' 0 N--CA 1.513 2.712 1 C-N-CA 131.726 4.01 . . . . 0.0 105.028 -172.317 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.257 1.7 p90 -150.74 170.77 18.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.75 132.64 33.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.065 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.26 154.33 45.7 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.45 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.11 -28.33 66.38 Favored 'General case' 0 N--CA 1.484 1.245 1 O-C-N 113.996 -5.44 . . . . 0.0 115.527 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.8 -17.85 46.13 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 165.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 N--CA 1.493 1.716 0 CA-C-N 120.249 1.386 . . . . 0.0 113.284 157.885 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.581 HG23 HD22 ' A' ' 4' ' ' LEU . 34.2 p . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 113.727 -3.035 . . . . 0.0 115.244 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.73 104.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 125.534 3.788 . . . . 0.0 106.777 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 -6.13 48.49 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.207 3.639 . . . . 0.0 121.626 -168.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -76.98 -8.18 56.93 Favored 'General case' 0 N--CA 1.492 1.671 1 O-C-N 114.36 -5.212 . . . . 0.0 117.733 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -67.39 131.04 93.29 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 121.503 1.956 . . . . 0.0 109.984 167.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.96 -52.95 7.67 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.58 2.854 . . . . 0.0 117.138 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.12 134.18 34.74 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.169 0.588 . . . . 0.0 110.365 167.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.6 mtm105 -134.63 97.91 13.89 Favored Pre-proline 0 N--CA 1.488 1.443 0 CA-C-O 116.044 -1.931 . . . . 0.0 109.963 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.49 150.73 84.77 Favored 'Cis proline' 0 CA--C 1.556 1.597 0 CA-C-N 123.253 2.198 . . . . 0.0 114.502 2.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 54' ' ' LEU 0.261 0.2 OUTLIER -67.83 137.94 92.79 Favored Pre-proline 0 N--CA 1.492 1.667 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 158.577 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.28 166.25 4.48 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.715 4.943 . . . . 0.0 119.323 -160.033 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.92 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.7 tp -108.42 101.97 11.1 Favored 'General case' 0 N--CA 1.515 2.811 1 C-N-CA 131.788 4.035 . . . . 0.0 104.957 -172.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.284 1.4 p90 -148.63 169.92 19.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 132.43 31.09 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.995 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.11 154.33 44.81 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.99 23.79 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.88 -22.44 61.51 Favored 'General case' 0 N--CA 1.487 1.408 1 O-C-N 113.455 -5.778 . . . . 0.0 115.999 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.72 -26.06 20.86 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 125.6 1.56 . . . . 0.0 114.821 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 . . . . . 0 CA--C 1.568 1.635 0 CA-C-N 119.574 1.079 . . . . 0.0 113.901 154.296 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.527 ' CG2' HD22 ' A' ' 4' ' ' LEU . 68.3 p . . . . . 0 CA--C 1.555 1.155 0 CA-C-O 114.627 -2.606 . . . . 0.0 116.17 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.275 0.9 OUTLIER -63.12 113.91 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 125.778 3.899 . . . . 0.0 106.012 169.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.78 -6.13 58.57 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.764 3.893 . . . . 0.0 121.626 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.87 71.58 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.0 p -79.68 -5.27 54.82 Favored 'General case' 0 N--CA 1.493 1.719 1 O-C-N 114.303 -5.248 . . . . 0.0 117.882 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.8 129.91 93.13 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-N 122.025 2.193 . . . . 0.0 109.876 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.77 -52.41 9.04 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 123.58 2.854 . . . . 0.0 117.322 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -91.69 134.82 34.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.092 0.557 . . . . 0.0 110.277 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -132.83 98.34 16.2 Favored Pre-proline 0 N--CA 1.488 1.453 0 CA-C-O 116.095 -1.907 . . . . 0.0 110.217 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.01 153.12 89.62 Favored 'Cis proline' 0 CA--C 1.557 1.632 0 CA-C-N 123.182 2.172 . . . . 0.0 114.686 1.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -65.55 137.86 96.62 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.236 0.541 . . . . 0.0 109.935 156.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.65 166.25 4.11 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.371 4.714 . . . . 0.0 119.323 -164.031 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.03 54.06 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.953 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.0 tp -108.49 102.32 11.42 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 131.677 3.991 . . . . 0.0 104.84 -172.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.281 1.5 p90 -148.61 169.81 19.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.54 32.46 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.983 173.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.91 154.33 45.03 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.91 23.23 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.31 -27.77 66.58 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.835 -5.54 . . . . 0.0 115.844 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.39 -23.72 34.81 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 166.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 . . . . . 0 N--CA 1.497 1.883 0 CA-C-N 120.855 1.661 . . . . 0.0 114.005 156.847 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.566 ' CG2' HD22 ' A' ' 4' ' ' LEU . 37.0 p . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 114.164 -2.826 . . . . 0.0 115.874 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 m -64.99 103.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 1 CA-C-O 111.52 -4.086 . . . . 0.0 106.901 -170.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.41 -6.13 45.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.17 4.532 . . . . 0.0 121.626 -167.776 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.18 71.87 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -79.3 -5.66 54.94 Favored 'General case' 0 N--CA 1.494 1.755 1 O-C-N 114.332 -5.23 . . . . 0.0 117.866 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.71 129.94 93.21 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 121.964 2.165 . . . . 0.0 109.791 167.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.42 -52.63 8.47 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 C-N-CA 123.637 2.891 . . . . 0.0 117.18 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.68 132.4 36.39 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.022 0.529 . . . . 0.0 110.099 165.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -130.36 99.47 19.27 Favored Pre-proline 0 N--CA 1.488 1.459 0 CA-C-O 115.987 -1.958 . . . . 0.0 110.045 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.12 155.95 91.15 Favored 'Cis proline' 0 CA--C 1.559 1.749 0 CA-C-N 123.323 2.223 . . . . 0.0 114.877 2.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 54' ' ' LEU 0.292 0.1 OUTLIER -69.3 131.58 90.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 121.377 0.608 . . . . 0.0 109.474 157.784 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.5 166.25 15.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.008 5.806 . . . . 0.0 119.323 -164.518 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.953 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.3 tp -108.95 100.52 9.71 Favored 'General case' 0 N--CA 1.517 2.903 1 C-N-CA 132.079 4.152 . . . . 0.0 104.999 -171.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.283 1.3 p90 -147.96 170.03 18.6 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 133.04 32.04 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.189 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.28 154.33 44.63 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.33 23.7 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.487 1.404 1 O-C-N 113.473 -5.767 . . . . 0.0 115.747 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.24 -21.84 33.25 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 N--CA 1.491 1.623 0 CA-C-N 119.892 1.224 . . . . 0.0 113.333 158.092 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 CA--C 1.561 1.378 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.87 136.63 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 137.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.35 -6.13 80.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.694 3.861 . . . . 0.0 121.626 165.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.9 71.6 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.71 -6.05 56.43 Favored 'General case' 0 N--CA 1.493 1.685 1 O-C-N 114.32 -5.238 . . . . 0.0 117.98 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -67.62 129.18 93.54 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 122.018 2.19 . . . . 0.0 109.663 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.13 -52.14 9.59 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.656 2.904 . . . . 0.0 117.344 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.12 133.43 35.35 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.047 0.539 . . . . 0.0 110.155 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -131.5 98.7 17.94 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-O 115.982 -1.961 . . . . 0.0 110.072 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 154.61 89.57 Favored 'Cis proline' 0 CA--C 1.559 1.748 0 CA-C-N 123.274 2.205 . . . . 0.0 114.768 2.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 54' ' ' LEU 0.281 0.1 OUTLIER -68.06 133.95 91.75 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-O 121.346 0.593 . . . . 0.0 109.663 157.326 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.48 166.25 10.59 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.684 5.589 . . . . 0.0 119.323 -163.715 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.8 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.945 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.1 tp -108.71 102.13 11.21 Favored 'General case' 0 N--CA 1.516 2.828 1 C-N-CA 131.813 4.045 . . . . 0.0 104.955 -172.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.272 1.5 p90 -148.77 170.32 18.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.09 132.85 32.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.185 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.82 154.33 45.12 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.21 23.44 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.65 -29.51 68.0 Favored 'General case' 0 N--CA 1.486 1.328 1 O-C-N 113.705 -5.622 . . . . 0.0 115.589 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.69 -24.69 36.07 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 . . . . . 0 N--CA 1.496 1.848 0 CA-C-N 120.887 1.676 . . . . 0.0 113.872 157.471 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.538 ' CG2' HD22 ' A' ' 4' ' ' LEU . 39.3 p . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 114.878 -2.487 . . . . 0.0 114.921 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.51 117.24 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 CA-C-N 125.743 3.883 . . . . 0.0 105.592 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.13 68.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.958 4.436 . . . . 0.0 121.626 179.382 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.28 71.99 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.78 -7.5 57.87 Favored 'General case' 0 N--CA 1.493 1.699 1 O-C-N 114.305 -5.247 . . . . 0.0 117.924 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -67.27 130.12 93.64 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-N 121.872 2.124 . . . . 0.0 109.893 167.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.57 -52.73 8.22 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.671 2.914 . . . . 0.0 117.168 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.46 132.53 36.18 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.105 0.562 . . . . 0.0 110.201 166.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -131.57 99.31 17.25 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 115.982 -1.961 . . . . 0.0 109.947 -172.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.28 154.6 89.91 Favored 'Cis proline' 0 CA--C 1.559 1.745 0 CA-C-N 123.356 2.234 . . . . 0.0 114.799 2.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 54' ' ' LEU 0.283 0.2 OUTLIER -69.33 129.95 91.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 158.755 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -81.56 166.25 17.8 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.225 5.95 . . . . 0.0 119.323 -163.359 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.945 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.2 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.82 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.956 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.5 tp -108.73 100.15 9.42 Favored 'General case' 0 N--CA 1.517 2.925 1 C-N-CA 131.974 4.11 . . . . 0.0 104.938 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.293 1.2 p90 -147.4 169.65 19.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.89 132.62 30.72 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.161 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.4 154.33 44.52 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.42 23.35 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.79 -25.37 61.14 Favored 'General case' 0 N--CA 1.486 1.353 1 O-C-N 113.46 -5.775 . . . . 0.0 115.815 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt -85.89 -26.84 25.39 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 . . . . . 0 N--CA 1.491 1.617 0 CA-C-N 119.626 1.103 . . . . 0.0 113.869 158.735 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 CA--C 1.561 1.378 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.36 139.43 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 CA-C-O 115.39 -2.243 . . . . 0.0 105.204 135.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 -6.13 82.09 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.626 3.83 . . . . 0.0 121.626 165.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.29 73.17 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.24 -5.63 52.5 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.362 -5.211 . . . . 0.0 117.697 173.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -67.46 129.93 93.47 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-N 121.568 1.986 . . . . 0.0 109.932 166.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.6 -52.9 7.83 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.653 2.902 . . . . 0.0 117.141 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.21 134.11 34.82 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.12 0.568 . . . . 0.0 110.24 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -132.91 98.21 16.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 116.046 -1.93 . . . . 0.0 110.106 -172.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.38 152.87 87.87 Favored 'Cis proline' 0 CA--C 1.558 1.679 0 CA-C-N 123.27 2.203 . . . . 0.0 114.723 2.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -65.06 137.54 97.11 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.124 0.488 . . . . 0.0 109.993 156.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.79 166.25 3.98 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.117 4.545 . . . . 0.0 119.323 -164.011 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.956 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.35 54.0 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.2 tp -109.33 104.2 13.28 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 131.668 3.987 . . . . 0.0 105.051 -172.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.251 1.7 p90 -150.79 170.85 18.26 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.5 132.79 33.78 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.88 1.272 . . . . 0.0 109.124 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.16 154.33 45.8 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.83 23.55 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.59 -26.2 64.35 Favored 'General case' 0 N--CA 1.481 1.11 1 O-C-N 114.193 -5.317 . . . . 0.0 115.451 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.2 -17.54 36.82 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 166.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 . . . . . 0 N--CA 1.495 1.78 0 CA-C-N 120.32 1.418 . . . . 0.0 113.037 155.492 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.583 HG23 HD22 ' A' ' 4' ' ' LEU . 25.4 p . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 113.469 -3.158 . . . . 0.0 115.411 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.253 2.7 m -61.24 107.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 125.886 3.948 . . . . 0.0 107.024 -173.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.88 -6.13 54.15 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.28 74.54 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.5 p -76.4 -7.48 55.13 Favored 'General case' 0 N--CA 1.492 1.657 1 O-C-N 114.427 -5.171 . . . . 0.0 117.576 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.42 131.67 93.17 Favored Pre-proline 0 CA--C 1.576 1.976 0 CA-C-N 121.33 1.877 . . . . 0.0 109.998 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -53.31 6.82 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.601 2.867 . . . . 0.0 117.034 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.15 134.11 34.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.169 0.587 . . . . 0.0 110.397 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 mtm105 -134.83 97.8 13.69 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.068 -1.92 . . . . 0.0 109.982 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.46 150.64 84.72 Favored 'Cis proline' 0 CA--C 1.557 1.643 0 CA-C-N 123.282 2.208 . . . . 0.0 114.499 2.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 54' ' ' LEU 0.262 0.2 OUTLIER -67.67 138.72 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 158.234 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -91.07 166.25 3.73 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.557 4.838 . . . . 0.0 119.323 -159.988 . . . . . . . . 5 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.7 tp -108.26 101.41 10.62 Favored 'General case' 0 N--CA 1.515 2.788 1 C-N-CA 131.767 4.027 . . . . 0.0 104.878 -172.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.291 1.3 p90 -147.83 169.7 19.23 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.48 132.58 31.5 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.035 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.3 23.71 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.61 -24.49 61.08 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.567 -5.708 . . . . 0.0 115.796 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.2 -27.11 26.34 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 . . . . . 0 CA--C 1.567 1.634 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 158.776 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.524 ' CG2' HD22 ' A' ' 4' ' ' LEU . 41.4 p . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 114.374 -2.727 . . . . 0.0 116.903 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.282 1.9 m -61.98 111.37 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-N 125.757 3.889 . . . . 0.0 106.528 173.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.69 -6.13 54.68 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.059 3.572 . . . . 0.0 121.626 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.69 72.47 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.34 -7.55 57.41 Favored 'General case' 0 N--CA 1.494 1.75 1 O-C-N 114.307 -5.246 . . . . 0.0 117.824 173.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.2 130.42 93.66 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 121.714 2.052 . . . . 0.0 110.1 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.34 -53.07 7.54 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.595 2.863 . . . . 0.0 117.222 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.72 134.52 34.65 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.109 0.564 . . . . 0.0 110.345 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -134.12 98.61 14.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 116.043 -1.932 . . . . 0.0 110.03 -171.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.27 151.15 86.27 Favored 'Cis proline' 0 CA--C 1.558 1.703 0 CA-C-N 123.227 2.188 . . . . 0.0 114.682 2.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.13 132.24 94.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 158.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.4 166.25 9.27 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.091 5.194 . . . . 0.0 119.323 -162.493 . . . . . . . . 5 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.5 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.9 tp -108.64 100.05 9.34 Favored 'General case' 0 N--CA 1.517 2.888 1 C-N-CA 131.936 4.094 . . . . 0.0 104.889 -171.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.295 1.2 p90 -147.01 169.63 18.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.77 132.71 31.1 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.337 -1.302 . . . . 0.0 109.144 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.44 154.33 44.47 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.43 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.21 -25.37 60.72 Favored 'General case' 0 N--CA 1.486 1.373 1 O-C-N 113.588 -5.695 . . . . 0.0 115.826 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.84 -31.76 23.64 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 171.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 158.134 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p . . . . . 0 CA--C 1.561 1.385 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.29 133.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 CA-C-O 115.23 -2.319 . . . . 0.0 104.866 143.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.16 -6.13 83.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.356 3.707 . . . . 0.0 121.626 168.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.93 -6.04 53.09 Favored 'General case' 0 N--CA 1.493 1.714 1 O-C-N 114.36 -5.212 . . . . 0.0 117.718 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.43 130.0 93.48 Favored Pre-proline 0 CA--C 1.574 1.9 0 CA-C-N 121.454 1.934 . . . . 0.0 110.021 167.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.58 -53.13 7.39 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.606 2.871 . . . . 0.0 117.148 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.21 134.05 34.87 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.078 0.551 . . . . 0.0 110.305 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -133.24 98.35 15.56 Favored Pre-proline 0 N--CA 1.488 1.427 0 CA-C-O 116.068 -1.92 . . . . 0.0 110.091 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.5 152.42 86.9 Favored 'Cis proline' 0 CA--C 1.558 1.704 0 CA-C-N 123.223 2.187 . . . . 0.0 114.785 2.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.636 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -64.51 135.21 96.26 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.86 156.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.43 166.25 5.31 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.314 4.676 . . . . 0.0 119.323 -164.281 . . . . . . . . 5 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.96 54.07 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 7.8 tp -108.54 100.4 9.67 Favored 'General case' 0 N--CA 1.513 2.705 0 C-N-CA 131.698 3.999 . . . . 0.0 104.934 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.3 1.3 p90 -146.66 169.3 19.29 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.26 31.03 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.023 173.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.3 154.33 44.62 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.32 -25.12 61.44 Favored 'General case' 0 N--CA 1.487 1.392 1 O-C-N 113.626 -5.671 . . . . 0.0 115.745 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -83.09 -33.72 26.3 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.099 1.36 . . . . 0.0 113.87 169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 158.791 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.55 ' CG2' HD22 ' A' ' 4' ' ' LEU . 50.5 p . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 m -66.82 102.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 CA-C-O 112.691 -3.528 . . . . 0.0 105.878 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.13 35.95 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.03 4.013 . . . . 0.0 121.626 -171.243 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.26 73.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.3 p -79.1 -4.21 49.2 Favored 'General case' 0 N--CA 1.494 1.742 1 O-C-N 114.415 -5.178 . . . . 0.0 117.696 172.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -67.25 129.1 93.86 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-N 121.562 1.983 . . . . 0.0 109.852 166.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -52.77 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.639 2.893 . . . . 0.0 117.176 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.73 133.87 35.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.13 0.572 . . . . 0.0 110.138 165.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -130.84 98.58 19.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 116.028 -1.939 . . . . 0.0 110.172 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -79.22 155.46 90.62 Favored 'Cis proline' 0 CA--C 1.558 1.688 0 CA-C-N 123.34 2.229 . . . . 0.0 114.753 1.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 54' ' ' LEU 0.289 0.2 OUTLIER -68.66 136.18 90.38 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.529 0.68 . . . . 0.0 109.759 157.029 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.75 166.25 8.77 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.487 5.458 . . . . 0.0 119.323 -163.908 . . . . . . . . 5 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.27 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.6 tp -109.0 102.92 11.87 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 131.678 3.991 . . . . 0.0 104.949 -172.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.269 1.6 p90 -149.4 170.19 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.72 132.62 33.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.058 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.34 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.88 23.24 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -68.6 -29.11 67.55 Favored 'General case' 0 N--CA 1.486 1.345 1 O-C-N 113.929 -5.482 . . . . 0.0 115.599 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.93 -23.16 41.93 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 . . . . . 0 N--CA 1.494 1.77 0 CA-C-N 120.75 1.614 . . . . 0.0 113.993 158.832 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.569 HG23 HD22 ' A' ' 4' ' ' LEU . 32.5 p . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 113.529 -3.129 . . . . 0.0 115.495 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.71 105.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 125.777 3.899 . . . . 0.0 107.246 -171.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.96 -6.13 51.14 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.889 3.949 . . . . 0.0 121.626 -169.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.42 72.15 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.58 -7.0 57.11 Favored 'General case' 0 N--CA 1.493 1.694 1 O-C-N 114.327 -5.233 . . . . 0.0 117.843 173.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.49 130.41 93.31 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-N 121.896 2.134 . . . . 0.0 109.848 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.36 -52.65 8.43 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.684 2.923 . . . . 0.0 117.177 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.45 133.78 35.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.097 0.559 . . . . 0.0 110.269 166.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -132.68 98.46 16.31 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-O 115.998 -1.954 . . . . 0.0 110.077 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.22 153.28 88.91 Favored 'Cis proline' 0 CA--C 1.557 1.663 0 CA-C-N 123.351 2.232 . . . . 0.0 114.62 2.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.509 ' H ' HD23 ' A' ' 54' ' ' LEU 0.281 0.2 OUTLIER -68.68 135.85 90.32 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-O 121.49 0.662 . . . . 0.0 109.839 158.144 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -87.13 166.25 8.24 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.416 5.411 . . . . 0.0 119.323 -162.012 . . . . . . . . 5 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.2 tp -108.51 101.79 10.93 Favored 'General case' 0 N--CA 1.516 2.847 1 C-N-CA 131.797 4.039 . . . . 0.0 104.856 -172.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.277 1.5 p90 -148.15 170.09 18.59 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.82 32.89 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.168 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.88 154.33 45.05 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.26 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.49 -29.89 66.55 Favored 'General case' 0 N--CA 1.484 1.261 1 O-C-N 113.843 -5.536 . . . . 0.0 115.454 -177.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.82 -23.0 36.73 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 165.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 . . . . . 0 N--CA 1.495 1.781 0 CA-C-N 120.025 1.284 . . . . 0.0 113.157 157.914 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.543 ' CG2' HD22 ' A' ' 4' ' ' LEU . 36.4 p . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 114.36 -2.733 . . . . 0.0 115.462 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.261 1.6 m -63.81 112.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-N 125.742 3.883 . . . . 0.0 105.703 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.13 59.34 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.279 3.672 . . . . 0.0 121.626 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.86 72.66 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.23 -7.26 56.92 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.345 -5.222 . . . . 0.0 117.797 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.27 130.19 93.63 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-N 121.708 2.049 . . . . 0.0 109.907 167.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.7 -52.84 7.95 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.607 2.871 . . . . 0.0 117.151 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 133.26 35.55 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.127 0.571 . . . . 0.0 110.253 166.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -132.58 98.75 16.21 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 116.05 -1.929 . . . . 0.0 110.031 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.28 153.61 89.0 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 CA-C-N 123.297 2.213 . . . . 0.0 114.75 2.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.1 OUTLIER -67.59 133.51 92.7 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-O 121.107 0.479 . . . . 0.0 109.778 158.033 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.87 166.25 10.04 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.196 5.264 . . . . 0.0 119.323 -163.246 . . . . . . . . 5 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.18 54.03 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.1 tp -108.82 102.85 11.84 Favored 'General case' 0 N--CA 1.512 2.663 1 C-N-CA 131.708 4.003 . . . . 0.0 104.876 -172.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.268 1.6 p90 -149.06 170.29 18.73 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.74 132.53 32.92 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.097 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.45 154.33 45.5 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.48 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.48 -29.77 66.39 Favored 'General case' 0 N--CA 1.483 1.224 1 O-C-N 114.226 -5.296 . . . . 0.0 115.281 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -81.29 -18.12 46.95 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 165.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 . . . . . 0 CA--C 1.569 1.69 0 CA-C-N 119.789 1.177 . . . . 0.0 112.754 157.336 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.56 ' CG2' HD22 ' A' ' 4' ' ' LEU . 32.3 p . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 113.986 -2.912 . . . . 0.0 115.32 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.26 103.4 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 125.45 3.75 . . . . 0.0 106.501 -169.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.22 -6.13 42.41 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.224 3.647 . . . . 0.0 121.626 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.07 74.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -77.04 -6.45 52.77 Favored 'General case' 0 N--CA 1.493 1.709 1 O-C-N 114.413 -5.18 . . . . 0.0 117.591 173.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.52 130.82 93.15 Favored Pre-proline 0 CA--C 1.576 1.948 0 CA-C-N 121.376 1.898 . . . . 0.0 109.899 166.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.32 -53.32 6.86 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 C-N-CA 123.627 2.885 . . . . 0.0 116.992 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.06 133.67 35.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.145 0.578 . . . . 0.0 110.312 167.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mtm105 -133.51 98.23 15.28 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-O 116.041 -1.933 . . . . 0.0 109.952 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.51 152.14 86.51 Favored 'Cis proline' 0 CA--C 1.556 1.62 0 CA-C-N 123.267 2.203 . . . . 0.0 114.594 2.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 54' ' ' LEU 0.276 0.1 OUTLIER -68.09 137.05 91.81 Favored Pre-proline 0 N--CA 1.493 1.71 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 158.172 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.92 166.25 5.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.974 5.116 . . . . 0.0 119.323 -161.045 . . . . . . . . 5 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.941 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.3 tp -108.5 101.41 10.58 Favored 'General case' 0 N--CA 1.516 2.869 1 C-N-CA 131.818 4.047 . . . . 0.0 104.885 -172.307 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.284 1.4 p90 -147.92 169.92 18.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.33 132.58 31.79 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.08 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.04 154.33 44.89 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.58 -28.97 66.42 Favored 'General case' 0 N--CA 1.488 1.426 1 O-C-N 113.626 -5.671 . . . . 0.0 115.681 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.22 -20.52 34.44 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 167.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 . . . . . 0 N--CA 1.494 1.73 0 CA-C-N 120.392 1.451 . . . . 0.0 113.348 157.406 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.517 ' CG2' HD22 ' A' ' 4' ' ' LEU . 40.9 p . . . . . 0 CA--C 1.555 1.16 0 CA-C-O 115.124 -2.37 . . . . 0.0 114.764 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 2.2 m -64.28 115.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-N 125.75 3.886 . . . . 0.0 105.903 168.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.08 -6.13 63.77 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.446 4.203 . . . . 0.0 121.626 179.588 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.92 -6.34 55.95 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.853 173.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.51 129.85 93.45 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 121.773 2.079 . . . . 0.0 109.799 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.48 -52.56 8.61 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 123.602 2.868 . . . . 0.0 117.221 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.25 133.5 35.34 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.037 0.535 . . . . 0.0 110.228 166.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.7 mtm105 -132.23 98.6 16.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.095 -172.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.36 154.06 89.08 Favored 'Cis proline' 0 CA--C 1.558 1.697 0 CA-C-N 123.282 2.208 . . . . 0.0 114.799 2.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.1 OUTLIER -66.72 134.45 94.22 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.173 0.511 . . . . 0.0 109.645 157.213 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.98 166.25 8.45 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.99 5.127 . . . . 0.0 119.323 -164.23 . . . . . . . . 5 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.941 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.07 54.05 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.963 HD23 ' HB2' ' A' ' 97' ' ' ALA . 8.1 tp -108.59 101.1 10.28 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 131.628 3.971 . . . . 0.0 104.828 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.29 1.4 p90 -147.13 169.18 19.85 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.59 132.99 33.88 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.07 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.63 23.52 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.73 -29.88 62.5 Favored 'General case' 0 N--CA 1.483 1.22 1 O-C-N 113.933 -5.48 . . . . 0.0 115.525 -176.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 mp -82.48 -27.15 31.99 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 . . . . . 0 N--CA 1.494 1.765 0 CA-C-N 120.54 1.518 . . . . 0.0 114.088 158.918 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.584 ' CG2' HD22 ' A' ' 4' ' ' LEU . 40.2 p . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 113.936 -2.935 . . . . 0.0 115.739 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 2.4 m -62.61 108.33 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 125.848 3.931 . . . . 0.0 106.519 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.43 -6.13 49.31 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.36 71.2 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.4 -8.09 58.85 Favored 'General case' 0 N--CA 1.494 1.764 1 O-C-N 114.224 -5.298 . . . . 0.0 118.004 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -66.67 131.21 94.05 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-N 122.132 2.242 . . . . 0.0 110.233 168.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.9 -52.97 7.8 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.585 2.857 . . . . 0.0 117.259 176.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -92.49 135.11 34.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.119 0.567 . . . . 0.0 110.354 166.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -134.22 98.87 13.76 Favored Pre-proline 0 N--CA 1.488 1.466 0 CA-C-O 116.111 -1.9 . . . . 0.0 110.102 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.69 151.03 88.14 Favored 'Cis proline' 0 CA--C 1.557 1.662 0 CA-C-N 123.25 2.196 . . . . 0.0 114.566 2.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 54' ' ' LEU 0.259 0.1 OUTLIER -67.63 132.97 92.65 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.897 159.327 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.94 166.25 9.93 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.376 5.384 . . . . 0.0 119.323 -161.521 . . . . . . . . 5 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.963 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.83 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.934 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.9 tp -109.01 102.21 11.22 Favored 'General case' 0 N--CA 1.517 2.914 1 C-N-CA 131.892 4.077 . . . . 0.0 104.994 -172.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.728 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.266 1.5 p90 -149.13 170.61 18.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.31 132.76 32.11 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.205 173.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.35 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD11 ' C13' ' A' ' 163' ' ' BDM . 32.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.49 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.88 -28.11 66.4 Favored 'General case' 0 N--CA 1.484 1.251 1 O-C-N 113.913 -5.492 . . . . 0.0 115.502 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -84.13 -20.93 31.67 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 166.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 -60.3 -45.01 94.85 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 120.643 1.565 . . . . 0.0 113.347 155.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -73.8 -19.84 60.64 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 116.689 -1.624 . . . . 0.0 115.181 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -60.65 -56.57 19.73 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 122.463 2.392 . . . . 0.0 111.05 161.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.108 ' HA ' HH12 ' A' ' 57' ' ' ARG . 69.0 ttt180 -53.06 -36.08 60.23 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.03 -27.37 10.68 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -60.09 -15.72 25.68 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 120.977 1.717 . . . . 0.0 115.123 154.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.511 ' CG2' HD22 ' A' ' 4' ' ' LEU . 43.8 p -125.54 27.33 6.54 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 115.969 -1.967 . . . . 0.0 114.196 161.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 31' ' ' ARG . 1.4 m -67.75 117.61 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.407 0 CA-C-N 125.257 3.662 . . . . 0.0 104.876 165.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.9 -6.13 66.8 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.231 4.56 . . . . 0.0 121.626 177.612 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.74 73.69 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.3 -7.57 56.22 Favored 'General case' 0 N--CA 1.493 1.687 1 O-C-N 114.37 -5.206 . . . . 0.0 117.66 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -67.22 130.45 93.63 Favored Pre-proline 0 CA--C 1.576 1.951 0 CA-C-N 121.495 1.952 . . . . 0.0 109.94 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.714 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.3 Cg_exo -53.06 -53.29 7.01 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.632 2.888 . . . . 0.0 117.088 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.62 133.47 35.08 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.097 0.559 . . . . 0.0 110.367 167.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -133.65 98.14 15.17 Favored Pre-proline 0 N--CA 1.488 1.431 0 CA-C-O 116.069 -1.92 . . . . 0.0 109.993 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.63 152.25 86.19 Favored 'Cis proline' 0 CA--C 1.557 1.666 0 CA-C-N 123.27 2.203 . . . . 0.0 114.67 2.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.591 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.87 136.19 94.41 Favored Pre-proline 0 N--CA 1.493 1.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.019 157.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.98 166.25 5.75 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.657 4.905 . . . . 0.0 119.323 -162.155 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.108 HH12 ' HA ' ' A' ' 31' ' ' ARG . 12.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.934 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.728 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.29 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.8 tp -109.41 102.88 11.74 Favored 'General case' 0 N--CA 1.514 2.733 1 C-N-CA 131.753 4.021 . . . . 0.0 105.077 -172.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.722 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.262 1.6 p90 -149.72 170.54 18.47 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 178.407 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.8 132.75 33.1 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.076 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.47 154.33 45.48 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD11 ' C13' ' A' ' 163' ' ' BDM . 36.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.12 23.46 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.39 -31.7 67.59 Favored 'General case' 0 N--CA 1.485 1.32 1 O-C-N 113.977 -5.452 . . . . 0.0 115.407 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.64 -29.36 56.42 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -66.98 -34.02 76.85 Favored 'General case' 0 CA--C 1.569 1.691 0 CA-C-N 120.356 1.435 . . . . 0.0 114.173 162.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -74.02 -26.15 60.27 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 116.64 -1.648 . . . . 0.0 114.724 163.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -54.28 -54.51 39.25 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 122.571 2.441 . . . . 0.0 111.646 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.022 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 57.2 ttt85 -48.1 -59.8 3.11 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.7 -24.48 25.18 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 -171.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -60.37 -14.69 20.06 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 155.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.573 ' CG2' HD22 ' A' ' 4' ' ' LEU . 37.0 p -118.45 3.5 11.84 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 114.242 -2.79 . . . . 0.0 115.721 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.75 103.6 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.147 0 CA-C-N 125.37 3.714 . . . . 0.0 106.149 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.21 -6.13 39.35 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.848 3.931 . . . . 0.0 121.626 -169.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.16 73.01 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -77.77 -7.09 56.09 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.404 -5.185 . . . . 0.0 117.715 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.49 130.67 93.24 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 121.652 2.024 . . . . 0.0 109.876 166.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.693 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.9 Cg_exo -52.94 -52.92 7.73 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.621 2.88 . . . . 0.0 117.138 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.96 133.7 35.06 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.135 0.574 . . . . 0.0 110.345 166.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -133.45 98.25 15.35 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-O 116.064 -1.922 . . . . 0.0 110.01 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.41 152.33 87.11 Favored 'Cis proline' 0 CA--C 1.557 1.645 0 CA-C-N 123.276 2.206 . . . . 0.0 114.652 2.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.2 OUTLIER -67.62 137.0 92.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-O 121.258 0.551 . . . . 0.0 110.017 157.984 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.11 166.25 5.62 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.879 5.053 . . . . 0.0 119.323 -161.602 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.022 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 9.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.722 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.6 tp -109.1 101.38 10.43 Favored 'General case' 0 N--CA 1.518 2.934 1 C-N-CA 131.995 4.118 . . . . 0.0 105.039 -171.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.701 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.272 1.4 p90 -148.83 170.39 18.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 179.099 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.96 32.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.922 1.289 . . . . 0.0 109.25 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.0 154.33 44.93 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.412 HD11 ' C13' ' A' ' 163' ' ' BDM . 36.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.24 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.02 -29.3 66.32 Favored 'General case' 0 N--CA 1.486 1.341 1 O-C-N 113.65 -5.656 . . . . 0.0 115.665 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.09 -24.6 32.6 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 69.6 m-70 -59.86 -41.17 90.88 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 120.709 1.595 . . . . 0.0 113.851 157.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -74.27 -20.94 59.97 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 168.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.457 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 3.4 t80 -63.44 -52.44 61.47 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 122.533 2.424 . . . . 0.0 111.88 161.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.097 ' HA ' HH12 ' A' ' 57' ' ' ARG . 47.3 ttt85 -38.98 -42.66 0.89 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 171.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.67 -27.58 7.04 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -60.02 -20.69 59.19 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 121.168 1.804 . . . . 0.0 114.711 153.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 p -126.06 64.17 1.23 Allowed 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 119.29 0.95 . . . . 0.0 109.792 153.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.09 133.3 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.162 0 CA-C-O 114.644 -2.598 . . . . 0.0 104.494 143.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.26 -6.13 82.53 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.169 4.077 . . . . 0.0 121.626 168.19 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.8 -6.98 57.37 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.824 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -67.49 128.28 93.57 Favored Pre-proline 0 CA--C 1.577 1.989 0 CA-C-N 121.82 2.1 . . . . 0.0 109.677 167.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.63 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.2 Cg_exo -52.51 -52.18 9.47 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.675 2.916 . . . . 0.0 117.255 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.7 131.63 36.28 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.073 0.549 . . . . 0.0 110.07 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -130.03 99.26 20.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 115.996 -1.954 . . . . 0.0 109.939 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -79.63 156.68 89.37 Favored 'Cis proline' 0 CA--C 1.559 1.762 0 CA-C-N 123.308 2.217 . . . . 0.0 114.981 2.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 54' ' ' LEU 0.284 0.1 OUTLIER -68.62 130.55 91.86 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 157.42 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.01 166.25 16.86 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.761 5.641 . . . . 0.0 119.323 -165.484 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.097 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.701 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.39 53.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.4 tp -109.37 104.0 13.03 Favored 'General case' 0 N--CA 1.513 2.712 1 C-N-CA 131.726 4.01 . . . . 0.0 105.028 -172.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.689 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.257 1.7 p90 -150.74 170.77 18.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.75 132.64 33.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.065 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.26 154.33 45.7 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD11 ' C13' ' A' ' 163' ' ' BDM . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.45 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.11 -28.33 66.38 Favored 'General case' 0 N--CA 1.484 1.245 1 O-C-N 113.996 -5.44 . . . . 0.0 115.527 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.8 -17.85 46.13 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 165.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.507 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 12.2 m-70 -67.55 -41.23 84.58 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.249 1.386 . . . . 0.0 113.284 157.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -72.3 -25.52 61.61 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 116.98 -1.486 . . . . 0.0 114.905 167.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -57.0 -52.23 66.07 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 122.117 2.235 . . . . 0.0 112.006 161.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.033 ' HA ' HH12 ' A' ' 57' ' ' ARG . 53.7 ttt85 -42.42 -64.05 0.66 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 170.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.35 -23.18 19.32 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 118.274 2.694 . . . . 0.0 118.274 -165.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -62.04 -6.22 2.77 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 154.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.581 HG23 HD22 ' A' ' 4' ' ' LEU . 34.2 p -122.63 -4.76 8.7 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 113.727 -3.035 . . . . 0.0 115.244 164.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.73 104.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 125.534 3.788 . . . . 0.0 106.777 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 -6.13 48.49 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.207 3.639 . . . . 0.0 121.626 -168.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -76.98 -8.18 56.93 Favored 'General case' 0 N--CA 1.492 1.671 1 O-C-N 114.36 -5.212 . . . . 0.0 117.733 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -67.39 131.04 93.29 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 121.503 1.956 . . . . 0.0 109.984 167.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.664 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.8 Cg_exo -52.96 -52.95 7.67 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.58 2.854 . . . . 0.0 117.138 175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.12 134.18 34.74 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.169 0.588 . . . . 0.0 110.365 167.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.6 mtm105 -134.63 97.91 13.89 Favored Pre-proline 0 N--CA 1.488 1.443 0 CA-C-O 116.044 -1.931 . . . . 0.0 109.963 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.49 150.73 84.77 Favored 'Cis proline' 0 CA--C 1.556 1.597 0 CA-C-N 123.253 2.198 . . . . 0.0 114.502 2.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 54' ' ' LEU 0.261 0.2 OUTLIER -67.83 137.94 92.79 Favored Pre-proline 0 N--CA 1.492 1.667 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 158.577 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.28 166.25 4.48 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.715 4.943 . . . . 0.0 119.323 -160.033 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.033 HH12 ' HA ' ' A' ' 31' ' ' ARG . 5.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.689 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.92 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.7 tp -108.42 101.97 11.1 Favored 'General case' 0 N--CA 1.515 2.811 1 C-N-CA 131.788 4.035 . . . . 0.0 104.957 -172.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.664 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.284 1.4 p90 -148.63 169.92 19.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 178.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 132.43 31.09 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.995 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.11 154.33 44.81 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.99 23.79 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.88 -22.44 61.51 Favored 'General case' 0 N--CA 1.487 1.408 1 O-C-N 113.455 -5.778 . . . . 0.0 115.999 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.72 -26.06 20.86 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 125.6 1.56 . . . . 0.0 114.821 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -61.39 -45.34 94.78 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 119.574 1.079 . . . . 0.0 113.901 154.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -77.35 -24.1 50.75 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.518 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.2 t80 -56.88 -56.96 14.88 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 122.393 2.36 . . . . 0.0 111.351 161.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.966 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 66.7 ttt180 -46.9 -42.37 17.47 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.87 -18.9 13.91 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -56.25 -45.85 79.87 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 121.009 1.732 . . . . 0.0 112.171 152.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.527 ' CG2' HD22 ' A' ' 4' ' ' LEU . 68.3 p -94.18 16.82 13.85 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 114.627 -2.606 . . . . 0.0 116.17 170.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.275 0.9 OUTLIER -63.12 113.91 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 125.778 3.899 . . . . 0.0 106.012 169.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.78 -6.13 58.57 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.764 3.893 . . . . 0.0 121.626 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.87 71.58 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.0 p -79.68 -5.27 54.82 Favored 'General case' 0 N--CA 1.493 1.719 1 O-C-N 114.303 -5.248 . . . . 0.0 117.882 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.8 129.91 93.13 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-N 122.025 2.193 . . . . 0.0 109.876 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.597 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.3 Cg_exo -51.77 -52.41 9.04 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 123.58 2.854 . . . . 0.0 117.322 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -91.69 134.82 34.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.092 0.557 . . . . 0.0 110.277 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -132.83 98.34 16.2 Favored Pre-proline 0 N--CA 1.488 1.453 0 CA-C-O 116.095 -1.907 . . . . 0.0 110.217 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.01 153.12 89.62 Favored 'Cis proline' 0 CA--C 1.557 1.632 0 CA-C-N 123.182 2.172 . . . . 0.0 114.686 1.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -65.55 137.86 96.62 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.236 0.541 . . . . 0.0 109.935 156.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.65 166.25 4.11 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.371 4.714 . . . . 0.0 119.323 -164.031 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.966 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 6.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.664 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.03 54.06 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.953 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.0 tp -108.49 102.32 11.42 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 131.677 3.991 . . . . 0.0 104.84 -172.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.701 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.281 1.5 p90 -148.61 169.81 19.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.54 32.46 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.983 173.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.91 154.33 45.03 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.419 HD11 ' C13' ' A' ' 163' ' ' BDM . 35.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.91 23.23 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.31 -27.77 66.58 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.835 -5.54 . . . . 0.0 115.844 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.39 -23.72 34.81 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 166.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -59.87 -42.77 94.46 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 120.855 1.661 . . . . 0.0 114.005 156.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -74.34 -26.08 59.93 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 116.678 -1.629 . . . . 0.0 114.829 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 12.9 t80 -55.41 -53.27 58.32 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 122.543 2.428 . . . . 0.0 111.614 162.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.921 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 53.7 ttt85 -44.66 -66.67 0.36 Allowed 'General case' 0 C--N 1.355 0.833 0 O-C-N 124.191 0.932 . . . . 0.0 113.024 172.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.76 -24.28 28.87 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 118.173 2.657 . . . . 0.0 118.173 -167.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -61.99 -9.64 7.69 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 155.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.566 ' CG2' HD22 ' A' ' 4' ' ' LEU . 37.0 p -122.13 1.49 9.75 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 114.164 -2.826 . . . . 0.0 115.874 165.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 m -64.99 103.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 1 CA-C-O 111.52 -4.086 . . . . 0.0 106.901 -170.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.41 -6.13 45.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.17 4.532 . . . . 0.0 121.626 -167.776 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.18 71.87 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -79.3 -5.66 54.94 Favored 'General case' 0 N--CA 1.494 1.755 1 O-C-N 114.332 -5.23 . . . . 0.0 117.866 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.71 129.94 93.21 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 121.964 2.165 . . . . 0.0 109.791 167.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.647 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.2 Cg_exo -52.42 -52.63 8.47 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 C-N-CA 123.637 2.891 . . . . 0.0 117.18 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.68 132.4 36.39 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.022 0.529 . . . . 0.0 110.099 165.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -130.36 99.47 19.27 Favored Pre-proline 0 N--CA 1.488 1.459 0 CA-C-O 115.987 -1.958 . . . . 0.0 110.045 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.12 155.95 91.15 Favored 'Cis proline' 0 CA--C 1.559 1.749 0 CA-C-N 123.323 2.223 . . . . 0.0 114.877 2.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 54' ' ' LEU 0.292 0.1 OUTLIER -69.3 131.58 90.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 121.377 0.608 . . . . 0.0 109.474 157.784 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.5 166.25 15.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.008 5.806 . . . . 0.0 119.323 -164.518 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.921 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 1.9 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.953 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.701 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.3 tp -108.95 100.52 9.71 Favored 'General case' 0 N--CA 1.517 2.903 1 C-N-CA 132.079 4.152 . . . . 0.0 104.999 -171.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.709 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.283 1.3 p90 -147.96 170.03 18.6 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 133.04 32.04 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.189 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.28 154.33 44.63 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.408 HD11 ' C13' ' A' ' 163' ' ' BDM . 37.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.33 23.7 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.487 1.404 1 O-C-N 113.473 -5.767 . . . . 0.0 115.747 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.24 -21.84 33.25 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.67 -40.75 95.94 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.892 1.224 . . . . 0.0 113.333 158.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -74.35 -20.87 59.93 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.476 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 3.7 t80 -63.34 -53.23 55.91 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 122.556 2.434 . . . . 0.0 111.713 161.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.033 ' HG3' HH22 ' A' ' 57' ' ' ARG . 56.0 ttt180 -54.19 -22.59 11.77 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.4 -27.58 5.17 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -60.55 -21.69 62.82 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 121.249 1.84 . . . . 0.0 114.569 151.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.6 p -124.3 72.68 1.2 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 151.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.87 136.63 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 137.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.35 -6.13 80.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.694 3.861 . . . . 0.0 121.626 165.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.9 71.6 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.71 -6.05 56.43 Favored 'General case' 0 N--CA 1.493 1.685 1 O-C-N 114.32 -5.238 . . . . 0.0 117.98 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -67.62 129.18 93.54 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 122.018 2.19 . . . . 0.0 109.663 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.632 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.1 Cg_exo -52.13 -52.14 9.59 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.656 2.904 . . . . 0.0 117.344 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.12 133.43 35.35 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.047 0.539 . . . . 0.0 110.155 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -131.5 98.7 17.94 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-O 115.982 -1.961 . . . . 0.0 110.072 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 154.61 89.57 Favored 'Cis proline' 0 CA--C 1.559 1.748 0 CA-C-N 123.274 2.205 . . . . 0.0 114.768 2.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 54' ' ' LEU 0.281 0.1 OUTLIER -68.06 133.95 91.75 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-O 121.346 0.593 . . . . 0.0 109.663 157.326 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.48 166.25 10.59 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.684 5.589 . . . . 0.0 119.323 -163.715 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.033 HH22 ' HG3' ' A' ' 31' ' ' ARG . 9.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.778 H191 ' HD2' ' A' ' 31' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.8 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.945 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.1 tp -108.71 102.13 11.21 Favored 'General case' 0 N--CA 1.516 2.828 1 C-N-CA 131.813 4.045 . . . . 0.0 104.955 -172.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.736 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.272 1.5 p90 -148.77 170.32 18.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.09 132.85 32.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.185 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.82 154.33 45.12 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.21 23.44 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.65 -29.51 68.0 Favored 'General case' 0 N--CA 1.486 1.328 1 O-C-N 113.705 -5.622 . . . . 0.0 115.589 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.69 -24.69 36.07 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -59.32 -42.57 91.73 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 120.887 1.676 . . . . 0.0 113.872 157.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -74.06 -22.15 59.65 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 116.687 -1.625 . . . . 0.0 115.234 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.456 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 5.7 t80 -60.09 -55.13 37.69 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 122.46 2.391 . . . . 0.0 111.437 161.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.098 ' HA ' HH12 ' A' ' 57' ' ' ARG . 57.8 ttt85 -43.64 -45.07 6.7 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.94 -27.63 10.57 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -170.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -59.76 -14.86 16.36 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 120.772 1.624 . . . . 0.0 115.238 154.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.538 ' CG2' HD22 ' A' ' 4' ' ' LEU . 39.3 p -124.01 19.84 9.17 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 114.878 -2.487 . . . . 0.0 114.921 161.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.51 117.24 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 CA-C-N 125.743 3.883 . . . . 0.0 105.592 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.13 68.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.958 4.436 . . . . 0.0 121.626 179.382 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.28 71.99 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.78 -7.5 57.87 Favored 'General case' 0 N--CA 1.493 1.699 1 O-C-N 114.305 -5.247 . . . . 0.0 117.924 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -67.27 130.12 93.64 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-N 121.872 2.124 . . . . 0.0 109.893 167.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.631 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.5 Cg_exo -52.57 -52.73 8.22 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.671 2.914 . . . . 0.0 117.168 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.46 132.53 36.18 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.105 0.562 . . . . 0.0 110.201 166.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -131.57 99.31 17.25 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 115.982 -1.961 . . . . 0.0 109.947 -172.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.28 154.6 89.91 Favored 'Cis proline' 0 CA--C 1.559 1.745 0 CA-C-N 123.356 2.234 . . . . 0.0 114.799 2.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 54' ' ' LEU 0.283 0.2 OUTLIER -69.33 129.95 91.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 158.755 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -81.56 166.25 17.8 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.225 5.95 . . . . 0.0 119.323 -163.359 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.098 HH12 ' HA ' ' A' ' 31' ' ' ARG . 13.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.945 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.2 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.736 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.82 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.956 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.5 tp -108.73 100.15 9.42 Favored 'General case' 0 N--CA 1.517 2.925 1 C-N-CA 131.974 4.11 . . . . 0.0 104.938 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.687 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.293 1.2 p90 -147.4 169.65 19.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.89 132.62 30.72 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.161 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.4 154.33 44.52 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.42 23.35 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.79 -25.37 61.14 Favored 'General case' 0 N--CA 1.486 1.353 1 O-C-N 113.46 -5.775 . . . . 0.0 115.815 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt -85.89 -26.84 25.39 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 88.4 m-70 -66.61 -40.98 89.07 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.626 1.103 . . . . 0.0 113.869 158.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -73.89 -20.49 60.39 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 172.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.7 t80 -61.01 -52.69 63.91 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 121.697 2.044 . . . . 0.0 111.973 158.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.059 ' HA ' HH12 ' A' ' 57' ' ' ARG . 73.5 ttt180 -42.05 -36.02 1.04 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 118.397 2.739 . . . . 0.0 118.397 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.28 -24.11 5.13 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -59.42 -36.06 75.15 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 121.217 1.826 . . . . 0.0 113.384 154.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.1 p -110.6 71.48 0.75 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 155.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.36 139.43 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 CA-C-O 115.39 -2.243 . . . . 0.0 105.204 135.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 -6.13 82.09 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.626 3.83 . . . . 0.0 121.626 165.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.29 73.17 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.24 -5.63 52.5 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.362 -5.211 . . . . 0.0 117.697 173.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -67.46 129.93 93.47 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-N 121.568 1.986 . . . . 0.0 109.932 166.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.659 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.2 Cg_exo -52.6 -52.9 7.83 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.653 2.902 . . . . 0.0 117.141 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.21 134.11 34.82 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.12 0.568 . . . . 0.0 110.24 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -132.91 98.21 16.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 116.046 -1.93 . . . . 0.0 110.106 -172.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.38 152.87 87.87 Favored 'Cis proline' 0 CA--C 1.558 1.679 0 CA-C-N 123.27 2.203 . . . . 0.0 114.723 2.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -65.06 137.54 97.11 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.124 0.488 . . . . 0.0 109.993 156.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.79 166.25 3.98 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.117 4.545 . . . . 0.0 119.323 -164.011 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.059 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.956 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.687 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.35 54.0 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.2 tp -109.33 104.2 13.28 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 131.668 3.987 . . . . 0.0 105.051 -172.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.719 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.251 1.7 p90 -150.79 170.85 18.26 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.5 132.79 33.78 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.88 1.272 . . . . 0.0 109.124 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.16 154.33 45.8 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.83 23.55 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.59 -26.2 64.35 Favored 'General case' 0 N--CA 1.481 1.11 1 O-C-N 114.193 -5.317 . . . . 0.0 115.451 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.2 -17.54 36.82 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 166.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -64.05 -45.14 90.14 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.32 1.418 . . . . 0.0 113.037 155.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -73.79 -22.89 59.67 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 116.835 -1.555 . . . . 0.0 115.146 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -57.55 -56.4 22.35 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 122.266 2.303 . . . . 0.0 111.172 161.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.956 ' HA ' HH12 ' A' ' 57' ' ' ARG . 59.3 ttt180 -49.35 -47.91 47.03 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.65 -24.11 14.15 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 117.993 2.59 . . . . 0.0 117.993 -169.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -60.09 -10.24 4.12 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 120.903 1.683 . . . . 0.0 115.511 152.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.583 HG23 HD22 ' A' ' 4' ' ' LEU . 25.4 p -117.94 -4.35 11.09 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 113.469 -3.158 . . . . 0.0 115.411 164.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.253 2.7 m -61.24 107.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 125.886 3.948 . . . . 0.0 107.024 -173.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.88 -6.13 54.15 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.28 74.54 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.5 p -76.4 -7.48 55.13 Favored 'General case' 0 N--CA 1.492 1.657 1 O-C-N 114.427 -5.171 . . . . 0.0 117.576 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.42 131.67 93.17 Favored Pre-proline 0 CA--C 1.576 1.976 0 CA-C-N 121.33 1.877 . . . . 0.0 109.998 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.729 ' HD3' BR11 ' A' ' 163' ' ' BDM . 50.3 Cg_exo -53.43 -53.31 6.82 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.601 2.867 . . . . 0.0 117.034 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.15 134.11 34.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.169 0.587 . . . . 0.0 110.397 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 mtm105 -134.83 97.8 13.69 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.068 -1.92 . . . . 0.0 109.982 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.46 150.64 84.72 Favored 'Cis proline' 0 CA--C 1.557 1.643 0 CA-C-N 123.282 2.208 . . . . 0.0 114.499 2.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 54' ' ' LEU 0.262 0.2 OUTLIER -67.67 138.72 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 158.234 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -91.07 166.25 3.73 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.557 4.838 . . . . 0.0 119.323 -159.988 . . . . . . . . 5 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.956 HH12 ' HA ' ' A' ' 31' ' ' ARG . 5.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.729 BR11 ' HD3' ' A' ' 50' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.7 tp -108.26 101.41 10.62 Favored 'General case' 0 N--CA 1.515 2.788 1 C-N-CA 131.767 4.027 . . . . 0.0 104.878 -172.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.694 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.291 1.3 p90 -147.83 169.7 19.23 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 178.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.48 132.58 31.5 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.035 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.3 23.71 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.61 -24.49 61.08 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.567 -5.708 . . . . 0.0 115.796 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.2 -27.11 26.34 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -66.24 -42.09 89.07 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 158.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -75.77 -25.16 56.22 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 116.723 -1.608 . . . . 0.0 114.911 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.522 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.7 t80 -55.6 -54.8 39.63 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 122.517 2.417 . . . . 0.0 111.275 159.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.071 ' HA ' HH12 ' A' ' 57' ' ' ARG . 53.3 ttt85 -44.87 -49.3 11.0 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.251 . . -103.64 -17.46 15.13 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 118.184 2.661 . . . . 0.0 118.184 -171.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -55.76 -46.56 77.84 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 120.935 1.698 . . . . 0.0 112.117 153.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.524 ' CG2' HD22 ' A' ' 4' ' ' LEU . 41.4 p -92.57 10.04 32.05 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 114.374 -2.727 . . . . 0.0 116.903 171.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.282 1.9 m -61.98 111.37 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-N 125.757 3.889 . . . . 0.0 106.528 173.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.69 -6.13 54.68 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.059 3.572 . . . . 0.0 121.626 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.69 72.47 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.34 -7.55 57.41 Favored 'General case' 0 N--CA 1.494 1.75 1 O-C-N 114.307 -5.246 . . . . 0.0 117.824 173.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.2 130.42 93.66 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 121.714 2.052 . . . . 0.0 110.1 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.633 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.1 Cg_exo -52.34 -53.07 7.54 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.595 2.863 . . . . 0.0 117.222 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.72 134.52 34.65 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.109 0.564 . . . . 0.0 110.345 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -134.12 98.61 14.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 116.043 -1.932 . . . . 0.0 110.03 -171.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.27 151.15 86.27 Favored 'Cis proline' 0 CA--C 1.558 1.703 0 CA-C-N 123.227 2.188 . . . . 0.0 114.682 2.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.13 132.24 94.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 158.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.4 166.25 9.27 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.091 5.194 . . . . 0.0 119.323 -162.493 . . . . . . . . 5 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.071 HH12 ' HA ' ' A' ' 31' ' ' ARG . 9.5 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.5 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.694 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.9 tp -108.64 100.05 9.34 Favored 'General case' 0 N--CA 1.517 2.888 1 C-N-CA 131.936 4.094 . . . . 0.0 104.889 -171.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.707 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.295 1.2 p90 -147.01 169.63 18.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.027 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.77 132.71 31.1 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.337 -1.302 . . . . 0.0 109.144 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.44 154.33 44.47 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.402 HD11 ' C12' ' A' ' 163' ' ' BDM . 21.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.43 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.21 -25.37 60.72 Favored 'General case' 0 N--CA 1.486 1.373 1 O-C-N 113.588 -5.695 . . . . 0.0 115.826 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.84 -31.76 23.64 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 171.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.555 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 73.7 m-70 -60.66 -42.59 97.33 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 158.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -74.13 -19.52 60.55 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.9 t80 -62.14 -52.37 64.11 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 122.008 2.185 . . . . 0.0 111.945 159.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.127 ' HA ' HH12 ' A' ' 57' ' ' ARG . 47.0 ttt85 -39.54 -42.25 1.12 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.57 -24.8 8.61 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -58.48 -29.92 66.59 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.198 1.817 . . . . 0.0 114.165 153.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p -118.57 62.58 0.78 Allowed 'General case' 0 CA--C 1.561 1.385 0 CA-C-N 118.97 0.804 . . . . 0.0 109.943 157.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.29 133.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 CA-C-O 115.23 -2.319 . . . . 0.0 104.866 143.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.16 -6.13 83.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.356 3.707 . . . . 0.0 121.626 168.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.93 -6.04 53.09 Favored 'General case' 0 N--CA 1.493 1.714 1 O-C-N 114.36 -5.212 . . . . 0.0 117.718 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.43 130.0 93.48 Favored Pre-proline 0 CA--C 1.574 1.9 0 CA-C-N 121.454 1.934 . . . . 0.0 110.021 167.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.672 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.0 Cg_exo -52.58 -53.13 7.39 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.606 2.871 . . . . 0.0 117.148 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.21 134.05 34.87 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.078 0.551 . . . . 0.0 110.305 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -133.24 98.35 15.56 Favored Pre-proline 0 N--CA 1.488 1.427 0 CA-C-O 116.068 -1.92 . . . . 0.0 110.091 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.5 152.42 86.9 Favored 'Cis proline' 0 CA--C 1.558 1.704 0 CA-C-N 123.223 2.187 . . . . 0.0 114.785 2.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.636 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -64.51 135.21 96.26 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.86 156.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.43 166.25 5.31 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.314 4.676 . . . . 0.0 119.323 -164.281 . . . . . . . . 5 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.127 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.707 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.96 54.07 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 7.8 tp -108.54 100.4 9.67 Favored 'General case' 0 N--CA 1.513 2.705 0 C-N-CA 131.698 3.999 . . . . 0.0 104.934 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.706 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.3 1.3 p90 -146.66 169.3 19.29 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 178.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.26 31.03 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.023 173.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.3 154.33 44.62 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.32 -25.12 61.44 Favored 'General case' 0 N--CA 1.487 1.392 1 O-C-N 113.626 -5.671 . . . . 0.0 115.745 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -83.09 -33.72 26.3 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.099 1.36 . . . . 0.0 113.87 169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -57.21 -44.67 83.9 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 158.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -76.51 -23.73 53.71 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 116.803 -1.57 . . . . 0.0 114.829 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 14.3 t80 -53.72 -52.99 58.34 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 122.332 2.333 . . . . 0.0 111.914 161.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.02 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 64.8 ttt180 -50.85 -67.04 0.29 Allowed 'General case' 0 C--N 1.355 0.808 0 O-C-N 123.912 0.757 . . . . 0.0 112.733 174.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.86 -11.76 59.54 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -170.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -61.32 -50.61 72.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.624 1.556 . . . . 0.0 111.689 154.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.55 ' CG2' HD22 ' A' ' 4' ' ' LEU . 50.5 p -88.9 10.85 19.79 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 m -66.82 102.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 CA-C-O 112.691 -3.528 . . . . 0.0 105.878 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.13 35.95 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.03 4.013 . . . . 0.0 121.626 -171.243 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.26 73.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.3 p -79.1 -4.21 49.2 Favored 'General case' 0 N--CA 1.494 1.742 1 O-C-N 114.415 -5.178 . . . . 0.0 117.696 172.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -67.25 129.1 93.86 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-N 121.562 1.983 . . . . 0.0 109.852 166.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.668 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.6 Cg_exo -52.25 -52.77 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.639 2.893 . . . . 0.0 117.176 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.73 133.87 35.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.13 0.572 . . . . 0.0 110.138 165.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -130.84 98.58 19.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 116.028 -1.939 . . . . 0.0 110.172 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -79.22 155.46 90.62 Favored 'Cis proline' 0 CA--C 1.558 1.688 0 CA-C-N 123.34 2.229 . . . . 0.0 114.753 1.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 54' ' ' LEU 0.289 0.2 OUTLIER -68.66 136.18 90.38 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.529 0.68 . . . . 0.0 109.759 157.029 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.75 166.25 8.77 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.487 5.458 . . . . 0.0 119.323 -163.908 . . . . . . . . 5 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.02 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.706 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.27 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.6 tp -109.0 102.92 11.87 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 131.678 3.991 . . . . 0.0 104.949 -172.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.713 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.269 1.6 p90 -149.4 170.19 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.033 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.72 132.62 33.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.058 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.34 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.419 HD11 ' C13' ' A' ' 163' ' ' BDM . 35.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.88 23.24 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -68.6 -29.11 67.55 Favored 'General case' 0 N--CA 1.486 1.345 1 O-C-N 113.929 -5.482 . . . . 0.0 115.599 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.93 -23.16 41.93 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 84.3 m-70 -62.92 -40.9 99.02 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 120.75 1.614 . . . . 0.0 113.993 158.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -73.86 -27.18 60.96 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 116.866 -1.54 . . . . 0.0 114.795 167.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -55.64 -51.01 68.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 122.293 2.315 . . . . 0.0 111.95 160.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.944 ' HA ' HH12 ' A' ' 57' ' ' ARG . 52.8 ttt85 -42.31 -59.43 1.83 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.53 -23.75 15.4 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.93 2.567 . . . . 0.0 117.93 -165.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -60.96 -6.61 1.93 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 152.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.569 HG23 HD22 ' A' ' 4' ' ' LEU . 32.5 p -122.32 -4.14 8.9 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 113.529 -3.129 . . . . 0.0 115.495 163.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.71 105.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 125.777 3.899 . . . . 0.0 107.246 -171.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.96 -6.13 51.14 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.889 3.949 . . . . 0.0 121.626 -169.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.42 72.15 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.58 -7.0 57.11 Favored 'General case' 0 N--CA 1.493 1.694 1 O-C-N 114.327 -5.233 . . . . 0.0 117.843 173.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.49 130.41 93.31 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-N 121.896 2.134 . . . . 0.0 109.848 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.637 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.7 Cg_exo -52.36 -52.65 8.43 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.684 2.923 . . . . 0.0 117.177 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.45 133.78 35.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.097 0.559 . . . . 0.0 110.269 166.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -132.68 98.46 16.31 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-O 115.998 -1.954 . . . . 0.0 110.077 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.22 153.28 88.91 Favored 'Cis proline' 0 CA--C 1.557 1.663 0 CA-C-N 123.351 2.232 . . . . 0.0 114.62 2.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' H ' HD23 ' A' ' 54' ' ' LEU 0.281 0.2 OUTLIER -68.68 135.85 90.32 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-O 121.49 0.662 . . . . 0.0 109.839 158.144 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -87.13 166.25 8.24 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.416 5.411 . . . . 0.0 119.323 -162.012 . . . . . . . . 5 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.944 HH12 ' HA ' ' A' ' 31' ' ' ARG . 6.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.713 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.2 tp -108.51 101.79 10.93 Favored 'General case' 0 N--CA 1.516 2.847 1 C-N-CA 131.797 4.039 . . . . 0.0 104.856 -172.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.752 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.277 1.5 p90 -148.15 170.09 18.59 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 178.077 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.82 32.89 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.168 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.88 154.33 45.05 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 HD11 ' C13' ' A' ' 163' ' ' BDM . 35.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.26 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.49 -29.89 66.55 Favored 'General case' 0 N--CA 1.484 1.261 1 O-C-N 113.843 -5.536 . . . . 0.0 115.454 -177.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.82 -23.0 36.73 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 165.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -58.69 -45.19 90.01 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 120.025 1.284 . . . . 0.0 113.157 157.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -76.04 -17.56 59.61 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-O 116.51 -1.709 . . . . 0.0 115.338 169.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 8.1 t80 -62.0 -57.68 10.75 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 122.751 2.523 . . . . 0.0 110.825 162.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.05 ' HA ' HH12 ' A' ' 57' ' ' ARG . 73.2 ttt180 -48.91 -42.46 37.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.62 -26.32 12.84 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 -170.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -59.42 -17.35 29.92 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 121.025 1.739 . . . . 0.0 115.166 153.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.543 ' CG2' HD22 ' A' ' 4' ' ' LEU . 36.4 p -118.11 12.28 13.54 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 114.36 -2.733 . . . . 0.0 115.462 163.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.261 1.6 m -63.81 112.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-N 125.742 3.883 . . . . 0.0 105.703 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.13 59.34 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.279 3.672 . . . . 0.0 121.626 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.86 72.66 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.23 -7.26 56.92 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.345 -5.222 . . . . 0.0 117.797 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.27 130.19 93.63 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-N 121.708 2.049 . . . . 0.0 109.907 167.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.66 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.3 Cg_exo -52.7 -52.84 7.95 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.607 2.871 . . . . 0.0 117.151 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 133.26 35.55 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.127 0.571 . . . . 0.0 110.253 166.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -132.58 98.75 16.21 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 116.05 -1.929 . . . . 0.0 110.031 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.28 153.61 89.0 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 CA-C-N 123.297 2.213 . . . . 0.0 114.75 2.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.1 OUTLIER -67.59 133.51 92.7 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-O 121.107 0.479 . . . . 0.0 109.778 158.033 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.87 166.25 10.04 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.196 5.264 . . . . 0.0 119.323 -163.246 . . . . . . . . 5 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.05 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.752 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.18 54.03 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.1 tp -108.82 102.85 11.84 Favored 'General case' 0 N--CA 1.512 2.663 1 C-N-CA 131.708 4.003 . . . . 0.0 104.876 -172.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.737 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.268 1.6 p90 -149.06 170.29 18.73 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.74 132.53 32.92 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.097 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.45 154.33 45.5 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD11 ' C13' ' A' ' 163' ' ' BDM . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.48 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.48 -29.77 66.39 Favored 'General case' 0 N--CA 1.483 1.224 1 O-C-N 114.226 -5.296 . . . . 0.0 115.281 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -81.29 -18.12 46.95 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 165.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -63.1 -46.42 87.45 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 119.789 1.177 . . . . 0.0 112.754 157.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -73.84 -23.34 59.61 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 116.762 -1.59 . . . . 0.0 115.119 170.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -55.39 -55.11 35.34 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 122.375 2.352 . . . . 0.0 111.575 162.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.936 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 55.7 ttt85 -47.19 -62.1 1.58 Allowed 'General case' 0 C--N 1.353 0.758 0 O-C-N 124.38 1.05 . . . . 0.0 113.539 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.97 -23.54 25.04 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -169.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -62.12 -8.32 5.33 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 154.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.56 ' CG2' HD22 ' A' ' 4' ' ' LEU . 32.3 p -121.09 -2.22 9.7 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 113.986 -2.912 . . . . 0.0 115.32 165.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.26 103.4 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 125.45 3.75 . . . . 0.0 106.501 -169.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.22 -6.13 42.41 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.224 3.647 . . . . 0.0 121.626 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.07 74.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -77.04 -6.45 52.77 Favored 'General case' 0 N--CA 1.493 1.709 1 O-C-N 114.413 -5.18 . . . . 0.0 117.591 173.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.52 130.82 93.15 Favored Pre-proline 0 CA--C 1.576 1.948 0 CA-C-N 121.376 1.898 . . . . 0.0 109.899 166.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.734 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.0 Cg_exo -53.32 -53.32 6.86 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 C-N-CA 123.627 2.885 . . . . 0.0 116.992 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.06 133.67 35.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.145 0.578 . . . . 0.0 110.312 167.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mtm105 -133.51 98.23 15.28 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-O 116.041 -1.933 . . . . 0.0 109.952 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.51 152.14 86.51 Favored 'Cis proline' 0 CA--C 1.556 1.62 0 CA-C-N 123.267 2.203 . . . . 0.0 114.594 2.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 54' ' ' LEU 0.276 0.1 OUTLIER -68.09 137.05 91.81 Favored Pre-proline 0 N--CA 1.493 1.71 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 158.172 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.92 166.25 5.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.974 5.116 . . . . 0.0 119.323 -161.045 . . . . . . . . 5 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.936 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 2.6 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.737 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.941 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.3 tp -108.5 101.41 10.58 Favored 'General case' 0 N--CA 1.516 2.869 1 C-N-CA 131.818 4.047 . . . . 0.0 104.885 -172.307 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.726 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.284 1.4 p90 -147.92 169.92 18.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.33 132.58 31.79 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.08 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.04 154.33 44.89 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.41 HD11 ' C13' ' A' ' 163' ' ' BDM . 35.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.58 -28.97 66.42 Favored 'General case' 0 N--CA 1.488 1.426 1 O-C-N 113.626 -5.671 . . . . 0.0 115.681 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.22 -20.52 34.44 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 167.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 21.9 m-70 -64.32 -41.38 96.84 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.392 1.451 . . . . 0.0 113.348 157.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -74.08 -22.18 59.61 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 116.626 -1.654 . . . . 0.0 115.152 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 5.1 t80 -61.07 -55.08 36.77 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 122.639 2.472 . . . . 0.0 111.408 161.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.038 ' HA ' HH12 ' A' ' 57' ' ' ARG . 51.9 ttt85 -37.79 -49.45 1.18 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 172.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.44 -26.42 10.47 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -168.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -59.78 -14.91 16.76 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 120.948 1.704 . . . . 0.0 115.126 154.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.517 ' CG2' HD22 ' A' ' 4' ' ' LEU . 40.9 p -123.18 20.33 9.82 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 115.124 -2.37 . . . . 0.0 114.764 161.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 2.2 m -64.28 115.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-N 125.75 3.886 . . . . 0.0 105.903 168.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.08 -6.13 63.77 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.446 4.203 . . . . 0.0 121.626 179.588 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.92 -6.34 55.95 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.853 173.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.51 129.85 93.45 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 121.773 2.079 . . . . 0.0 109.799 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.652 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.6 Cg_exo -52.48 -52.56 8.61 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 123.602 2.868 . . . . 0.0 117.221 176.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.25 133.5 35.34 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.037 0.535 . . . . 0.0 110.228 166.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.7 mtm105 -132.23 98.6 16.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.095 -172.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.36 154.06 89.08 Favored 'Cis proline' 0 CA--C 1.558 1.697 0 CA-C-N 123.282 2.208 . . . . 0.0 114.799 2.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.1 OUTLIER -66.72 134.45 94.22 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.173 0.511 . . . . 0.0 109.645 157.213 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.98 166.25 8.45 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.99 5.127 . . . . 0.0 119.323 -164.23 . . . . . . . . 5 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.038 HH12 ' HA ' ' A' ' 31' ' ' ARG . 9.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.941 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.726 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.07 54.05 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.963 HD23 ' HB2' ' A' ' 97' ' ' ALA . 8.1 tp -108.59 101.1 10.28 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 131.628 3.971 . . . . 0.0 104.828 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.739 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.29 1.4 p90 -147.13 169.18 19.85 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.59 132.99 33.88 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.07 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.507 HD11 ' C13' ' A' ' 163' ' ' BDM . 40.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.63 23.52 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.73 -29.88 62.5 Favored 'General case' 0 N--CA 1.483 1.22 1 O-C-N 113.933 -5.48 . . . . 0.0 115.525 -176.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.431 HD23 H152 ' A' ' 163' ' ' BDM . 6.4 mp -82.48 -27.15 31.99 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 169.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -60.95 -41.83 97.06 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.54 1.518 . . . . 0.0 114.088 158.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -74.61 -23.92 58.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 116.93 -1.51 . . . . 0.0 114.995 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.584 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 12.1 t80 -57.59 -53.56 56.83 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 122.183 2.265 . . . . 0.0 111.929 161.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.031 ' HA ' HH12 ' A' ' 57' ' ' ARG . 57.0 ttt85 -40.73 -54.09 2.69 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 172.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.25 -24.56 14.22 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -168.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -57.87 -18.56 23.44 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 153.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.584 ' CG2' HD22 ' A' ' 4' ' ' LEU . 40.2 p -114.49 4.25 15.18 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 113.936 -2.935 . . . . 0.0 115.739 164.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 2.4 m -62.61 108.33 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 125.848 3.931 . . . . 0.0 106.519 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.43 -6.13 49.31 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.36 71.2 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.4 -8.09 58.85 Favored 'General case' 0 N--CA 1.494 1.764 1 O-C-N 114.224 -5.298 . . . . 0.0 118.004 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -66.67 131.21 94.05 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-N 122.132 2.242 . . . . 0.0 110.233 168.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.643 ' HD2' BR11 ' A' ' 163' ' ' BDM . 53.3 Cg_exo -51.9 -52.97 7.8 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.585 2.857 . . . . 0.0 117.259 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -92.49 135.11 34.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.119 0.567 . . . . 0.0 110.354 166.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -134.22 98.87 13.76 Favored Pre-proline 0 N--CA 1.488 1.466 0 CA-C-O 116.111 -1.9 . . . . 0.0 110.102 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.69 151.03 88.14 Favored 'Cis proline' 0 CA--C 1.557 1.662 0 CA-C-N 123.25 2.196 . . . . 0.0 114.566 2.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 54' ' ' LEU 0.259 0.1 OUTLIER -67.63 132.97 92.65 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.897 159.327 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.94 166.25 9.93 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.376 5.384 . . . . 0.0 119.323 -161.521 . . . . . . . . 5 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 1.031 HH12 ' HA ' ' A' ' 31' ' ' ARG . 4.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.963 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 50.6 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' BDM . . . . . 0.739 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.83 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.934 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.9 tp -109.01 102.21 11.22 Favored 'General case' 0 N--CA 1.517 2.914 1 C-N-CA 131.892 4.077 . . . . 0.0 104.994 -172.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.266 1.5 p90 -149.13 170.61 18.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.31 132.76 32.11 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.205 173.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.35 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.49 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.88 -28.11 66.4 Favored 'General case' 0 N--CA 1.484 1.251 1 O-C-N 113.913 -5.492 . . . . 0.0 115.502 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -84.13 -20.93 31.67 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 166.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 . . . . . 0 N--CA 1.497 1.878 0 CA-C-N 120.643 1.565 . . . . 0.0 113.347 155.677 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.511 ' CG2' HD22 ' A' ' 4' ' ' LEU . 43.8 p . . . . . 0 CA--C 1.557 1.238 0 CA-C-O 115.969 -1.967 . . . . 0.0 114.196 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 m -67.75 117.61 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.407 0 CA-C-N 125.257 3.662 . . . . 0.0 104.876 165.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.9 -6.13 66.8 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.231 4.56 . . . . 0.0 121.626 177.612 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.74 73.69 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.3 -7.57 56.22 Favored 'General case' 0 N--CA 1.493 1.687 1 O-C-N 114.37 -5.206 . . . . 0.0 117.66 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -67.22 130.45 93.63 Favored Pre-proline 0 CA--C 1.576 1.951 0 CA-C-N 121.495 1.952 . . . . 0.0 109.94 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.06 -53.29 7.01 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.632 2.888 . . . . 0.0 117.088 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.62 133.47 35.08 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.097 0.559 . . . . 0.0 110.367 167.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -133.65 98.14 15.17 Favored Pre-proline 0 N--CA 1.488 1.431 0 CA-C-O 116.069 -1.92 . . . . 0.0 109.993 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.63 152.25 86.19 Favored 'Cis proline' 0 CA--C 1.557 1.666 0 CA-C-N 123.27 2.203 . . . . 0.0 114.67 2.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.591 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.87 136.19 94.41 Favored Pre-proline 0 N--CA 1.493 1.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.019 157.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.98 166.25 5.75 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.657 4.905 . . . . 0.0 119.323 -162.155 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.934 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.29 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.8 tp -109.41 102.88 11.74 Favored 'General case' 0 N--CA 1.514 2.733 1 C-N-CA 131.753 4.021 . . . . 0.0 105.077 -172.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.262 1.6 p90 -149.72 170.54 18.47 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.8 132.75 33.1 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.076 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.47 154.33 45.48 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.12 23.46 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.39 -31.7 67.59 Favored 'General case' 0 N--CA 1.485 1.32 1 O-C-N 113.977 -5.452 . . . . 0.0 115.407 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.64 -29.36 56.42 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 . . . . . 0 CA--C 1.569 1.691 0 CA-C-N 120.356 1.435 . . . . 0.0 114.173 162.656 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.573 ' CG2' HD22 ' A' ' 4' ' ' LEU . 37.0 p . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 114.242 -2.79 . . . . 0.0 115.721 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.75 103.6 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.147 0 CA-C-N 125.37 3.714 . . . . 0.0 106.149 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.21 -6.13 39.35 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.848 3.931 . . . . 0.0 121.626 -169.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.16 73.01 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -77.77 -7.09 56.09 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.404 -5.185 . . . . 0.0 117.715 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.49 130.67 93.24 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 121.652 2.024 . . . . 0.0 109.876 166.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.94 -52.92 7.73 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.621 2.88 . . . . 0.0 117.138 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.96 133.7 35.06 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.135 0.574 . . . . 0.0 110.345 166.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -133.45 98.25 15.35 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-O 116.064 -1.922 . . . . 0.0 110.01 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.41 152.33 87.11 Favored 'Cis proline' 0 CA--C 1.557 1.645 0 CA-C-N 123.276 2.206 . . . . 0.0 114.652 2.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.2 OUTLIER -67.62 137.0 92.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-O 121.258 0.551 . . . . 0.0 110.017 157.984 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.11 166.25 5.62 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.879 5.053 . . . . 0.0 119.323 -161.602 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.6 tp -109.1 101.38 10.43 Favored 'General case' 0 N--CA 1.518 2.934 1 C-N-CA 131.995 4.118 . . . . 0.0 105.039 -171.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.272 1.4 p90 -148.83 170.39 18.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.96 32.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.922 1.289 . . . . 0.0 109.25 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.0 154.33 44.93 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.24 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.02 -29.3 66.32 Favored 'General case' 0 N--CA 1.486 1.341 1 O-C-N 113.65 -5.656 . . . . 0.0 115.665 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.09 -24.6 32.6 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 . . . . . 0 N--CA 1.494 1.75 0 CA-C-N 120.709 1.595 . . . . 0.0 113.851 157.192 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 p . . . . . 0 CA--C 1.56 1.348 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.09 133.3 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.162 0 CA-C-O 114.644 -2.598 . . . . 0.0 104.494 143.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.26 -6.13 82.53 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.169 4.077 . . . . 0.0 121.626 168.19 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.8 -6.98 57.37 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.824 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -67.49 128.28 93.57 Favored Pre-proline 0 CA--C 1.577 1.989 0 CA-C-N 121.82 2.1 . . . . 0.0 109.677 167.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.51 -52.18 9.47 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.675 2.916 . . . . 0.0 117.255 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.7 131.63 36.28 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.073 0.549 . . . . 0.0 110.07 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -130.03 99.26 20.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 115.996 -1.954 . . . . 0.0 109.939 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -79.63 156.68 89.37 Favored 'Cis proline' 0 CA--C 1.559 1.762 0 CA-C-N 123.308 2.217 . . . . 0.0 114.981 2.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 54' ' ' LEU 0.284 0.1 OUTLIER -68.62 130.55 91.86 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 157.42 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.01 166.25 16.86 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.761 5.641 . . . . 0.0 119.323 -165.484 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.39 53.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.4 tp -109.37 104.0 13.03 Favored 'General case' 0 N--CA 1.513 2.712 1 C-N-CA 131.726 4.01 . . . . 0.0 105.028 -172.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.257 1.7 p90 -150.74 170.77 18.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.75 132.64 33.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.065 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.26 154.33 45.7 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.45 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.11 -28.33 66.38 Favored 'General case' 0 N--CA 1.484 1.245 1 O-C-N 113.996 -5.44 . . . . 0.0 115.527 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.8 -17.85 46.13 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 165.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 N--CA 1.493 1.716 0 CA-C-N 120.249 1.386 . . . . 0.0 113.284 157.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.581 HG23 HD22 ' A' ' 4' ' ' LEU . 34.2 p . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 113.727 -3.035 . . . . 0.0 115.244 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.73 104.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 125.534 3.788 . . . . 0.0 106.777 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 -6.13 48.49 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.207 3.639 . . . . 0.0 121.626 -168.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -76.98 -8.18 56.93 Favored 'General case' 0 N--CA 1.492 1.671 1 O-C-N 114.36 -5.212 . . . . 0.0 117.733 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -67.39 131.04 93.29 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 121.503 1.956 . . . . 0.0 109.984 167.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.96 -52.95 7.67 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.58 2.854 . . . . 0.0 117.138 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.12 134.18 34.74 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.169 0.588 . . . . 0.0 110.365 167.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.6 mtm105 -134.63 97.91 13.89 Favored Pre-proline 0 N--CA 1.488 1.443 0 CA-C-O 116.044 -1.931 . . . . 0.0 109.963 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.49 150.73 84.77 Favored 'Cis proline' 0 CA--C 1.556 1.597 0 CA-C-N 123.253 2.198 . . . . 0.0 114.502 2.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 54' ' ' LEU 0.261 0.2 OUTLIER -67.83 137.94 92.79 Favored Pre-proline 0 N--CA 1.492 1.667 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 158.577 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.28 166.25 4.48 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.715 4.943 . . . . 0.0 119.323 -160.033 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.92 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.7 tp -108.42 101.97 11.1 Favored 'General case' 0 N--CA 1.515 2.811 1 C-N-CA 131.788 4.035 . . . . 0.0 104.957 -172.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.284 1.4 p90 -148.63 169.92 19.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 132.43 31.09 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.995 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.11 154.33 44.81 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.99 23.79 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.88 -22.44 61.51 Favored 'General case' 0 N--CA 1.487 1.408 1 O-C-N 113.455 -5.778 . . . . 0.0 115.999 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.72 -26.06 20.86 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 125.6 1.56 . . . . 0.0 114.821 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 . . . . . 0 CA--C 1.568 1.635 0 CA-C-N 119.574 1.079 . . . . 0.0 113.901 154.296 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.527 ' CG2' HD22 ' A' ' 4' ' ' LEU . 68.3 p . . . . . 0 CA--C 1.555 1.155 0 CA-C-O 114.627 -2.606 . . . . 0.0 116.17 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.275 0.9 OUTLIER -63.12 113.91 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 125.778 3.899 . . . . 0.0 106.012 169.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.78 -6.13 58.57 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.764 3.893 . . . . 0.0 121.626 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.87 71.58 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.0 p -79.68 -5.27 54.82 Favored 'General case' 0 N--CA 1.493 1.719 1 O-C-N 114.303 -5.248 . . . . 0.0 117.882 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.8 129.91 93.13 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-N 122.025 2.193 . . . . 0.0 109.876 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.77 -52.41 9.04 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 123.58 2.854 . . . . 0.0 117.322 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -91.69 134.82 34.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.092 0.557 . . . . 0.0 110.277 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -132.83 98.34 16.2 Favored Pre-proline 0 N--CA 1.488 1.453 0 CA-C-O 116.095 -1.907 . . . . 0.0 110.217 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.01 153.12 89.62 Favored 'Cis proline' 0 CA--C 1.557 1.632 0 CA-C-N 123.182 2.172 . . . . 0.0 114.686 1.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -65.55 137.86 96.62 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.236 0.541 . . . . 0.0 109.935 156.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.65 166.25 4.11 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.371 4.714 . . . . 0.0 119.323 -164.031 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.03 54.06 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.953 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.0 tp -108.49 102.32 11.42 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 131.677 3.991 . . . . 0.0 104.84 -172.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.281 1.5 p90 -148.61 169.81 19.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.54 32.46 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.983 173.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.91 154.33 45.03 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.91 23.23 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.31 -27.77 66.58 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.835 -5.54 . . . . 0.0 115.844 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.39 -23.72 34.81 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 166.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 . . . . . 0 N--CA 1.497 1.883 0 CA-C-N 120.855 1.661 . . . . 0.0 114.005 156.847 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.566 ' CG2' HD22 ' A' ' 4' ' ' LEU . 37.0 p . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 114.164 -2.826 . . . . 0.0 115.874 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 m -64.99 103.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 1 CA-C-O 111.52 -4.086 . . . . 0.0 106.901 -170.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.41 -6.13 45.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.17 4.532 . . . . 0.0 121.626 -167.776 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.18 71.87 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -79.3 -5.66 54.94 Favored 'General case' 0 N--CA 1.494 1.755 1 O-C-N 114.332 -5.23 . . . . 0.0 117.866 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.71 129.94 93.21 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 121.964 2.165 . . . . 0.0 109.791 167.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.42 -52.63 8.47 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 C-N-CA 123.637 2.891 . . . . 0.0 117.18 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.68 132.4 36.39 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.022 0.529 . . . . 0.0 110.099 165.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -130.36 99.47 19.27 Favored Pre-proline 0 N--CA 1.488 1.459 0 CA-C-O 115.987 -1.958 . . . . 0.0 110.045 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.12 155.95 91.15 Favored 'Cis proline' 0 CA--C 1.559 1.749 0 CA-C-N 123.323 2.223 . . . . 0.0 114.877 2.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 54' ' ' LEU 0.292 0.1 OUTLIER -69.3 131.58 90.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 121.377 0.608 . . . . 0.0 109.474 157.784 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.5 166.25 15.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.008 5.806 . . . . 0.0 119.323 -164.518 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.953 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.3 tp -108.95 100.52 9.71 Favored 'General case' 0 N--CA 1.517 2.903 1 C-N-CA 132.079 4.152 . . . . 0.0 104.999 -171.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.283 1.3 p90 -147.96 170.03 18.6 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 133.04 32.04 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.189 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.28 154.33 44.63 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.33 23.7 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.487 1.404 1 O-C-N 113.473 -5.767 . . . . 0.0 115.747 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.24 -21.84 33.25 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 N--CA 1.491 1.623 0 CA-C-N 119.892 1.224 . . . . 0.0 113.333 158.092 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 CA--C 1.561 1.378 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.87 136.63 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 137.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.35 -6.13 80.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.694 3.861 . . . . 0.0 121.626 165.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.9 71.6 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.71 -6.05 56.43 Favored 'General case' 0 N--CA 1.493 1.685 1 O-C-N 114.32 -5.238 . . . . 0.0 117.98 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -67.62 129.18 93.54 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 122.018 2.19 . . . . 0.0 109.663 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.13 -52.14 9.59 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.656 2.904 . . . . 0.0 117.344 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.12 133.43 35.35 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.047 0.539 . . . . 0.0 110.155 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -131.5 98.7 17.94 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-O 115.982 -1.961 . . . . 0.0 110.072 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 154.61 89.57 Favored 'Cis proline' 0 CA--C 1.559 1.748 0 CA-C-N 123.274 2.205 . . . . 0.0 114.768 2.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 54' ' ' LEU 0.281 0.1 OUTLIER -68.06 133.95 91.75 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-O 121.346 0.593 . . . . 0.0 109.663 157.326 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.48 166.25 10.59 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.684 5.589 . . . . 0.0 119.323 -163.715 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.8 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.945 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.1 tp -108.71 102.13 11.21 Favored 'General case' 0 N--CA 1.516 2.828 1 C-N-CA 131.813 4.045 . . . . 0.0 104.955 -172.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.272 1.5 p90 -148.77 170.32 18.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.09 132.85 32.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.185 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.82 154.33 45.12 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.21 23.44 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.65 -29.51 68.0 Favored 'General case' 0 N--CA 1.486 1.328 1 O-C-N 113.705 -5.622 . . . . 0.0 115.589 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.69 -24.69 36.07 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 . . . . . 0 N--CA 1.496 1.848 0 CA-C-N 120.887 1.676 . . . . 0.0 113.872 157.471 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.538 ' CG2' HD22 ' A' ' 4' ' ' LEU . 39.3 p . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 114.878 -2.487 . . . . 0.0 114.921 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.51 117.24 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 CA-C-N 125.743 3.883 . . . . 0.0 105.592 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.13 68.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.958 4.436 . . . . 0.0 121.626 179.382 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.28 71.99 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.78 -7.5 57.87 Favored 'General case' 0 N--CA 1.493 1.699 1 O-C-N 114.305 -5.247 . . . . 0.0 117.924 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -67.27 130.12 93.64 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-N 121.872 2.124 . . . . 0.0 109.893 167.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.57 -52.73 8.22 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.671 2.914 . . . . 0.0 117.168 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.46 132.53 36.18 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.105 0.562 . . . . 0.0 110.201 166.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -131.57 99.31 17.25 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 115.982 -1.961 . . . . 0.0 109.947 -172.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.28 154.6 89.91 Favored 'Cis proline' 0 CA--C 1.559 1.745 0 CA-C-N 123.356 2.234 . . . . 0.0 114.799 2.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 54' ' ' LEU 0.283 0.2 OUTLIER -69.33 129.95 91.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 158.755 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -81.56 166.25 17.8 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.225 5.95 . . . . 0.0 119.323 -163.359 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.945 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.2 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.82 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.956 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.5 tp -108.73 100.15 9.42 Favored 'General case' 0 N--CA 1.517 2.925 1 C-N-CA 131.974 4.11 . . . . 0.0 104.938 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.293 1.2 p90 -147.4 169.65 19.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.89 132.62 30.72 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.161 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.4 154.33 44.52 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.42 23.35 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.79 -25.37 61.14 Favored 'General case' 0 N--CA 1.486 1.353 1 O-C-N 113.46 -5.775 . . . . 0.0 115.815 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt -85.89 -26.84 25.39 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 . . . . . 0 N--CA 1.491 1.617 0 CA-C-N 119.626 1.103 . . . . 0.0 113.869 158.735 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 CA--C 1.561 1.378 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.36 139.43 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 CA-C-O 115.39 -2.243 . . . . 0.0 105.204 135.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 -6.13 82.09 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.626 3.83 . . . . 0.0 121.626 165.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.29 73.17 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.24 -5.63 52.5 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.362 -5.211 . . . . 0.0 117.697 173.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -67.46 129.93 93.47 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-N 121.568 1.986 . . . . 0.0 109.932 166.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.6 -52.9 7.83 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.653 2.902 . . . . 0.0 117.141 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.21 134.11 34.82 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.12 0.568 . . . . 0.0 110.24 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -132.91 98.21 16.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 116.046 -1.93 . . . . 0.0 110.106 -172.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.38 152.87 87.87 Favored 'Cis proline' 0 CA--C 1.558 1.679 0 CA-C-N 123.27 2.203 . . . . 0.0 114.723 2.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -65.06 137.54 97.11 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.124 0.488 . . . . 0.0 109.993 156.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.79 166.25 3.98 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.117 4.545 . . . . 0.0 119.323 -164.011 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.956 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.35 54.0 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.2 tp -109.33 104.2 13.28 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 131.668 3.987 . . . . 0.0 105.051 -172.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.251 1.7 p90 -150.79 170.85 18.26 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.5 132.79 33.78 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.88 1.272 . . . . 0.0 109.124 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.16 154.33 45.8 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.83 23.55 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.59 -26.2 64.35 Favored 'General case' 0 N--CA 1.481 1.11 1 O-C-N 114.193 -5.317 . . . . 0.0 115.451 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.2 -17.54 36.82 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 166.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 . . . . . 0 N--CA 1.495 1.78 0 CA-C-N 120.32 1.418 . . . . 0.0 113.037 155.492 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.583 HG23 HD22 ' A' ' 4' ' ' LEU . 25.4 p . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 113.469 -3.158 . . . . 0.0 115.411 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.253 2.7 m -61.24 107.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 125.886 3.948 . . . . 0.0 107.024 -173.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.88 -6.13 54.15 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.28 74.54 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.5 p -76.4 -7.48 55.13 Favored 'General case' 0 N--CA 1.492 1.657 1 O-C-N 114.427 -5.171 . . . . 0.0 117.576 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.42 131.67 93.17 Favored Pre-proline 0 CA--C 1.576 1.976 0 CA-C-N 121.33 1.877 . . . . 0.0 109.998 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -53.31 6.82 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.601 2.867 . . . . 0.0 117.034 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.15 134.11 34.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.169 0.587 . . . . 0.0 110.397 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 mtm105 -134.83 97.8 13.69 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.068 -1.92 . . . . 0.0 109.982 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.46 150.64 84.72 Favored 'Cis proline' 0 CA--C 1.557 1.643 0 CA-C-N 123.282 2.208 . . . . 0.0 114.499 2.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 54' ' ' LEU 0.262 0.2 OUTLIER -67.67 138.72 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 158.234 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -91.07 166.25 3.73 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.557 4.838 . . . . 0.0 119.323 -159.988 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.7 tp -108.26 101.41 10.62 Favored 'General case' 0 N--CA 1.515 2.788 1 C-N-CA 131.767 4.027 . . . . 0.0 104.878 -172.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.291 1.3 p90 -147.83 169.7 19.23 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.48 132.58 31.5 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.035 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.3 23.71 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.61 -24.49 61.08 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.567 -5.708 . . . . 0.0 115.796 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.2 -27.11 26.34 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 . . . . . 0 CA--C 1.567 1.634 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 158.776 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.524 ' CG2' HD22 ' A' ' 4' ' ' LEU . 41.4 p . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 114.374 -2.727 . . . . 0.0 116.903 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.282 1.9 m -61.98 111.37 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-N 125.757 3.889 . . . . 0.0 106.528 173.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.69 -6.13 54.68 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.059 3.572 . . . . 0.0 121.626 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.69 72.47 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.34 -7.55 57.41 Favored 'General case' 0 N--CA 1.494 1.75 1 O-C-N 114.307 -5.246 . . . . 0.0 117.824 173.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.2 130.42 93.66 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 121.714 2.052 . . . . 0.0 110.1 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.34 -53.07 7.54 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.595 2.863 . . . . 0.0 117.222 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.72 134.52 34.65 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.109 0.564 . . . . 0.0 110.345 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -134.12 98.61 14.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 116.043 -1.932 . . . . 0.0 110.03 -171.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.27 151.15 86.27 Favored 'Cis proline' 0 CA--C 1.558 1.703 0 CA-C-N 123.227 2.188 . . . . 0.0 114.682 2.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.13 132.24 94.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 158.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.4 166.25 9.27 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.091 5.194 . . . . 0.0 119.323 -162.493 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.5 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.9 tp -108.64 100.05 9.34 Favored 'General case' 0 N--CA 1.517 2.888 1 C-N-CA 131.936 4.094 . . . . 0.0 104.889 -171.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.295 1.2 p90 -147.01 169.63 18.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.77 132.71 31.1 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.337 -1.302 . . . . 0.0 109.144 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.44 154.33 44.47 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.43 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.21 -25.37 60.72 Favored 'General case' 0 N--CA 1.486 1.373 1 O-C-N 113.588 -5.695 . . . . 0.0 115.826 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.84 -31.76 23.64 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 171.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 158.134 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p . . . . . 0 CA--C 1.561 1.385 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.29 133.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 CA-C-O 115.23 -2.319 . . . . 0.0 104.866 143.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.16 -6.13 83.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.356 3.707 . . . . 0.0 121.626 168.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.93 -6.04 53.09 Favored 'General case' 0 N--CA 1.493 1.714 1 O-C-N 114.36 -5.212 . . . . 0.0 117.718 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.43 130.0 93.48 Favored Pre-proline 0 CA--C 1.574 1.9 0 CA-C-N 121.454 1.934 . . . . 0.0 110.021 167.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.58 -53.13 7.39 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.606 2.871 . . . . 0.0 117.148 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.21 134.05 34.87 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.078 0.551 . . . . 0.0 110.305 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -133.24 98.35 15.56 Favored Pre-proline 0 N--CA 1.488 1.427 0 CA-C-O 116.068 -1.92 . . . . 0.0 110.091 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.5 152.42 86.9 Favored 'Cis proline' 0 CA--C 1.558 1.704 0 CA-C-N 123.223 2.187 . . . . 0.0 114.785 2.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.636 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -64.51 135.21 96.26 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.86 156.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.43 166.25 5.31 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.314 4.676 . . . . 0.0 119.323 -164.281 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.96 54.07 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 7.8 tp -108.54 100.4 9.67 Favored 'General case' 0 N--CA 1.513 2.705 0 C-N-CA 131.698 3.999 . . . . 0.0 104.934 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.3 1.3 p90 -146.66 169.3 19.29 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.26 31.03 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.023 173.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.3 154.33 44.62 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.32 -25.12 61.44 Favored 'General case' 0 N--CA 1.487 1.392 1 O-C-N 113.626 -5.671 . . . . 0.0 115.745 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -83.09 -33.72 26.3 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.099 1.36 . . . . 0.0 113.87 169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 158.791 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.55 ' CG2' HD22 ' A' ' 4' ' ' LEU . 50.5 p . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 m -66.82 102.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 CA-C-O 112.691 -3.528 . . . . 0.0 105.878 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.13 35.95 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.03 4.013 . . . . 0.0 121.626 -171.243 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.26 73.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.3 p -79.1 -4.21 49.2 Favored 'General case' 0 N--CA 1.494 1.742 1 O-C-N 114.415 -5.178 . . . . 0.0 117.696 172.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -67.25 129.1 93.86 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-N 121.562 1.983 . . . . 0.0 109.852 166.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -52.77 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.639 2.893 . . . . 0.0 117.176 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.73 133.87 35.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.13 0.572 . . . . 0.0 110.138 165.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -130.84 98.58 19.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 116.028 -1.939 . . . . 0.0 110.172 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -79.22 155.46 90.62 Favored 'Cis proline' 0 CA--C 1.558 1.688 0 CA-C-N 123.34 2.229 . . . . 0.0 114.753 1.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 54' ' ' LEU 0.289 0.2 OUTLIER -68.66 136.18 90.38 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.529 0.68 . . . . 0.0 109.759 157.029 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.75 166.25 8.77 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.487 5.458 . . . . 0.0 119.323 -163.908 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.27 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.6 tp -109.0 102.92 11.87 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 131.678 3.991 . . . . 0.0 104.949 -172.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.269 1.6 p90 -149.4 170.19 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.72 132.62 33.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.058 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.34 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.88 23.24 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -68.6 -29.11 67.55 Favored 'General case' 0 N--CA 1.486 1.345 1 O-C-N 113.929 -5.482 . . . . 0.0 115.599 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.93 -23.16 41.93 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 . . . . . 0 N--CA 1.494 1.77 0 CA-C-N 120.75 1.614 . . . . 0.0 113.993 158.832 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.569 HG23 HD22 ' A' ' 4' ' ' LEU . 32.5 p . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 113.529 -3.129 . . . . 0.0 115.495 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.71 105.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 125.777 3.899 . . . . 0.0 107.246 -171.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.96 -6.13 51.14 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.889 3.949 . . . . 0.0 121.626 -169.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.42 72.15 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.58 -7.0 57.11 Favored 'General case' 0 N--CA 1.493 1.694 1 O-C-N 114.327 -5.233 . . . . 0.0 117.843 173.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.49 130.41 93.31 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-N 121.896 2.134 . . . . 0.0 109.848 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.36 -52.65 8.43 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.684 2.923 . . . . 0.0 117.177 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.45 133.78 35.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.097 0.559 . . . . 0.0 110.269 166.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -132.68 98.46 16.31 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-O 115.998 -1.954 . . . . 0.0 110.077 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.22 153.28 88.91 Favored 'Cis proline' 0 CA--C 1.557 1.663 0 CA-C-N 123.351 2.232 . . . . 0.0 114.62 2.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.509 ' H ' HD23 ' A' ' 54' ' ' LEU 0.281 0.2 OUTLIER -68.68 135.85 90.32 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-O 121.49 0.662 . . . . 0.0 109.839 158.144 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -87.13 166.25 8.24 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.416 5.411 . . . . 0.0 119.323 -162.012 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.2 tp -108.51 101.79 10.93 Favored 'General case' 0 N--CA 1.516 2.847 1 C-N-CA 131.797 4.039 . . . . 0.0 104.856 -172.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.277 1.5 p90 -148.15 170.09 18.59 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.82 32.89 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.168 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.88 154.33 45.05 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.26 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.49 -29.89 66.55 Favored 'General case' 0 N--CA 1.484 1.261 1 O-C-N 113.843 -5.536 . . . . 0.0 115.454 -177.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.82 -23.0 36.73 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 165.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 . . . . . 0 N--CA 1.495 1.781 0 CA-C-N 120.025 1.284 . . . . 0.0 113.157 157.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.543 ' CG2' HD22 ' A' ' 4' ' ' LEU . 36.4 p . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 114.36 -2.733 . . . . 0.0 115.462 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.261 1.6 m -63.81 112.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-N 125.742 3.883 . . . . 0.0 105.703 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.13 59.34 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.279 3.672 . . . . 0.0 121.626 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.86 72.66 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.23 -7.26 56.92 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.345 -5.222 . . . . 0.0 117.797 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.27 130.19 93.63 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-N 121.708 2.049 . . . . 0.0 109.907 167.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.7 -52.84 7.95 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.607 2.871 . . . . 0.0 117.151 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 133.26 35.55 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.127 0.571 . . . . 0.0 110.253 166.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -132.58 98.75 16.21 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 116.05 -1.929 . . . . 0.0 110.031 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.28 153.61 89.0 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 CA-C-N 123.297 2.213 . . . . 0.0 114.75 2.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.1 OUTLIER -67.59 133.51 92.7 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-O 121.107 0.479 . . . . 0.0 109.778 158.033 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.87 166.25 10.04 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.196 5.264 . . . . 0.0 119.323 -163.246 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.18 54.03 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.1 tp -108.82 102.85 11.84 Favored 'General case' 0 N--CA 1.512 2.663 1 C-N-CA 131.708 4.003 . . . . 0.0 104.876 -172.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.268 1.6 p90 -149.06 170.29 18.73 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.74 132.53 32.92 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.097 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.45 154.33 45.5 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.48 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.48 -29.77 66.39 Favored 'General case' 0 N--CA 1.483 1.224 1 O-C-N 114.226 -5.296 . . . . 0.0 115.281 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -81.29 -18.12 46.95 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 165.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 . . . . . 0 CA--C 1.569 1.69 0 CA-C-N 119.789 1.177 . . . . 0.0 112.754 157.336 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.56 ' CG2' HD22 ' A' ' 4' ' ' LEU . 32.3 p . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 113.986 -2.912 . . . . 0.0 115.32 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.26 103.4 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 125.45 3.75 . . . . 0.0 106.501 -169.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.22 -6.13 42.41 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.224 3.647 . . . . 0.0 121.626 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.07 74.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -77.04 -6.45 52.77 Favored 'General case' 0 N--CA 1.493 1.709 1 O-C-N 114.413 -5.18 . . . . 0.0 117.591 173.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.52 130.82 93.15 Favored Pre-proline 0 CA--C 1.576 1.948 0 CA-C-N 121.376 1.898 . . . . 0.0 109.899 166.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.32 -53.32 6.86 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 C-N-CA 123.627 2.885 . . . . 0.0 116.992 175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.06 133.67 35.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.145 0.578 . . . . 0.0 110.312 167.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mtm105 -133.51 98.23 15.28 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-O 116.041 -1.933 . . . . 0.0 109.952 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.51 152.14 86.51 Favored 'Cis proline' 0 CA--C 1.556 1.62 0 CA-C-N 123.267 2.203 . . . . 0.0 114.594 2.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 54' ' ' LEU 0.276 0.1 OUTLIER -68.09 137.05 91.81 Favored Pre-proline 0 N--CA 1.493 1.71 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 158.172 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.92 166.25 5.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.974 5.116 . . . . 0.0 119.323 -161.045 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.941 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.3 tp -108.5 101.41 10.58 Favored 'General case' 0 N--CA 1.516 2.869 1 C-N-CA 131.818 4.047 . . . . 0.0 104.885 -172.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.284 1.4 p90 -147.92 169.92 18.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.33 132.58 31.79 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.08 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.04 154.33 44.89 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.58 -28.97 66.42 Favored 'General case' 0 N--CA 1.488 1.426 1 O-C-N 113.626 -5.671 . . . . 0.0 115.681 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.22 -20.52 34.44 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 167.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 . . . . . 0 N--CA 1.494 1.73 0 CA-C-N 120.392 1.451 . . . . 0.0 113.348 157.406 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.517 ' CG2' HD22 ' A' ' 4' ' ' LEU . 40.9 p . . . . . 0 CA--C 1.555 1.16 0 CA-C-O 115.124 -2.37 . . . . 0.0 114.764 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 2.2 m -64.28 115.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-N 125.75 3.886 . . . . 0.0 105.903 168.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.08 -6.13 63.77 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.446 4.203 . . . . 0.0 121.626 179.588 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.92 -6.34 55.95 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.853 173.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.51 129.85 93.45 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 121.773 2.079 . . . . 0.0 109.799 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.48 -52.56 8.61 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 123.602 2.868 . . . . 0.0 117.221 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.25 133.5 35.34 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.037 0.535 . . . . 0.0 110.228 166.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.7 mtm105 -132.23 98.6 16.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.095 -172.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.36 154.06 89.08 Favored 'Cis proline' 0 CA--C 1.558 1.697 0 CA-C-N 123.282 2.208 . . . . 0.0 114.799 2.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.1 OUTLIER -66.72 134.45 94.22 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.173 0.511 . . . . 0.0 109.645 157.213 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.98 166.25 8.45 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.99 5.127 . . . . 0.0 119.323 -164.23 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.941 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.07 54.05 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.963 HD23 ' HB2' ' A' ' 97' ' ' ALA . 8.1 tp -108.59 101.1 10.28 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 131.628 3.971 . . . . 0.0 104.828 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . 0.29 1.4 p90 -147.13 169.18 19.85 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.59 132.99 33.88 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.07 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.63 23.52 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.73 -29.88 62.5 Favored 'General case' 0 N--CA 1.483 1.22 1 O-C-N 113.933 -5.48 . . . . 0.0 115.525 -176.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 mp -82.48 -27.15 31.99 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 . . . . . 0 N--CA 1.494 1.765 0 CA-C-N 120.54 1.518 . . . . 0.0 114.088 158.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.584 ' CG2' HD22 ' A' ' 4' ' ' LEU . 40.2 p . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 113.936 -2.935 . . . . 0.0 115.739 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 2.4 m -62.61 108.33 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 125.848 3.931 . . . . 0.0 106.519 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.43 -6.13 49.31 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.36 71.2 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.4 -8.09 58.85 Favored 'General case' 0 N--CA 1.494 1.764 1 O-C-N 114.224 -5.298 . . . . 0.0 118.004 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -66.67 131.21 94.05 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-N 122.132 2.242 . . . . 0.0 110.233 168.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.9 -52.97 7.8 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.585 2.857 . . . . 0.0 117.259 176.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -92.49 135.11 34.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.119 0.567 . . . . 0.0 110.354 166.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -134.22 98.87 13.76 Favored Pre-proline 0 N--CA 1.488 1.466 0 CA-C-O 116.111 -1.9 . . . . 0.0 110.102 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.69 151.03 88.14 Favored 'Cis proline' 0 CA--C 1.557 1.662 0 CA-C-N 123.25 2.196 . . . . 0.0 114.566 2.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 54' ' ' LEU 0.259 0.1 OUTLIER -67.63 132.97 92.65 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.897 159.327 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.94 166.25 9.93 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.376 5.384 . . . . 0.0 119.323 -161.521 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.963 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.83 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.934 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.9 tp -109.01 102.21 11.22 Favored 'General case' 0 N--CA 1.517 2.914 1 C-N-CA 131.892 4.077 . . . . 0.0 104.994 -172.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.728 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.266 1.5 p90 -149.13 170.61 18.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.31 132.76 32.11 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.205 173.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.35 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD11 ' C13' ' A' ' 163' ' ' BDM . 32.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.49 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.88 -28.11 66.4 Favored 'General case' 0 N--CA 1.484 1.251 1 O-C-N 113.913 -5.492 . . . . 0.0 115.502 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -84.13 -20.93 31.67 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 166.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 -60.3 -45.01 94.85 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 120.643 1.565 . . . . 0.0 113.347 155.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -73.8 -19.84 60.64 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 116.689 -1.624 . . . . 0.0 115.181 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -60.65 -56.57 19.73 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 122.463 2.392 . . . . 0.0 111.05 161.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.108 ' HA ' HH12 ' A' ' 57' ' ' ARG . 69.0 ttt180 -53.06 -36.08 60.23 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.03 -27.37 10.68 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -60.09 -15.72 25.68 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 120.977 1.717 . . . . 0.0 115.123 154.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.511 ' CG2' HD22 ' A' ' 4' ' ' LEU . 43.8 p -125.54 27.33 6.54 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 115.969 -1.967 . . . . 0.0 114.196 161.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 31' ' ' ARG . 1.4 m -67.75 117.61 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.407 0 CA-C-N 125.257 3.662 . . . . 0.0 104.876 165.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.9 -6.13 66.8 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.231 4.56 . . . . 0.0 121.626 177.612 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.74 73.69 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.3 -7.57 56.22 Favored 'General case' 0 N--CA 1.493 1.687 1 O-C-N 114.37 -5.206 . . . . 0.0 117.66 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -67.22 130.45 93.63 Favored Pre-proline 0 CA--C 1.576 1.951 0 CA-C-N 121.495 1.952 . . . . 0.0 109.94 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.714 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.3 Cg_exo -53.06 -53.29 7.01 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.632 2.888 . . . . 0.0 117.088 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.62 133.47 35.08 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.097 0.559 . . . . 0.0 110.367 167.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -133.65 98.14 15.17 Favored Pre-proline 0 N--CA 1.488 1.431 0 CA-C-O 116.069 -1.92 . . . . 0.0 109.993 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.63 152.25 86.19 Favored 'Cis proline' 0 CA--C 1.557 1.666 0 CA-C-N 123.27 2.203 . . . . 0.0 114.67 2.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.591 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.87 136.19 94.41 Favored Pre-proline 0 N--CA 1.493 1.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.019 157.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.98 166.25 5.75 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.657 4.905 . . . . 0.0 119.323 -162.155 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.108 HH12 ' HA ' ' A' ' 31' ' ' ARG . 12.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.934 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.728 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.29 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.8 tp -109.41 102.88 11.74 Favored 'General case' 0 N--CA 1.514 2.733 1 C-N-CA 131.753 4.021 . . . . 0.0 105.077 -172.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.722 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.262 1.6 p90 -149.72 170.54 18.47 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 178.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.8 132.75 33.1 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.076 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.47 154.33 45.48 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD11 ' C13' ' A' ' 163' ' ' BDM . 36.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.12 23.46 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.39 -31.7 67.59 Favored 'General case' 0 N--CA 1.485 1.32 1 O-C-N 113.977 -5.452 . . . . 0.0 115.407 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.64 -29.36 56.42 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -66.98 -34.02 76.85 Favored 'General case' 0 CA--C 1.569 1.691 0 CA-C-N 120.356 1.435 . . . . 0.0 114.173 162.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -74.02 -26.15 60.27 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 116.64 -1.648 . . . . 0.0 114.724 163.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -54.28 -54.51 39.25 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 122.571 2.441 . . . . 0.0 111.646 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.022 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 57.2 ttt85 -48.1 -59.8 3.11 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.7 -24.48 25.18 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 -171.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -60.37 -14.69 20.06 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 155.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.573 ' CG2' HD22 ' A' ' 4' ' ' LEU . 37.0 p -118.45 3.5 11.84 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 114.242 -2.79 . . . . 0.0 115.721 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.75 103.6 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.147 0 CA-C-N 125.37 3.714 . . . . 0.0 106.149 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.21 -6.13 39.35 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.848 3.931 . . . . 0.0 121.626 -169.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.16 73.01 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -77.77 -7.09 56.09 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.404 -5.185 . . . . 0.0 117.715 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.49 130.67 93.24 Favored Pre-proline 0 CA--C 1.577 1.987 0 CA-C-N 121.652 2.024 . . . . 0.0 109.876 166.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.693 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.9 Cg_exo -52.94 -52.92 7.73 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.621 2.88 . . . . 0.0 117.138 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.96 133.7 35.06 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.135 0.574 . . . . 0.0 110.345 166.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -133.45 98.25 15.35 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-O 116.064 -1.922 . . . . 0.0 110.01 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.41 152.33 87.11 Favored 'Cis proline' 0 CA--C 1.557 1.645 0 CA-C-N 123.276 2.206 . . . . 0.0 114.652 2.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.2 OUTLIER -67.62 137.0 92.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-O 121.258 0.551 . . . . 0.0 110.017 157.984 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.11 166.25 5.62 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.879 5.053 . . . . 0.0 119.323 -161.602 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.022 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 9.4 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.722 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.6 tp -109.1 101.38 10.43 Favored 'General case' 0 N--CA 1.518 2.934 1 C-N-CA 131.995 4.118 . . . . 0.0 105.039 -171.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.701 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.272 1.4 p90 -148.83 170.39 18.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 179.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.96 32.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.922 1.289 . . . . 0.0 109.25 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.0 154.33 44.93 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.412 HD11 ' C13' ' A' ' 163' ' ' BDM . 36.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.24 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.02 -29.3 66.32 Favored 'General case' 0 N--CA 1.486 1.341 1 O-C-N 113.65 -5.656 . . . . 0.0 115.665 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.09 -24.6 32.6 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 69.6 m-70 -59.86 -41.17 90.88 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 120.709 1.595 . . . . 0.0 113.851 157.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -74.27 -20.94 59.97 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 168.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.457 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 3.4 t80 -63.44 -52.44 61.47 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 122.533 2.424 . . . . 0.0 111.88 161.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.097 ' HA ' HH12 ' A' ' 57' ' ' ARG . 47.3 ttt85 -38.98 -42.66 0.89 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 171.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.67 -27.58 7.04 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -60.02 -20.69 59.19 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 121.168 1.804 . . . . 0.0 114.711 153.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 p -126.06 64.17 1.23 Allowed 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 119.29 0.95 . . . . 0.0 109.792 153.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.09 133.3 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.162 0 CA-C-O 114.644 -2.598 . . . . 0.0 104.494 143.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.26 -6.13 82.53 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.169 4.077 . . . . 0.0 121.626 168.19 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.8 -6.98 57.37 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.824 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -67.49 128.28 93.57 Favored Pre-proline 0 CA--C 1.577 1.989 0 CA-C-N 121.82 2.1 . . . . 0.0 109.677 167.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.63 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.2 Cg_exo -52.51 -52.18 9.47 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.675 2.916 . . . . 0.0 117.255 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -90.7 131.63 36.28 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.073 0.549 . . . . 0.0 110.07 165.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -130.03 99.26 20.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 115.996 -1.954 . . . . 0.0 109.939 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -79.63 156.68 89.37 Favored 'Cis proline' 0 CA--C 1.559 1.762 0 CA-C-N 123.308 2.217 . . . . 0.0 114.981 2.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 54' ' ' LEU 0.284 0.1 OUTLIER -68.62 130.55 91.86 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 157.42 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.01 166.25 16.86 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.761 5.641 . . . . 0.0 119.323 -165.484 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.097 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.701 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.39 53.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.4 tp -109.37 104.0 13.03 Favored 'General case' 0 N--CA 1.513 2.712 1 C-N-CA 131.726 4.01 . . . . 0.0 105.028 -172.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.689 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.257 1.7 p90 -150.74 170.77 18.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.75 132.64 33.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.065 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.26 154.33 45.7 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD11 ' C13' ' A' ' 163' ' ' BDM . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.45 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.11 -28.33 66.38 Favored 'General case' 0 N--CA 1.484 1.245 1 O-C-N 113.996 -5.44 . . . . 0.0 115.527 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.8 -17.85 46.13 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 165.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.507 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 12.2 m-70 -67.55 -41.23 84.58 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.249 1.386 . . . . 0.0 113.284 157.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -72.3 -25.52 61.61 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 116.98 -1.486 . . . . 0.0 114.905 167.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -57.0 -52.23 66.07 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 122.117 2.235 . . . . 0.0 112.006 161.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.033 ' HA ' HH12 ' A' ' 57' ' ' ARG . 53.7 ttt85 -42.42 -64.05 0.66 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 170.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.35 -23.18 19.32 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 118.274 2.694 . . . . 0.0 118.274 -165.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -62.04 -6.22 2.77 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 154.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.581 HG23 HD22 ' A' ' 4' ' ' LEU . 34.2 p -122.63 -4.76 8.7 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 113.727 -3.035 . . . . 0.0 115.244 164.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.73 104.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 125.534 3.788 . . . . 0.0 106.777 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 -6.13 48.49 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.207 3.639 . . . . 0.0 121.626 -168.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -76.98 -8.18 56.93 Favored 'General case' 0 N--CA 1.492 1.671 1 O-C-N 114.36 -5.212 . . . . 0.0 117.733 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -67.39 131.04 93.29 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 121.503 1.956 . . . . 0.0 109.984 167.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.664 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.8 Cg_exo -52.96 -52.95 7.67 Favored 'Trans proline' 0 CA--C 1.561 1.851 0 C-N-CA 123.58 2.854 . . . . 0.0 117.138 175.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.12 134.18 34.74 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.169 0.588 . . . . 0.0 110.365 167.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.6 mtm105 -134.63 97.91 13.89 Favored Pre-proline 0 N--CA 1.488 1.443 0 CA-C-O 116.044 -1.931 . . . . 0.0 109.963 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.49 150.73 84.77 Favored 'Cis proline' 0 CA--C 1.556 1.597 0 CA-C-N 123.253 2.198 . . . . 0.0 114.502 2.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 54' ' ' LEU 0.261 0.2 OUTLIER -67.83 137.94 92.79 Favored Pre-proline 0 N--CA 1.492 1.667 0 CA-C-O 121.31 0.576 . . . . 0.0 110.189 158.577 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.28 166.25 4.48 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.715 4.943 . . . . 0.0 119.323 -160.033 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.033 HH12 ' HA ' ' A' ' 31' ' ' ARG . 5.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.689 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.92 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.7 tp -108.42 101.97 11.1 Favored 'General case' 0 N--CA 1.515 2.811 1 C-N-CA 131.788 4.035 . . . . 0.0 104.957 -172.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.664 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.284 1.4 p90 -148.63 169.92 19.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 178.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 132.43 31.09 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.995 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.11 154.33 44.81 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.99 23.79 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.88 -22.44 61.51 Favored 'General case' 0 N--CA 1.487 1.408 1 O-C-N 113.455 -5.778 . . . . 0.0 115.999 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.72 -26.06 20.86 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 125.6 1.56 . . . . 0.0 114.821 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -61.39 -45.34 94.78 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 119.574 1.079 . . . . 0.0 113.901 154.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -77.35 -24.1 50.75 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.518 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.2 t80 -56.88 -56.96 14.88 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 122.393 2.36 . . . . 0.0 111.351 161.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.966 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 66.7 ttt180 -46.9 -42.37 17.47 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.87 -18.9 13.91 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -56.25 -45.85 79.87 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 121.009 1.732 . . . . 0.0 112.171 152.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.527 ' CG2' HD22 ' A' ' 4' ' ' LEU . 68.3 p -94.18 16.82 13.85 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 114.627 -2.606 . . . . 0.0 116.17 170.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.275 0.9 OUTLIER -63.12 113.91 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 125.778 3.899 . . . . 0.0 106.012 169.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.78 -6.13 58.57 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.764 3.893 . . . . 0.0 121.626 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.87 71.58 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.0 p -79.68 -5.27 54.82 Favored 'General case' 0 N--CA 1.493 1.719 1 O-C-N 114.303 -5.248 . . . . 0.0 117.882 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -67.8 129.91 93.13 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-N 122.025 2.193 . . . . 0.0 109.876 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.597 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.3 Cg_exo -51.77 -52.41 9.04 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 123.58 2.854 . . . . 0.0 117.322 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -91.69 134.82 34.37 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.092 0.557 . . . . 0.0 110.277 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -132.83 98.34 16.2 Favored Pre-proline 0 N--CA 1.488 1.453 0 CA-C-O 116.095 -1.907 . . . . 0.0 110.217 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.01 153.12 89.62 Favored 'Cis proline' 0 CA--C 1.557 1.632 0 CA-C-N 123.182 2.172 . . . . 0.0 114.686 1.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -65.55 137.86 96.62 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.236 0.541 . . . . 0.0 109.935 156.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.65 166.25 4.11 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.371 4.714 . . . . 0.0 119.323 -164.031 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.966 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 6.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.664 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.03 54.06 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.953 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.0 tp -108.49 102.32 11.42 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 131.677 3.991 . . . . 0.0 104.84 -172.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.701 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.281 1.5 p90 -148.61 169.81 19.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.54 32.46 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.983 173.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.91 154.33 45.03 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.419 HD11 ' C13' ' A' ' 163' ' ' BDM . 35.8 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.91 23.23 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.31 -27.77 66.58 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.835 -5.54 . . . . 0.0 115.844 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.39 -23.72 34.81 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 166.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -59.87 -42.77 94.46 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 120.855 1.661 . . . . 0.0 114.005 156.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -74.34 -26.08 59.93 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 116.678 -1.629 . . . . 0.0 114.829 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 12.9 t80 -55.41 -53.27 58.32 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 122.543 2.428 . . . . 0.0 111.614 162.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.921 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 53.7 ttt85 -44.66 -66.67 0.36 Allowed 'General case' 0 C--N 1.355 0.833 0 O-C-N 124.191 0.932 . . . . 0.0 113.024 172.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.76 -24.28 28.87 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 118.173 2.657 . . . . 0.0 118.173 -167.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -61.99 -9.64 7.69 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 155.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.566 ' CG2' HD22 ' A' ' 4' ' ' LEU . 37.0 p -122.13 1.49 9.75 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 114.164 -2.826 . . . . 0.0 115.874 165.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 m -64.99 103.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 1 CA-C-O 111.52 -4.086 . . . . 0.0 106.901 -170.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.41 -6.13 45.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 127.17 4.532 . . . . 0.0 121.626 -167.776 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.18 71.87 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -79.3 -5.66 54.94 Favored 'General case' 0 N--CA 1.494 1.755 1 O-C-N 114.332 -5.23 . . . . 0.0 117.866 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.71 129.94 93.21 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-N 121.964 2.165 . . . . 0.0 109.791 167.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.647 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.2 Cg_exo -52.42 -52.63 8.47 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 C-N-CA 123.637 2.891 . . . . 0.0 117.18 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.68 132.4 36.39 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.022 0.529 . . . . 0.0 110.099 165.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -130.36 99.47 19.27 Favored Pre-proline 0 N--CA 1.488 1.459 0 CA-C-O 115.987 -1.958 . . . . 0.0 110.045 -172.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.12 155.95 91.15 Favored 'Cis proline' 0 CA--C 1.559 1.749 0 CA-C-N 123.323 2.223 . . . . 0.0 114.877 2.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 54' ' ' LEU 0.292 0.1 OUTLIER -69.3 131.58 90.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 121.377 0.608 . . . . 0.0 109.474 157.784 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -82.5 166.25 15.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.008 5.806 . . . . 0.0 119.323 -164.518 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.921 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 1.9 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.953 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.3 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.701 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.89 54.08 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.3 tp -108.95 100.52 9.71 Favored 'General case' 0 N--CA 1.517 2.903 1 C-N-CA 132.079 4.152 . . . . 0.0 104.999 -171.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.709 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.283 1.3 p90 -147.96 170.03 18.6 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.56 133.04 32.04 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.189 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.28 154.33 44.63 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.408 HD11 ' C13' ' A' ' 163' ' ' BDM . 37.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.33 23.7 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.487 1.404 1 O-C-N 113.473 -5.767 . . . . 0.0 115.747 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.24 -21.84 33.25 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.67 -40.75 95.94 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.892 1.224 . . . . 0.0 113.333 158.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -74.35 -20.87 59.93 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.476 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 3.7 t80 -63.34 -53.23 55.91 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 122.556 2.434 . . . . 0.0 111.713 161.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.033 ' HG3' HH22 ' A' ' 57' ' ' ARG . 56.0 ttt180 -54.19 -22.59 11.77 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.4 -27.58 5.17 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -60.55 -21.69 62.82 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 121.249 1.84 . . . . 0.0 114.569 151.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.6 p -124.3 72.68 1.2 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 151.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.87 136.63 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 137.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.35 -6.13 80.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.694 3.861 . . . . 0.0 121.626 165.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.9 71.6 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.71 -6.05 56.43 Favored 'General case' 0 N--CA 1.493 1.685 1 O-C-N 114.32 -5.238 . . . . 0.0 117.98 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -67.62 129.18 93.54 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 122.018 2.19 . . . . 0.0 109.663 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.632 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.1 Cg_exo -52.13 -52.14 9.59 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.656 2.904 . . . . 0.0 117.344 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.12 133.43 35.35 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.047 0.539 . . . . 0.0 110.155 165.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 mtm105 -131.5 98.7 17.94 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-O 115.982 -1.961 . . . . 0.0 110.072 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 154.61 89.57 Favored 'Cis proline' 0 CA--C 1.559 1.748 0 CA-C-N 123.274 2.205 . . . . 0.0 114.768 2.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 54' ' ' LEU 0.281 0.1 OUTLIER -68.06 133.95 91.75 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-O 121.346 0.593 . . . . 0.0 109.663 157.326 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.48 166.25 10.59 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.684 5.589 . . . . 0.0 119.323 -163.715 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.033 HH22 ' HG3' ' A' ' 31' ' ' ARG . 9.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.778 H191 ' HD2' ' A' ' 31' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.8 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.945 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.1 tp -108.71 102.13 11.21 Favored 'General case' 0 N--CA 1.516 2.828 1 C-N-CA 131.813 4.045 . . . . 0.0 104.955 -172.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.736 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.272 1.5 p90 -148.77 170.32 18.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.09 132.85 32.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.185 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.82 154.33 45.12 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.0 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.21 23.44 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.65 -29.51 68.0 Favored 'General case' 0 N--CA 1.486 1.328 1 O-C-N 113.705 -5.622 . . . . 0.0 115.589 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.69 -24.69 36.07 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -59.32 -42.57 91.73 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 120.887 1.676 . . . . 0.0 113.872 157.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -74.06 -22.15 59.65 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 116.687 -1.625 . . . . 0.0 115.234 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.456 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 5.7 t80 -60.09 -55.13 37.69 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 122.46 2.391 . . . . 0.0 111.437 161.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.098 ' HA ' HH12 ' A' ' 57' ' ' ARG . 57.8 ttt85 -43.64 -45.07 6.7 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.94 -27.63 10.57 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 -170.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -59.76 -14.86 16.36 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 120.772 1.624 . . . . 0.0 115.238 154.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.538 ' CG2' HD22 ' A' ' 4' ' ' LEU . 39.3 p -124.01 19.84 9.17 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 114.878 -2.487 . . . . 0.0 114.921 161.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.51 117.24 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 CA-C-N 125.743 3.883 . . . . 0.0 105.592 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.13 68.43 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.958 4.436 . . . . 0.0 121.626 179.382 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.28 71.99 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.78 -7.5 57.87 Favored 'General case' 0 N--CA 1.493 1.699 1 O-C-N 114.305 -5.247 . . . . 0.0 117.924 174.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -67.27 130.12 93.64 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-N 121.872 2.124 . . . . 0.0 109.893 167.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.631 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.5 Cg_exo -52.57 -52.73 8.22 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.671 2.914 . . . . 0.0 117.168 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.46 132.53 36.18 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.105 0.562 . . . . 0.0 110.201 166.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -131.57 99.31 17.25 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 115.982 -1.961 . . . . 0.0 109.947 -172.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.28 154.6 89.91 Favored 'Cis proline' 0 CA--C 1.559 1.745 0 CA-C-N 123.356 2.234 . . . . 0.0 114.799 2.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 54' ' ' LEU 0.283 0.2 OUTLIER -69.33 129.95 91.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 158.755 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -81.56 166.25 17.8 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 128.225 5.95 . . . . 0.0 119.323 -163.359 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.098 HH12 ' HA ' ' A' ' 31' ' ' ARG . 13.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.945 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.2 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.736 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.82 54.1 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.956 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.5 tp -108.73 100.15 9.42 Favored 'General case' 0 N--CA 1.517 2.925 1 C-N-CA 131.974 4.11 . . . . 0.0 104.938 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.687 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.293 1.2 p90 -147.4 169.65 19.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.89 132.62 30.72 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.161 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.4 154.33 44.52 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.42 23.35 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.79 -25.37 61.14 Favored 'General case' 0 N--CA 1.486 1.353 1 O-C-N 113.46 -5.775 . . . . 0.0 115.815 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt -85.89 -26.84 25.39 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 88.4 m-70 -66.61 -40.98 89.07 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.626 1.103 . . . . 0.0 113.869 158.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -73.89 -20.49 60.39 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 172.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.7 t80 -61.01 -52.69 63.91 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 121.697 2.044 . . . . 0.0 111.973 158.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.059 ' HA ' HH12 ' A' ' 57' ' ' ARG . 73.5 ttt180 -42.05 -36.02 1.04 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 118.397 2.739 . . . . 0.0 118.397 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.28 -24.11 5.13 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -59.42 -36.06 75.15 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 121.217 1.826 . . . . 0.0 113.384 154.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.1 p -110.6 71.48 0.75 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 155.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.36 139.43 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.323 0 CA-C-O 115.39 -2.243 . . . . 0.0 105.204 135.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 -6.13 82.09 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.626 3.83 . . . . 0.0 121.626 165.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.29 73.17 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.24 -5.63 52.5 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.362 -5.211 . . . . 0.0 117.697 173.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -67.46 129.93 93.47 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-N 121.568 1.986 . . . . 0.0 109.932 166.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.659 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.2 Cg_exo -52.6 -52.9 7.83 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.653 2.902 . . . . 0.0 117.141 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -91.21 134.11 34.82 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.12 0.568 . . . . 0.0 110.24 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -132.91 98.21 16.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 116.046 -1.93 . . . . 0.0 110.106 -172.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.38 152.87 87.87 Favored 'Cis proline' 0 CA--C 1.558 1.679 0 CA-C-N 123.27 2.203 . . . . 0.0 114.723 2.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -65.06 137.54 97.11 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.124 0.488 . . . . 0.0 109.993 156.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -90.79 166.25 3.98 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.117 4.545 . . . . 0.0 119.323 -164.011 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.059 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.956 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.687 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.35 54.0 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.2 tp -109.33 104.2 13.28 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 131.668 3.987 . . . . 0.0 105.051 -172.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.719 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.251 1.7 p90 -150.79 170.85 18.26 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.5 132.79 33.78 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.88 1.272 . . . . 0.0 109.124 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.16 154.33 45.8 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.83 23.55 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.59 -26.2 64.35 Favored 'General case' 0 N--CA 1.481 1.11 1 O-C-N 114.193 -5.317 . . . . 0.0 115.451 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.2 -17.54 36.82 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 166.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -64.05 -45.14 90.14 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.32 1.418 . . . . 0.0 113.037 155.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -73.79 -22.89 59.67 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 116.835 -1.555 . . . . 0.0 115.146 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -57.55 -56.4 22.35 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 122.266 2.303 . . . . 0.0 111.172 161.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.956 ' HA ' HH12 ' A' ' 57' ' ' ARG . 59.3 ttt180 -49.35 -47.91 47.03 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.65 -24.11 14.15 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 117.993 2.59 . . . . 0.0 117.993 -169.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -60.09 -10.24 4.12 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 120.903 1.683 . . . . 0.0 115.511 152.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.583 HG23 HD22 ' A' ' 4' ' ' LEU . 25.4 p -117.94 -4.35 11.09 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 113.469 -3.158 . . . . 0.0 115.411 164.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.253 2.7 m -61.24 107.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 125.886 3.948 . . . . 0.0 107.024 -173.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.88 -6.13 54.15 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -171.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.28 74.54 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.5 p -76.4 -7.48 55.13 Favored 'General case' 0 N--CA 1.492 1.657 1 O-C-N 114.427 -5.171 . . . . 0.0 117.576 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.42 131.67 93.17 Favored Pre-proline 0 CA--C 1.576 1.976 0 CA-C-N 121.33 1.877 . . . . 0.0 109.998 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.729 ' HD3' BR11 ' A' ' 163' ' ' BDM . 50.3 Cg_exo -53.43 -53.31 6.82 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.601 2.867 . . . . 0.0 117.034 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.15 134.11 34.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.169 0.587 . . . . 0.0 110.397 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 mtm105 -134.83 97.8 13.69 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.068 -1.92 . . . . 0.0 109.982 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.46 150.64 84.72 Favored 'Cis proline' 0 CA--C 1.557 1.643 0 CA-C-N 123.282 2.208 . . . . 0.0 114.499 2.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 54' ' ' LEU 0.262 0.2 OUTLIER -67.67 138.72 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 158.234 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -91.07 166.25 3.73 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.557 4.838 . . . . 0.0 119.323 -159.988 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.956 HH12 ' HA ' ' A' ' 31' ' ' ARG . 5.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.9 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.729 BR11 ' HD3' ' A' ' 50' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.7 tp -108.26 101.41 10.62 Favored 'General case' 0 N--CA 1.515 2.788 1 C-N-CA 131.767 4.027 . . . . 0.0 104.878 -172.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.694 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.291 1.3 p90 -147.83 169.7 19.23 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 178.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.48 132.58 31.5 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.035 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.3 23.71 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.61 -24.49 61.08 Favored 'General case' 0 N--CA 1.487 1.409 1 O-C-N 113.567 -5.708 . . . . 0.0 115.796 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.2 -27.11 26.34 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -66.24 -42.09 89.07 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 158.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -75.77 -25.16 56.22 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 116.723 -1.608 . . . . 0.0 114.911 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.522 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.7 t80 -55.6 -54.8 39.63 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 122.517 2.417 . . . . 0.0 111.275 159.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.071 ' HA ' HH12 ' A' ' 57' ' ' ARG . 53.3 ttt85 -44.87 -49.3 11.0 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.251 . . -103.64 -17.46 15.13 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 118.184 2.661 . . . . 0.0 118.184 -171.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -55.76 -46.56 77.84 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 120.935 1.698 . . . . 0.0 112.117 153.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.524 ' CG2' HD22 ' A' ' 4' ' ' LEU . 41.4 p -92.57 10.04 32.05 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 114.374 -2.727 . . . . 0.0 116.903 171.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.282 1.9 m -61.98 111.37 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-N 125.757 3.889 . . . . 0.0 106.528 173.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.69 -6.13 54.68 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.059 3.572 . . . . 0.0 121.626 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.69 72.47 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -78.34 -7.55 57.41 Favored 'General case' 0 N--CA 1.494 1.75 1 O-C-N 114.307 -5.246 . . . . 0.0 117.824 173.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.2 130.42 93.66 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 121.714 2.052 . . . . 0.0 110.1 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.633 ' CD ' BR11 ' A' ' 163' ' ' BDM . 53.1 Cg_exo -52.34 -53.07 7.54 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.595 2.863 . . . . 0.0 117.222 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.72 134.52 34.65 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.109 0.564 . . . . 0.0 110.345 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -134.12 98.61 14.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 116.043 -1.932 . . . . 0.0 110.03 -171.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.27 151.15 86.27 Favored 'Cis proline' 0 CA--C 1.558 1.703 0 CA-C-N 123.227 2.188 . . . . 0.0 114.682 2.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.13 132.24 94.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 158.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.4 166.25 9.27 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.091 5.194 . . . . 0.0 119.323 -162.493 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.071 HH12 ' HA ' ' A' ' 31' ' ' ARG . 9.5 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.5 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.694 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.77 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 5.9 tp -108.64 100.05 9.34 Favored 'General case' 0 N--CA 1.517 2.888 1 C-N-CA 131.936 4.094 . . . . 0.0 104.889 -171.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.707 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.295 1.2 p90 -147.01 169.63 18.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 179.027 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.77 132.71 31.1 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.337 -1.302 . . . . 0.0 109.144 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.44 154.33 44.47 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.402 HD11 ' C12' ' A' ' 163' ' ' BDM . 21.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.43 23.36 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.21 -25.37 60.72 Favored 'General case' 0 N--CA 1.486 1.373 1 O-C-N 113.588 -5.695 . . . . 0.0 115.826 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.84 -31.76 23.64 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 171.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.555 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 73.7 m-70 -60.66 -42.59 97.33 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 158.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -74.13 -19.52 60.55 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 2.9 t80 -62.14 -52.37 64.11 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 122.008 2.185 . . . . 0.0 111.945 159.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.127 ' HA ' HH12 ' A' ' 57' ' ' ARG . 47.0 ttt85 -39.54 -42.25 1.12 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.57 -24.8 8.61 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -58.48 -29.92 66.59 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.198 1.817 . . . . 0.0 114.165 153.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p -118.57 62.58 0.78 Allowed 'General case' 0 CA--C 1.561 1.385 0 CA-C-N 118.97 0.804 . . . . 0.0 109.943 157.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.29 133.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 CA-C-O 115.23 -2.319 . . . . 0.0 104.866 143.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.16 -6.13 83.89 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.356 3.707 . . . . 0.0 121.626 168.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.47 73.37 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -77.93 -6.04 53.09 Favored 'General case' 0 N--CA 1.493 1.714 1 O-C-N 114.36 -5.212 . . . . 0.0 117.718 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.43 130.0 93.48 Favored Pre-proline 0 CA--C 1.574 1.9 0 CA-C-N 121.454 1.934 . . . . 0.0 110.021 167.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.672 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.0 Cg_exo -52.58 -53.13 7.39 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.606 2.871 . . . . 0.0 117.148 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.21 134.05 34.87 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.078 0.551 . . . . 0.0 110.305 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -133.24 98.35 15.56 Favored Pre-proline 0 N--CA 1.488 1.427 0 CA-C-O 116.068 -1.92 . . . . 0.0 110.091 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.5 152.42 86.9 Favored 'Cis proline' 0 CA--C 1.558 1.704 0 CA-C-N 123.223 2.187 . . . . 0.0 114.785 2.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.636 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -64.51 135.21 96.26 Favored Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.86 156.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -89.43 166.25 5.31 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.314 4.676 . . . . 0.0 119.323 -164.281 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.127 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.707 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.96 54.07 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD23 ' HB2' ' A' ' 97' ' ' ALA . 7.8 tp -108.54 100.4 9.67 Favored 'General case' 0 N--CA 1.513 2.705 0 C-N-CA 131.698 3.999 . . . . 0.0 104.934 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.706 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.3 1.3 p90 -146.66 169.3 19.29 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 178.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.46 132.26 31.03 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.023 173.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.3 154.33 44.62 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -172.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.32 -25.12 61.44 Favored 'General case' 0 N--CA 1.487 1.392 1 O-C-N 113.626 -5.671 . . . . 0.0 115.745 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -83.09 -33.72 26.3 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.099 1.36 . . . . 0.0 113.87 169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -57.21 -44.67 83.9 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 158.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -76.51 -23.73 53.71 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 116.803 -1.57 . . . . 0.0 114.829 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 14.3 t80 -53.72 -52.99 58.34 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 122.332 2.333 . . . . 0.0 111.914 161.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.02 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 64.8 ttt180 -50.85 -67.04 0.29 Allowed 'General case' 0 C--N 1.355 0.808 0 O-C-N 123.912 0.757 . . . . 0.0 112.733 174.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.86 -11.76 59.54 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -170.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -61.32 -50.61 72.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.624 1.556 . . . . 0.0 111.689 154.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.55 ' CG2' HD22 ' A' ' 4' ' ' LEU . 50.5 p -88.9 10.85 19.79 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 m -66.82 102.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 CA-C-O 112.691 -3.528 . . . . 0.0 105.878 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.13 35.95 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.03 4.013 . . . . 0.0 121.626 -171.243 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -32.26 73.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.3 p -79.1 -4.21 49.2 Favored 'General case' 0 N--CA 1.494 1.742 1 O-C-N 114.415 -5.178 . . . . 0.0 117.696 172.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -67.25 129.1 93.86 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-N 121.562 1.983 . . . . 0.0 109.852 166.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.668 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.6 Cg_exo -52.25 -52.77 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.639 2.893 . . . . 0.0 117.176 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.73 133.87 35.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.13 0.572 . . . . 0.0 110.138 165.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -130.84 98.58 19.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 116.028 -1.939 . . . . 0.0 110.172 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -79.22 155.46 90.62 Favored 'Cis proline' 0 CA--C 1.558 1.688 0 CA-C-N 123.34 2.229 . . . . 0.0 114.753 1.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 54' ' ' LEU 0.289 0.2 OUTLIER -68.66 136.18 90.38 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.529 0.68 . . . . 0.0 109.759 157.029 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.75 166.25 8.77 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.487 5.458 . . . . 0.0 119.323 -163.908 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.02 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 11.0 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.954 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.706 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.27 54.01 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.951 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.6 tp -109.0 102.92 11.87 Favored 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 131.678 3.991 . . . . 0.0 104.949 -172.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.713 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.269 1.6 p90 -149.4 170.19 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.72 132.62 33.09 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.058 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.6 154.33 45.34 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.419 HD11 ' C13' ' A' ' 163' ' ' BDM . 35.7 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -48.88 23.24 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -68.6 -29.11 67.55 Favored 'General case' 0 N--CA 1.486 1.345 1 O-C-N 113.929 -5.482 . . . . 0.0 115.599 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.93 -23.16 41.93 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 84.3 m-70 -62.92 -40.9 99.02 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 120.75 1.614 . . . . 0.0 113.993 158.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -73.86 -27.18 60.96 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 116.866 -1.54 . . . . 0.0 114.795 167.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -55.64 -51.01 68.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 122.293 2.315 . . . . 0.0 111.95 160.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.944 ' HA ' HH12 ' A' ' 57' ' ' ARG . 52.8 ttt85 -42.31 -59.43 1.83 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.53 -23.75 15.4 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.93 2.567 . . . . 0.0 117.93 -165.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -60.96 -6.61 1.93 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 152.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.569 HG23 HD22 ' A' ' 4' ' ' LEU . 32.5 p -122.32 -4.14 8.9 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 113.529 -3.129 . . . . 0.0 115.495 163.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.71 105.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 125.777 3.899 . . . . 0.0 107.246 -171.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.96 -6.13 51.14 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.889 3.949 . . . . 0.0 121.626 -169.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.42 72.15 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.58 -7.0 57.11 Favored 'General case' 0 N--CA 1.493 1.694 1 O-C-N 114.327 -5.233 . . . . 0.0 117.843 173.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -67.49 130.41 93.31 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-N 121.896 2.134 . . . . 0.0 109.848 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.637 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.7 Cg_exo -52.36 -52.65 8.43 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.684 2.923 . . . . 0.0 117.177 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.45 133.78 35.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.097 0.559 . . . . 0.0 110.269 166.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -132.68 98.46 16.31 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-O 115.998 -1.954 . . . . 0.0 110.077 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.22 153.28 88.91 Favored 'Cis proline' 0 CA--C 1.557 1.663 0 CA-C-N 123.351 2.232 . . . . 0.0 114.62 2.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' H ' HD23 ' A' ' 54' ' ' LEU 0.281 0.2 OUTLIER -68.68 135.85 90.32 Favored Pre-proline 0 N--CA 1.493 1.708 0 CA-C-O 121.49 0.662 . . . . 0.0 109.839 158.144 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -87.13 166.25 8.24 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.416 5.411 . . . . 0.0 119.323 -162.012 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.944 HH12 ' HA ' ' A' ' 31' ' ' ARG . 6.2 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.951 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.713 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.2 tp -108.51 101.79 10.93 Favored 'General case' 0 N--CA 1.516 2.847 1 C-N-CA 131.797 4.039 . . . . 0.0 104.856 -172.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.752 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.277 1.5 p90 -148.15 170.09 18.59 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 178.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.97 132.82 32.89 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.168 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.88 154.33 45.05 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 HD11 ' C13' ' A' ' 163' ' ' BDM . 35.6 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.26 23.72 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.49 -29.89 66.55 Favored 'General case' 0 N--CA 1.484 1.261 1 O-C-N 113.843 -5.536 . . . . 0.0 115.454 -177.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.82 -23.0 36.73 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 165.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -58.69 -45.19 90.01 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 120.025 1.284 . . . . 0.0 113.157 157.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -76.04 -17.56 59.61 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-O 116.51 -1.709 . . . . 0.0 115.338 169.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 8.1 t80 -62.0 -57.68 10.75 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 122.751 2.523 . . . . 0.0 110.825 162.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.05 ' HA ' HH12 ' A' ' 57' ' ' ARG . 73.2 ttt180 -48.91 -42.46 37.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.62 -26.32 12.84 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 -170.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -59.42 -17.35 29.92 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 121.025 1.739 . . . . 0.0 115.166 153.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.543 ' CG2' HD22 ' A' ' 4' ' ' LEU . 36.4 p -118.11 12.28 13.54 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 114.36 -2.733 . . . . 0.0 115.462 163.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.261 1.6 m -63.81 112.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-N 125.742 3.883 . . . . 0.0 105.703 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.13 59.34 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.279 3.672 . . . . 0.0 121.626 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.86 72.66 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.7 p -78.23 -7.26 56.92 Favored 'General case' 0 N--CA 1.494 1.73 1 O-C-N 114.345 -5.222 . . . . 0.0 117.797 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.27 130.19 93.63 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-N 121.708 2.049 . . . . 0.0 109.907 167.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.66 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.3 Cg_exo -52.7 -52.84 7.95 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 123.607 2.871 . . . . 0.0 117.151 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 133.26 35.55 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.127 0.571 . . . . 0.0 110.253 166.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 mtm105 -132.58 98.75 16.21 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 116.05 -1.929 . . . . 0.0 110.031 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.28 153.61 89.0 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 CA-C-N 123.297 2.213 . . . . 0.0 114.75 2.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.1 OUTLIER -67.59 133.51 92.7 Favored Pre-proline 0 N--CA 1.494 1.769 0 CA-C-O 121.107 0.479 . . . . 0.0 109.778 158.033 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.87 166.25 10.04 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.196 5.264 . . . . 0.0 119.323 -163.246 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.05 HH12 ' HA ' ' A' ' 31' ' ' ARG . 11.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 56.0 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.752 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.18 54.03 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.1 tp -108.82 102.85 11.84 Favored 'General case' 0 N--CA 1.512 2.663 1 C-N-CA 131.708 4.003 . . . . 0.0 104.876 -172.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.737 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.268 1.6 p90 -149.06 170.29 18.73 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.74 132.53 32.92 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.097 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -141.45 154.33 45.5 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD11 ' C13' ' A' ' 163' ' ' BDM . 34.5 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.48 23.65 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.48 -29.77 66.39 Favored 'General case' 0 N--CA 1.483 1.224 1 O-C-N 114.226 -5.296 . . . . 0.0 115.281 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 mp -81.29 -18.12 46.95 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 165.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -63.1 -46.42 87.45 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 119.789 1.177 . . . . 0.0 112.754 157.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -73.84 -23.34 59.61 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 116.762 -1.59 . . . . 0.0 115.119 170.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -55.39 -55.11 35.34 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 122.375 2.352 . . . . 0.0 111.575 162.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.936 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 55.7 ttt85 -47.19 -62.1 1.58 Allowed 'General case' 0 C--N 1.353 0.758 0 O-C-N 124.38 1.05 . . . . 0.0 113.539 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.97 -23.54 25.04 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -169.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -62.12 -8.32 5.33 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 154.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.56 ' CG2' HD22 ' A' ' 4' ' ' LEU . 32.3 p -121.09 -2.22 9.7 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 113.986 -2.912 . . . . 0.0 115.32 165.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.26 103.4 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 125.45 3.75 . . . . 0.0 106.501 -169.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.22 -6.13 42.41 Favored Glycine 2 CA--C 1.429 -5.282 0 CA-C-N 125.224 3.647 . . . . 0.0 121.626 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -33.07 74.13 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.6 p -77.04 -6.45 52.77 Favored 'General case' 0 N--CA 1.493 1.709 1 O-C-N 114.413 -5.18 . . . . 0.0 117.591 173.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.52 130.82 93.15 Favored Pre-proline 0 CA--C 1.576 1.948 0 CA-C-N 121.376 1.898 . . . . 0.0 109.899 166.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.734 ' HD3' BR11 ' A' ' 163' ' ' BDM . 51.0 Cg_exo -53.32 -53.32 6.86 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 C-N-CA 123.627 2.885 . . . . 0.0 116.992 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.06 133.67 35.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.145 0.578 . . . . 0.0 110.312 167.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mtm105 -133.51 98.23 15.28 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-O 116.041 -1.933 . . . . 0.0 109.952 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.51 152.14 86.51 Favored 'Cis proline' 0 CA--C 1.556 1.62 0 CA-C-N 123.267 2.203 . . . . 0.0 114.594 2.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 54' ' ' LEU 0.276 0.1 OUTLIER -68.09 137.05 91.81 Favored Pre-proline 0 N--CA 1.493 1.71 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 158.172 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -88.92 166.25 5.83 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.974 5.116 . . . . 0.0 119.323 -161.045 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.936 ' NH1' ' HA ' ' A' ' 31' ' ' ARG . 2.6 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.737 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 129.76 54.11 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.941 HD23 ' HB2' ' A' ' 97' ' ' ALA . 6.3 tp -108.5 101.41 10.58 Favored 'General case' 0 N--CA 1.516 2.869 1 C-N-CA 131.818 4.047 . . . . 0.0 104.885 -172.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.726 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.284 1.4 p90 -147.92 169.92 18.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.33 132.58 31.79 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.08 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.04 154.33 44.89 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.41 HD11 ' C13' ' A' ' 163' ' ' BDM . 35.3 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -47.9 23.53 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.58 -28.97 66.42 Favored 'General case' 0 N--CA 1.488 1.426 1 O-C-N 113.626 -5.671 . . . . 0.0 115.681 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.22 -20.52 34.44 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 167.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 21.9 m-70 -64.32 -41.38 96.84 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.392 1.451 . . . . 0.0 113.348 157.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -74.08 -22.18 59.61 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 116.626 -1.654 . . . . 0.0 115.152 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 5.1 t80 -61.07 -55.08 36.77 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 122.639 2.472 . . . . 0.0 111.408 161.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.038 ' HA ' HH12 ' A' ' 57' ' ' ARG . 51.9 ttt85 -37.79 -49.45 1.18 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 172.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.44 -26.42 10.47 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -168.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -59.78 -14.91 16.76 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 120.948 1.704 . . . . 0.0 115.126 154.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.517 ' CG2' HD22 ' A' ' 4' ' ' LEU . 40.9 p -123.18 20.33 9.82 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 115.124 -2.37 . . . . 0.0 114.764 161.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 2.2 m -64.28 115.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-N 125.75 3.886 . . . . 0.0 105.903 168.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.08 -6.13 63.77 Favored Glycine 2 CA--C 1.429 -5.282 1 CA-C-N 126.446 4.203 . . . . 0.0 121.626 179.588 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -31.59 72.35 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.9 p -78.92 -6.34 55.95 Favored 'General case' 0 N--CA 1.493 1.722 1 O-C-N 114.365 -5.209 . . . . 0.0 117.853 173.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -67.51 129.85 93.45 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 121.773 2.079 . . . . 0.0 109.799 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.652 ' CD ' BR11 ' A' ' 163' ' ' BDM . 52.6 Cg_exo -52.48 -52.56 8.61 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 123.602 2.868 . . . . 0.0 117.221 176.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -91.25 133.5 35.34 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.037 0.535 . . . . 0.0 110.228 166.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.7 mtm105 -132.23 98.6 16.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.095 -172.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.36 154.06 89.08 Favored 'Cis proline' 0 CA--C 1.558 1.697 0 CA-C-N 123.282 2.208 . . . . 0.0 114.799 2.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 54' ' ' LEU 0.263 0.1 OUTLIER -66.72 134.45 94.22 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 121.173 0.511 . . . . 0.0 109.645 157.213 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -86.98 166.25 8.45 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 126.99 5.127 . . . . 0.0 119.323 -164.23 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.038 HH12 ' HA ' ' A' ' 31' ' ' ARG . 9.7 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.941 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.8 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.726 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.374 54.7 m . . . . . 0 C--O 1.215 -0.752 0 CA-C-O 121.348 0.594 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.93 150.5 24.14 Favored 'General case' 0 CA--C 1.608 3.203 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.734 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.354 4.0 m-30 -106.07 130.07 54.05 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 163.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.963 HD23 ' HB2' ' A' ' 97' ' ' ALA . 8.1 tp -108.59 101.1 10.28 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 131.628 3.971 . . . . 0.0 104.828 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.739 ' HA ' HN41 ' A' ' 163' ' ' BDM 0.29 1.4 p90 -147.13 169.18 19.85 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.59 132.99 33.88 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.07 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.25 154.33 44.67 Favored 'General case' 0 C--O 1.162 -3.511 1 CA-C-O 128.737 4.113 . . . . 0.0 101.853 -173.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 8' ' ' ASP . 9.0 p-10 -77.17 -177.28 4.45 Favored 'General case' 1 N--CA 1.573 5.692 2 CA-C-O 134.334 6.778 . . . . 0.0 97.766 172.445 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -60.87 -24.67 66.11 Favored 'General case' 0 C--N 1.421 3.684 1 CA-C-N 104.46 -5.791 . . . . 0.0 119.533 -179.982 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.33 0.02 39.24 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 116.412 -3.93 . . . . 0.0 107.414 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.89 -2.42 56.91 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 123.515 2.871 . . . . 0.0 119.677 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.9 tp -63.53 135.46 56.87 Favored 'General case' 1 C--N 1.454 5.131 0 CA-C-N 108.42 -3.89 . . . . 0.0 114.681 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -118.59 -16.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 3 O-C-N 115.193 -4.692 . . . . 0.0 119.986 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.88 166.98 31.57 Favored Glycine 2 CA--C 1.631 7.31 1 C-N-CA 110.083 -5.818 . . . . 0.0 111.171 -175.152 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG3' ' HA2' ' A' ' 124' ' ' GLY 0.278 57.4 tttp -154.99 118.5 4.51 Favored 'General case' 0 C--O 1.297 3.603 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.283 67.9 m-20 60.46 35.23 20.37 Favored 'General case' 0 N--CA 1.506 2.332 1 O-C-N 115.257 -4.652 . . . . 0.0 107.813 168.591 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.13 9.96 86.05 Favored Glycine 1 N--CA 1.569 7.5 0 CA-C-O 113.534 -3.926 . . . . 0.0 115.671 -177.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -140.17 -179.78 6.18 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.507 HD11 ' C13' ' A' ' 163' ' ' BDM . 40.4 mt -80.23 146.55 62.74 Favored Pre-proline 1 C--O 1.099 -6.842 1 CA-C-O 139.808 9.385 . . . . 0.0 100.662 179.37 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . 0.404 84.9 Cg_exo -84.32 2.48 8.12 Favored 'Trans proline' 2 C--N 1.555 11.408 2 C-N-CA 103.996 -10.203 . . . . 0.0 111.078 -179.833 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -143.09 -179.71 6.54 Favored 'General case' 0 CA--C 1.555 1.164 3 O-C-N 112.48 -6.388 . . . . 0.0 102.405 -172.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -147.62 113.15 5.65 Favored 'General case' 1 C--O 1.144 -4.457 2 CA-C-O 137.479 8.276 . . . . 0.0 101.186 172.977 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -143.13 84.24 10.54 Favored Pre-proline 2 C--O 1.088 -7.414 2 CA-C-O 134.436 6.827 . . . . 0.0 111.514 -170.838 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.295 ' CD ' ' N ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.55 -43.78 51.94 Favored 'Trans proline' 1 C--N 1.505 8.774 3 C-N-CA 107.162 -8.092 . . . . 0.0 112.136 -178.869 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.15 -46.63 23.52 Favored 'General case' 2 C--O 1.132 -5.127 2 CA-C-N 132.818 7.099 . . . . 0.0 114.458 -176.205 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.73 -29.88 62.5 Favored 'General case' 0 N--CA 1.483 1.22 1 O-C-N 113.933 -5.48 . . . . 0.0 115.525 -176.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.431 HD23 H152 ' A' ' 163' ' ' BDM . 6.4 mp -82.48 -27.15 31.99 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 169.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -60.95 -41.83 97.06 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.54 1.518 . . . . 0.0 114.088 158.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -74.61 -23.92 58.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 116.93 -1.51 . . . . 0.0 114.995 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.584 ' CD2' ' H9 ' ' A' ' 163' ' ' BDM . 12.1 t80 -57.59 -53.56 56.83 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 122.183 2.265 . . . . 0.0 111.929 161.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.031 ' HA ' HH12 ' A' ' 57' ' ' ARG . 57.0 ttt85 -40.73 -54.09 2.69 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 172.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.25 -24.56 14.22 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -168.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -57.87 -18.56 23.44 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 153.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.584 ' CG2' HD22 ' A' ' 4' ' ' LEU . 40.2 p -114.49 4.25 15.18 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 113.936 -2.935 . . . . 0.0 115.739 164.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 2.4 m -62.61 108.33 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 125.848 3.931 . . . . 0.0 106.519 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.43 -6.13 49.31 Favored Glycine 2 CA--C 1.429 -5.282 0 N-CA-C 121.626 3.41 . . . . 0.0 121.626 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.356 56.4 mttp -111.0 -177.91 3.33 Favored 'General case' 0 CA--C 1.47 -2.107 1 O-C-N 116.326 -4.044 . . . . 0.0 106.802 -172.507 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 92' ' ' GLN . 72.0 mt -93.54 106.61 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.776 0 O-C-N 117.333 -3.354 . . . . 0.0 109.735 168.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.2 ttp -94.2 109.13 20.95 Favored 'General case' 1 N--CA 1.36 -4.952 1 O-C-N 115.289 -4.632 . . . . 0.0 111.792 -171.077 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.89 125.14 54.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 1 CA-C-N 128.444 5.111 . . . . 0.0 113.16 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.44 147.17 28.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 1 O-C-N 129.374 4.171 . . . . 0.0 108.351 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.62 152.93 52.1 Favored Glycine 0 C--O 1.283 3.215 1 CA-C-O 130.353 5.419 . . . . 0.0 105.677 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -52.19 -49.32 64.1 Favored 'General case' 0 CA--C 1.606 3.126 1 O-C-N 114.22 -5.282 . . . . 0.0 109.024 -174.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.451 2.9 ttm180 -64.63 -35.21 80.26 Favored 'General case' 0 C--N 1.425 3.872 1 C-N-CA 108.52 -5.272 . . . . 0.0 118.41 -177.785 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -66.91 -50.27 62.93 Favored 'General case' 0 N--CA 1.527 3.424 3 O-C-N 112.651 -6.281 . . . . 0.0 98.993 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -54.14 -44.79 71.67 Favored 'General case' 1 C--O 1.317 4.64 1 CA-C-N 128.173 4.988 . . . . 0.0 114.582 -177.003 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -62.48 -30.36 71.2 Favored 'General case' 0 CA--C 1.462 -2.41 1 O-C-N 113.092 -6.005 . . . . 0.0 112.455 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -79.4 -8.09 58.85 Favored 'General case' 0 N--CA 1.494 1.764 1 O-C-N 114.224 -5.298 . . . . 0.0 118.004 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -66.67 131.21 94.05 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-N 122.132 2.242 . . . . 0.0 110.233 168.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.643 ' HD2' BR11 ' A' ' 163' ' ' BDM . 53.3 Cg_exo -51.9 -52.97 7.8 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.585 2.857 . . . . 0.0 117.259 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -92.49 135.11 34.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.119 0.567 . . . . 0.0 110.354 166.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -134.22 98.87 13.76 Favored Pre-proline 0 N--CA 1.488 1.466 0 CA-C-O 116.111 -1.9 . . . . 0.0 110.102 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.69 151.03 88.14 Favored 'Cis proline' 0 CA--C 1.557 1.662 0 CA-C-N 123.25 2.196 . . . . 0.0 114.566 2.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 54' ' ' LEU 0.259 0.1 OUTLIER -67.63 132.97 92.65 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.897 159.327 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 1.35 ' N ' ' CD ' ' A' ' 55' ' ' PRO 0.299 39.5 Cg_endo -85.94 166.25 9.93 Favored 'Trans proline' 1 N--CA 1.553 5.02 1 C-N-CA 127.376 5.384 . . . . 0.0 119.323 -161.521 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 70.02 22.47 5.74 Favored 'General case' 0 C--O 1.274 2.352 0 CA-C-O 114.479 -2.677 . . . . 0.0 114.153 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 1.031 HH12 ' HA ' ' A' ' 31' ' ' ARG . 4.1 ptp180 -156.57 161.65 39.94 Favored 'General case' 0 C--O 1.261 1.672 1 N-CA-C 96.203 -5.48 . . . . 0.0 96.203 178.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.9 m -85.63 119.75 26.31 Favored 'General case' 0 C--O 1.175 -2.863 0 CA-C-O 114.58 -2.629 . . . . 0.0 104.1 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.314 1.4 m-80 -97.25 121.29 38.97 Favored 'General case' 0 CA--C 1.443 -3.154 1 O-C-N 130.132 4.645 . . . . 0.0 101.902 177.014 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.278 54.3 t -107.05 124.94 63.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 1 O-C-N 110.479 -7.638 . . . . 0.0 107.982 168.9 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.96 127.25 64.25 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.741 0 CA-C-O 126.345 2.974 . . . . 0.0 104.256 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . 0.346 25.2 mt -99.01 115.42 28.89 Favored 'General case' 0 N--CA 1.508 2.46 1 O-C-N 113.556 -5.715 . . . . 0.0 107.213 179.492 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -140.79 143.0 34.63 Favored 'General case' 1 C--O 1.331 5.351 3 O-C-N 107.425 -9.547 . . . . 0.0 109.653 -169.673 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . 0.257 68.4 m-70 -88.39 -5.07 58.51 Favored 'General case' 0 C--N 1.254 -3.568 1 CA-C-N 134.936 8.062 . . . . 0.0 111.056 173.852 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -71.38 102.76 2.7 Favored 'General case' 1 C--O 1.313 4.396 1 O-C-N 131.98 5.8 . . . . 0.0 104.725 -175.704 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.284 8.2 mt-10 -42.85 -41.8 3.4 Favored 'General case' 0 CA--C 1.574 1.884 4 O-C-N 108.623 -8.798 . . . . 0.0 115.869 174.935 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.476 ' CA ' ' CB ' ' A' ' 67' ' ' ASP 1.024 51.6 m-20 -81.24 -3.58 52.83 Favored 'General case' 0 C--N 1.391 2.396 2 N-CA-C 125.272 5.286 . . . . 0.0 125.272 179.272 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.263 87.3 t80 -61.82 146.48 49.46 Favored 'General case' 1 C--N 1.478 6.177 0 O-C-N 117.472 -3.268 . . . . 0.0 105.739 -164.691 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -117.76 133.49 55.89 Favored 'General case' 1 C--O 1.151 -4.115 1 CA-C-O 128.533 4.016 . . . . 0.0 112.607 172.672 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.65 93.9 2.2 Favored 'General case' 1 C--O 1.331 5.361 0 CA-C-N 108.761 -3.836 . . . . 0.0 102.953 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -58.05 134.18 56.19 Favored 'General case' 0 C--O 1.183 -2.442 0 O-C-N 118.299 -2.75 . . . . 0.0 109.245 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.35 -5.65 67.08 Favored Glycine 0 CA--C 1.55 2.251 1 CA-C-O 113.168 -4.129 . . . . 0.0 112.811 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.57 9.27 Favored 'General case' 0 C--O 1.29 3.235 0 CA-C-N 121.39 2.595 . . . . 0.0 106.257 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -105.02 110.26 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 5 O-C-N 106.936 -9.852 . . . . 0.0 98.761 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -97.98 112.07 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 1 O-C-N 113.286 -5.883 . . . . 0.0 105.252 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.56 169.49 21.27 Favored 'Isoleucine or valine' 1 C--N 1.441 4.556 2 CA-C-O 135.387 7.279 . . . . 0.0 104.294 173.784 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.312 30.3 m-70 -122.13 2.52 9.83 Favored 'General case' 1 C--N 1.442 4.6 1 CA-C-N 104.844 -5.617 . . . . 0.0 116.791 -166.263 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.373 39.3 p30 -156.13 174.3 15.57 Favored 'General case' 1 C--O 1.382 8.078 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 176.945 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.84 -33.62 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 1 O-C-N 110.476 -7.64 . . . . 0.0 115.196 171.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.34 98.52 Favored 'General case' 0 CA--C 1.564 1.491 1 N-CA-C 99.842 -4.133 . . . . 0.0 99.842 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.64 -26.85 66.43 Favored 'General case' 1 CA--C 1.409 -4.48 0 CA-C-N 122.26 2.3 . . . . 0.0 115.44 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.255 73.0 t -66.13 -57.48 10.36 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.589 1 CA-C-O 130.01 4.719 . . . . 0.0 103.896 -179.436 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.89 -41.31 97.75 Favored 'General case' 0 CA--C 1.598 2.811 2 O-C-N 113.421 -5.799 . . . . 0.0 107.157 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.3 -37.82 70.42 Favored 'General case' 2 C--N 1.218 -5.136 0 O-C-N 127.825 3.203 . . . . 0.0 105.517 176.47 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -68.4 -53.33 24.51 Favored 'General case' 0 C--O 1.197 -1.671 1 O-C-N 114.6 -5.063 . . . . 0.0 108.073 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.48 -39.81 61.61 Favored 'General case' 1 CA--C 1.642 4.518 1 O-C-N 115.742 -4.349 . . . . 0.0 113.074 177.773 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.35 2.4 mtpp -58.74 -41.52 86.68 Favored 'General case' 0 CA--C 1.602 2.98 0 CA-C-O 125.749 2.69 . . . . 0.0 107.975 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.433 0.0 OUTLIER -68.23 -20.84 64.85 Favored 'General case' 0 CA--C 1.469 -2.147 3 CA-C-O 138.907 8.956 . . . . 0.0 122.754 179.794 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 1.335 ' C ' ' CD ' ' A' ' 90' ' ' PRO 1.37 0.0 OUTLIER -100.97 -113.71 0.0 OUTLIER Pre-proline 2 C--O 1.572 18.04 3 CA-C-O 98.51 -10.281 . . . . 0.0 108.994 -168.629 . . . . . . . . 6 4 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 1.335 ' CD ' ' C ' ' A' ' 89' ' ' HIS 1.083 0.0 OUTLIER 132.53 -67.47 0.0 OUTLIER 'Trans proline' 2 C--N 0.965 -19.652 3 CA-C-N 136.144 6.801 . . . . 0.0 109.887 165.843 . . . . . . . . 6 4 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.082 ' OD1' ' HD2' ' A' ' 90' ' ' PRO 0.336 6.6 p-10 -93.12 -11.33 33.14 Favored 'General case' 2 C--O 1.34 5.816 2 O-C-N 111.022 -7.299 . . . . 0.0 105.569 -173.546 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 38' ' ' ILE . 62.2 mt-30 -108.69 134.98 50.68 Favored 'General case' 1 C--N 1.453 5.081 1 CA-C-O 128.848 4.166 . . . . 0.0 100.544 178.088 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.0 143.89 43.38 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 117.103 -3.498 . . . . 0.0 109.962 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.3 17.7 tp -98.57 122.0 41.22 Favored 'General case' 1 CA--C 1.652 4.889 0 O-C-N 116.536 -3.853 . . . . 0.0 109.974 178.333 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -120.08 121.13 65.08 Favored 'Isoleucine or valine' 1 CA--C 1.677 5.858 0 CA-C-N 110.683 -2.962 . . . . 0.0 108.513 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.62 116.58 37.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.676 2 O-C-N 130.231 4.707 . . . . 0.0 103.158 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.963 ' HB2' HD23 ' A' ' 4' ' ' LEU . . . -107.36 9.22 29.92 Favored 'General case' 0 CA--C 1.615 3.473 2 CA-C-O 109.33 -5.129 . . . . 0.0 112.698 -175.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.86 -177.25 24.34 Favored Glycine 1 C--O 1.156 -4.758 1 O-C-N 131.703 5.627 . . . . 0.0 119.697 177.439 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.61 -149.28 20.92 Favored Glycine 2 CA--C 1.392 -7.635 1 CA-C-O 129.872 5.151 . . . . 0.0 107.469 2.289 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.6 -42.62 64.72 Favored 'General case' 0 CA--C 1.593 2.616 1 O-C-N 112.497 -6.296 . . . . 0.0 117.45 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . 0.313 16.5 mt-30 -67.17 -38.67 85.81 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 115.24 -2.584 . . . . 0.0 106.394 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -32.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 C-N-CA 114.82 -2.752 . . . . 0.0 116.938 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -57.96 -40.06 79.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 127.758 3.161 . . . . 0.0 112.67 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.425 14.8 m -63.34 -39.66 95.16 Favored 'General case' 0 N--CA 1.536 3.835 0 O-C-N 118.544 -2.597 . . . . 0.0 110.445 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . 0.304 . . -67.07 -34.49 77.78 Favored 'General case' 1 C--O 1.415 9.772 0 CA-C-O 112.117 -3.801 . . . . 0.0 101.129 -177.865 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -106.85 14.88 26.11 Favored 'General case' 0 N--CA 1.524 3.247 3 CA-C-N 143.104 11.775 . . . . 0.0 104.684 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 130' ' ' PRO 0.305 39.8 tttt -58.88 -23.01 60.45 Favored 'General case' 1 N--CA 1.545 4.322 1 CA-C-N 126.332 4.151 . . . . 0.0 103.759 -172.288 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.08 -0.39 47.21 Favored 'General case' 0 N--CA 1.514 2.758 1 CA-C-N 129.349 5.522 . . . . 0.0 117.413 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . 0.646 10.3 m-20 -120.61 14.01 11.76 Favored 'General case' 0 C--N 1.268 -2.954 2 O-C-N 135.991 8.307 . . . . 0.0 103.365 -175.071 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.74 141.37 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.271 3 CA-C-O 137.606 8.336 . . . . 0.0 105.238 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.386 0.4 OUTLIER -113.47 -22.45 10.34 Favored 'General case' 1 N--CA 1.555 4.823 1 O-C-N 108.57 -8.831 . . . . 0.0 110.347 176.139 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . 0.425 88.0 m -136.18 141.16 44.02 Favored 'General case' 0 C--O 1.285 2.962 0 CA-C-N 121.209 1.822 . . . . 0.0 110.225 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -109.88 124.79 51.97 Favored 'General case' 0 C--O 1.301 3.799 1 CA-C-O 111.483 -4.103 . . . . 0.0 108.953 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -109.41 95.9 5.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 101.5 -3.519 . . . . 0.0 101.5 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.05 134.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.379 1.878 0 O-C-N 127.614 3.071 . . . . 0.0 109.96 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.4 m -106.1 123.13 47.53 Favored 'General case' 0 CA--C 1.588 2.438 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -101.83 118.46 36.97 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-O 111.866 -3.921 . . . . 0.0 109.569 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.15 150.44 24.83 Favored 'General case' 0 N--CA 1.528 3.47 1 O-C-N 131.187 5.305 . . . . 0.0 101.832 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . 0.381 . . -79.96 -23.87 41.35 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -94.15 -175.4 39.24 Favored Glycine 1 N--CA 1.378 -5.207 3 CA-C-N 129.905 5.775 . . . . 0.0 115.328 -174.701 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . 0.301 16.2 t -124.88 134.09 52.83 Favored 'General case' 1 C--O 1.31 4.277 1 CA-C-N 107.317 -4.442 . . . . 0.0 111.115 -177.068 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -128.08 159.83 33.85 Favored 'General case' 0 C--O 1.252 1.204 0 O-C-N 116.543 -3.848 . . . . 0.0 105.331 -165.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.524 54.5 tt0 -98.28 141.18 31.5 Favored 'General case' 1 C--O 1.309 4.191 1 CA-C-O 129.832 4.634 . . . . 0.0 106.636 177.274 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . -172.29 -160.18 20.3 Favored Glycine 0 CA--C 1.563 3.067 2 O-C-N 107.586 -9.446 . . . . 0.0 109.146 173.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.99 2.85 2.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 110.135 -3.033 . . . . 0.0 115.265 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 m -135.13 132.25 37.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -119.74 157.76 27.9 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.4 144.79 56.31 Favored 'General case' 0 CA--C 1.609 3.239 3 CA-C-N 105.611 -5.268 . . . . 0.0 104.867 172.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.7 146.05 99.02 Favored Pre-proline 1 C--O 1.135 -4.966 1 CA-C-O 135.756 7.455 . . . . 0.0 103.147 175.523 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.334 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 13.7 Cg_endo -65.18 132.77 32.85 Favored 'Trans proline' 2 C--N 1.543 10.791 2 C-N-CA 108.318 -7.321 . . . . 0.0 119.123 176.682 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.28 4.1 mt -129.93 162.23 29.09 Favored 'General case' 1 C--O 1.334 5.517 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 -177.622 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.389 49.3 t30 -79.53 90.29 5.1 Favored 'General case' 2 N--CA 1.594 6.767 1 CA-C-O 107.702 -5.904 . . . . 0.0 105.417 176.881 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -57.66 -35.6 70.77 Favored 'General case' 0 C--O 1.189 -2.118 2 CA-C-N 134.87 8.032 . . . . 0.0 105.383 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.313 41.9 m-20 -66.14 -25.79 67.13 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -170.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.347 90.9 m-20 -82.93 4.33 26.18 Favored 'General case' 1 CA--C 1.708 7.05 3 O-C-N 114.002 -5.436 . . . . 0.0 113.237 178.38 . . . . . . . . 4 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 158' ' ' TRP . 74.6 m-85 -132.72 157.97 43.56 Favored 'General case' 0 C--N 1.311 -1.069 1 O-C-N 132.034 5.834 . . . . 0.0 105.95 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 m -112.31 137.99 49.65 Favored 'General case' 1 C--O 1.345 6.122 1 CA-C-O 106.395 -6.526 . . . . 0.0 112.842 173.026 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -80.06 112.4 17.33 Favored 'General case' 0 N--CA 1.379 -3.999 1 CA-C-N 133.54 7.427 . . . . 0.0 106.718 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.68 -39.49 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.36 0 O-C-N 118.496 -2.628 . . . . 0.0 112.889 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . 0.587 3.8 t -139.44 146.57 40.25 Favored 'General case' 0 C--N 1.383 2.051 0 O-C-N 116.665 -3.772 . . . . 0.0 102.421 -169.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.342 47.8 t -145.82 132.01 19.45 Favored 'General case' 1 C--O 1.323 4.924 0 CA-C-N 112.247 -2.252 . . . . 0.0 106.907 172.662 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 142' ' ' ARG 0.304 33.7 ttp85 -135.92 130.81 34.32 Favored 'General case' 2 CA--C 1.647 4.703 2 O-C-N 112.806 -6.184 . . . . 0.0 96.221 -178.121 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.5 m -107.94 133.57 52.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.839 2.257 . . . . 0.0 116.821 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.41 124.05 72.53 Favored 'Isoleucine or valine' 1 CA--C 1.633 4.137 0 O-C-N 116.501 -3.874 . . . . 0.0 106.777 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 1.581 ' CG ' ' CB ' ' A' ' 145' ' ' GLU 0.315 18.7 mt-10 -98.08 141.87 30.48 Favored 'General case' 0 CA--C 1.467 -2.231 2 C-N-CA 110.682 -4.407 . . . . 0.0 104.29 -177.755 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.29 153.94 30.03 Favored 'General case' 1 CA--C 1.657 5.096 1 O-C-N 115.222 -4.674 . . . . 0.0 107.317 -179.104 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 p -70.81 -18.94 62.72 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 121.686 2.039 . . . . 0.0 112.598 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -94.07 116.07 65.98 Favored Pre-proline 3 C--O 1.107 -6.429 2 CA-C-O 136.976 8.036 . . . . 0.0 95.722 163.267 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 1.367 ' N ' ' CD ' ' A' ' 149' ' ' PRO 0.335 96.9 Cg_endo -69.78 -11.37 30.68 Favored 'Trans proline' 2 C--N 1.507 8.881 2 C-N-CA 103.344 -10.637 . . . . 0.0 119.26 178.229 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.27 68.22 Favored 'General case' 0 C--N 1.271 -2.84 3 C-N-CA 135.185 5.394 . . . . 0.0 105.655 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' A' ' 151' ' ' LEU 0.484 93.7 mt -94.85 -18.42 21.2 Favored 'General case' 0 C--N 1.406 3.041 2 O-C-N 111.771 -6.831 . . . . 0.0 113.917 -166.219 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.1 m -54.4 127.82 29.05 Favored 'General case' 1 CA--C 1.645 4.599 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 173.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -139.09 158.74 43.65 Favored 'General case' 0 N--CA 1.533 3.722 0 O-C-N 127.748 3.155 . . . . 0.0 113.971 -171.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.2 m -126.62 126.61 43.88 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -89.9 119.76 30.55 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -117.25 146.09 43.51 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.16 120.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 2 CA-C-O 106.942 -6.266 . . . . 0.0 107.233 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 136' ' ' PHE . 54.3 m95 -120.23 141.88 49.53 Favored 'General case' 0 N--CA 1.395 -3.209 1 O-C-N 133.37 6.669 . . . . 0.0 106.661 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -129.24 142.12 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 127.899 3.714 . . . . 0.0 103.799 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -64.23 123.91 20.34 Favored 'General case' 0 CA--C 1.583 2.241 0 C-N-CA 129.04 2.936 . . . . 0.0 109.435 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -56.76 152.8 11.74 Favored 'General case' 1 C--O 1.314 4.481 1 CA-C-O 110.545 -4.55 . . . . 0.0 115.316 177.446 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . 0.463 . . . . . . . 3 C--O 1.389 8.447 3 CA-C-N 134.387 7.812 . . . . 0.0 108.214 166.123 . . . . . . . . 3 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' BDM . . . . . 0.739 HN41 ' HA ' ' A' ' 5' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_